Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
Date: 2007-12-04
Institutions: European Commission
Subjects: chemical product, market approval, marketing standard, plant health control, plant health product

11.12.2007

EN

Official Journal of the European Union

L 325/3

COMMISSION REGULATION (EC) No 1451/2007

of 4 December 2007

on the second phase of the 10-year work programme referred to in Article 16(2) of Directive
98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products
on the market

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(3)

Having regard to the Treaty
Community,

establishing the European

Having regard to Directive 98/8/EC of the European Parliament
and of the Council of 16 February 1998 concerning the placing
of biocidal products on the market (1), and in particular Article
16(2) thereof,

Whereas:

(1)

Pursuant to Directive 98/8/EC, Member States may only
authorise the placing on the market of biocidal products
containing active substances included in Annex I, IA or
IB to that Directive. However, under the transitional
measures provided for
in Article 16(1) of Directive
98/8/EC Member States may allow the placing on the
market of biocidal products containing active substances
IA or IB to Directive 98/8/EC
not listed in Annex I,
which were already on the market on 14 May 2000,
hereinafter
to
paragraph 2 of that same Article, a 10-year programme
of work is to be carried out for the review of all existing
active substances. This programme of work was intended
to identify the existing active substances and determine
those to be evaluated under the review programme with
a view to their possible inclusion in Annex I, IA or IB to
Directive 98/8/EC.

substances’. Pursuant

‘existing active

(2)

The initial phase of the programme was laid down in
Commission Regulation (EC) No 1896/2000 of 7
September 2000 on the first phase of the programme
referred to in Article 16(2) of Directive 98/8/EC of the
European Parliament and of
the Council on biocidal
products (2).

(1) OJ L 123, 24.4.1998, p. 1. Directive as last amended by Directive

2007/47/EC (OJ L 247, 21.9.2007, p. 21).

(4)

(5)

(6)

(7)

Under Regulation (EC) No 1896/2000, existing active
substances for use in biocidal products had to be identi-
fied, and those to be evaluated with a view to their
IA or IB to Directive
possible inclusion in Annex I,
types had to be
98/8/EC in one or more product
notified no later than 28 March 2002.

Commission Regulation (EC) No 2032/2003 of 4
November 2003 on the second phase of the 10-year
work programme
referred to in Article 16(2) of
Directive 98/8/EC of the European Parliament and of
the Council concerning the placing of biocidal products
on the market, and amending Regulation (EC) No
1896/2000 (3)
existing active
substances. That list covered active substances that had
been identified in accordance with Article 3(1) or Article
5(2) of Regulation (EC) No 1896/2000 or in respect of
which equivalent information had been submitted in a
notification in accordance with Article 4(1) of that Regu-
lation.

established a

list of

Regulation (EC) No 2032/2003 also established,
in
Annex II, an exhaustive list of existing active substances
to be evaluated under the review programme. That list
covered active substances in respect of which at least one
notification had been accepted in accordance with Article
4(2) of Regulation (EC) No 1896/2000 or in which a
Member State had expressed an interest in accordance
with Article 5(3) of that Regulation. That list specified
the product types concerned.

substances or

substance/product

Regulation (EC) No 2032/2003 allowed for a number of
active
type combi-
nations that were not originally covered by the review
programme, to be examined on the same conditions as
review
the
active
programme,
operators
submitted complete dossiers before 1 March 2006.

substances
provided

evaluated under

interested

that

the

Article 4(2) of Regulation (EC) No 2032/2003 set 1
September 2006 as
the date from which products
containing active substances not examined under the
review programme should be withdrawn from the
market.

(2) OJ L 228, 8.9.2000, p. 6. Regulation as amended by Regulation

(3) OJ L 307, 24.11.2003, p. 1. Regulation as last amended by Regu-

(EC) No 2032/2003 (OJ L 307, 24.11.2003, p. 1).

lation (EC) No 1849/2006 (OJ L 355, 15.12.2006, p. 63).

L 325/4

EN

Official Journal of the European Union

11.12.2007

(8)

(9)

(10)

Article 4(3) of Regulation (EC) No 2032/2003 provided
that the existing active substances that had not been
identified by the persons using them in biocidal
products were to be deemed not to have been placed
for biocidal purposes before 14 May
on the market
assimilation to new active
2000. However,
substances
the
unlawfully non-identified existing active substances may
benefit
from a provisional authorisation or from the
longer data protection period reserved to genuinely
new active substances. Whereas a clarification in that
sense should be added to that provision.

should not be taken to mean that

this

and

feasible

alternatives

economically

Regulation (EC) No 2032/2003 introduced the possibility
for Member States to apply for a derogation for biocidal
products containing identified existing active substances
that are not examined under the review programme,
which Member States claim are essential for reasons of
health, safety, or protection of cultural heritage or critical
for the functioning of society in the absence of tech-
nically
or
substitutes that are acceptable from the standpoint of
environment or health. Such derogation is granted to
the requesting Member States only if the requests are
justified,
to
concerns for human health and the environment, and
if, where appropriate, alternatives are being developed.
It is appropriate to continue to allow Member States to
apply for such a derogation, including in respect of an
active substance which it has been decided not to include
in Annex I, IA or IB to Directive 98/8/EC. Since the
review programme referred to in Article 16(2) of
Directive 98/8/EC runs only until 14 May 2010, any
such derogation should not continue beyond that date.

continued use does not give

rise

if

the

For

that

that

these

Certain substances or products
are normally
consumed by humans or animals for their subsistence
to repel harmful
may also be used to attract or
organisms.
general
is
there
substances,
agreement
authorisation/registration
requirements of Directive 98/8/EC seem unjustified and
that they should be expressly excluded from its scope.
Considering that a revision of Directive 98/8/EC will take
a significant amount of time during which the viability of
those products on the market might be irreversibly
affected,
it is appropriate to postpone their withdrawal
from the market until 14 May 2010.

(11) A Member State which has indicated an interest

in
seeking review of a particular active substance should
not be designated Rapporteur Member State for that
substance.

(12)

(13)

to act

collectively,

testing involving vertebrate animals,

In order to avoid duplication of work, and in particular
to reduce
the
requirements concerning preparation and submission of
the complete dossier should be such as to encourage
those whose notifications have been accepted, hereinafter
‘participants’,
in particular by
submitting collective dossiers. It should be possible for
the Rapporteur Member State to make available the
reference to any test involving vertebrate animals that
has been carried out in respect of a notified existing
reference is confidential
active substance unless that
under Article 19 of Directive 98/8/EC. Also,
in order
to gain experience on the appropriateness of data
requirements and to ensure that
the review of active
substances is carried out in a cost-effective way, par-
ticipants should be encouraged to provide information
on the costs of compiling a dossier and on the need to
carry out tests on vertebrate animals.

early
in order

to avoid delays, participants

should start
In order
as possible with Rapporteur
discussions
as
Member States
in
to resolve uncertainties
relation to data requirements. Applicants, other than
participants, who wish to apply in accordance with
Article 11 of Directive 98/8/EC for inclusion in Annex
I, IA or IB thereto of an active substance/product type
combination
review
evaluated
programme should submit complete dossiers for that
combination no earlier or no later than participants so
as not to disturb the smooth functioning of the review
programme or create a disadvantage to the participants.

under

being

the

(14)

The requirements concerning the content and format of
dossiers and the number of dossiers to be submitted
should be defined.

(15)

Provision should be made for cases in which a parti-
cipant is joined by a producer, formulator or association
and in which a participant withdraws from the review
programme.

(16)

formulators or associations

should within
Producers,
certain time limits have the opportunity of taking over
the role of participant for an existing active substance/
product type combination in respect of which all parti-
cipants have withdrawn or none of the dossiers meets
the requirements. Subject
it
should also be possible in certain circumstances for
Member States to indicate an interest and act as a parti-
cipant for the inclusion in Annex I, IA or IB to Directive
98/8/EC of such a combination.

to the same time-limits,

11.12.2007

EN

Official Journal of the European Union

L 325/5

(17)

(18)

(19)

the opportunity to
In order to discourage abuse of
maintain an active substance on the market while it is
examined under the review programme,
it should be
possible for another person or a Member State to take
over the role of participant only once in relation to a
given active substance/product type combination. For the
same purpose, a person or Member State taking over the
role of participant should provide within a certain period
evidence of commencing work on a complete dossier.

for

the dossiers.

should be specified within which the
Time limits
Rapporteur Member States must verify the completeness
of
in exceptional
It should be possible,
circumstances,
the Rapporteur Member States to
establish a new deadline for the submission of parts of
a dossier, in particular where the participant has demon-
strated that it was impossible to submit information in
due time or in order to resolve uncertainties regarding
data requirements that remain despite earlier discussions
between the participant and the Rapporteur Member
State.

substance,

each existing active

For
the Rapporteur
Member State should examine and evaluate the dossier
and present the results to the Commission and the other
Member States in the form of a competent authority
report and a recommendation as to the decision to be
taken with regard to the active substance concerned. In
order not to prolong decision-making unnecessarily, the
the same time
Rapporteur Member State should at
consider carefully the need for additional studies. For
the same reason, Rapporteur Member States should be
obliged to take into consideration information submitted
after acceptance of
the dossier only under specified
conditions.

(22)

(23)

(24)

(25)

(20)

The competent authority reports should be examined by
the other Member States before the assessment reports
are submitted to the Standing Committee on Biocidal
Products.

access

to ensure better

to information,
In order
assessment reports should be drafted on the basis of
the reports submitted by the competent authorities of
the Member States and should be covered by the same
rules regarding access to information as the reports of
the competent authorities. The assessment reports should
be derived from the original competent authority report
as amended in the light of all the documents, comments
and information taken into account during the evaluation
process.

It should be possible to suspend the procedures provided
for in this Regulation in the light of the application of
other Community acts, in particular as regards Council
Directive 76/769/EEC of 27 July 1976 on the approx-
regulations and administrative
imation of
provisions of the Member States relating to restrictions
on the marketing
certain dangerous
and use of
substances and preparations (1), and after 1 June 2009,
as regards Title VIII and Annex XVII of Regulation
(EC) No 1907/2006.

the laws,

In order to ensure the most efficient course of the review
programme, a number of active substance/product type
combinations
different
rapporteur Member States. These developments should
be reflected in Annex II of this Regulation.

reassigned

been

have

to

the

substances,

Regulation (EC) No 2032/2003 has been amended on
several occasions (2) in order to take into consideration
lessons learned
the accession of new Member States,
review
implementation to date of
from the
programme, and in particular in order to provide for
IA or IB to Directive
the non-inclusion in Annex I,
98/8/EC of a number of active
either
because the requisite information was not submitted
in cases where the
within the prescribed period or
requirements of Article 10 of the said Directive were
not satisfied. This practice of constantly updating Regu-
lation (EC) No 2032/2003 in order
to follow the
the review programme has proven inef-
evolution of
fectual and time-consuming; furthermore it could create
confusion to stakeholders as to which rules apply and
which active substances are currently under review. In
the interest of clarity,
is preferable to repeal and
replace Regulation (EC) No 2032/2003 by a new
lay down the rules for the
simplified act which will
the Commission should
review programme, and that
adopt
future non-inclusion
decisions.

separate

acts

the

for

it

IA or

(21) Where, despite a recommendation for inclusion of an
active substance in Annex I,
IB to Directive
98/8/EC, concerns as referred to in Article 10(5) of
that Directive remain,
the
but without
into
take
Commission
prejudice to Article 12 of that Directive, the finalisation
of
the evaluation on other existing active substances
applied for the same use. Provision should be made for
Rapporteur Member
competent
to
authority reports where necessary.

it should be possible for

account,

update

States

to

(1) OJ L 262, 27.9.1976, p. 201. Directive as last amended by Directive
the Council

the European Parliament and of

2007/51/EC of
(OJ L 257, 3.10.2007, p. 13).

(2) By Regulation (EC) No 1048/2005 (OJ L 178, 9.7.2005, p. 1); and
Regulation (EC) No 1849/2006, (OJ L 355, 15.12.2006, p. 63).

L 325/6

EN

Official Journal of the European Union

11.12.2007

(26)

The measures provided for in this Regulation are in
accordance with
Standing
Committee on Biocidal Products,

opinion

the

the

of

HAS ADOPTED THIS REGULATION:

Article 1

Subject matter

This Regulation lays down detailed rules for the implementation
of the programme of work for the systematic examination of all
active substances already on the market on 14 May 2000 as
active substances of biocidal products, hereinafter ‘the review
programme’, referred to in Article 16(2) of Directive 98/8/EC.

Article 2

Definitions

For the purposes of this Regulation the definitions in Article 2
of Directive 98/8/EC and Article 2 of Regulation (EC) No
1896/2000 shall apply.

‘participant’ means a producer, formulator or as-
In addition,
sociation which has submitted a notification that has been
accepted by the Commission in accordance with Article 4(2)
of Regulation (EC) No 1896/2000 or a Member State which has
indicated an interest in accordance with Article 5(3) of that
Regulation.

Article 3

Existing active substances

1.
The list of active substances identified as available on the
market before 14 May 2000 as active substances of biocidal
products for purposes other than those referred to in Article
2(2)(c) and (d) of Directive 98/8/EC is set out in Annex I.

The exhaustive list of existing active substances to be
2.
examined under the review programme is set out in Annex II.

The list includes the following active substances:

(b) existing active substances that were not notified, but in
respect of which a Member State has indicated an interest
in supporting their inclusion in Annex I,
IA or IB to
Directive 98/8/EC;

(c) existing active substances that were not notified, but for
the Member
which a dossier was submitted to one of
States by 1 March 2006, which was found to comply
with the requirements of Annex III to this Regulation and
was accepted as complete.

types

The list specifies, for each existing active substance included, the
in respect of which the substance will be
product
the
examined under
review programme, as well as
Rapporteur Member State designated to carry out
the
evaluation.

the

Article 4

Non-inclusion

1. Without prejudice to Articles 5 and 6 of this Regulation
and paragraph 2 of this Article, biocidal products containing
active substances not listed in Annex II to this Regulation or in
Annex I or IA to Directive 98/8/EC shall no longer be placed
on the market.

In the case of an active substance listed in Annex II to this
Regulation,
the first subparagraph shall also apply to that
substance in relation to any product type not listed in that
Annex.

2.
Biocidal products containing active substances listed in
Annex II to this Regulation for which a decision was taken
to include these active substances for certain or all of
not
types in Annex I or IA to Directive
their notified product
98/8/EC, shall no longer be placed on the market
for the
product types concerned, with effect from 12 months after
the date of such a measure being published, unless otherwise
stipulated therein.

(a) existing active substances notified in accordance with Article
4(1) of Regulation (EC) No 1896/2000 or Article 4(2) of
Commission Regulation (EC) No 1687/2002 (1);

(1) OJ L 258, 26.9.2002, p. 15.

3. Without prejudice to Articles 12(1)(b) and 15(2) of
Directive 98/8/EC, from the day of entry into force of this
Regulation, any active substance not listed in Annex I shall be
deemed not to have been placed on the market for biocidal
purposes before 14 May 2000.

11.12.2007

EN

Official Journal of the European Union

L 325/7

Article 5

Derogation for essential use

The Member States concerned shall annually inform the
4.
Commission on the application of paragraph 3 and in particular
on the actions taken pursuant to point (e).

1. Member States may apply to the Commission for a dero-
gation from Article 4(1) where they consider that an active
substance is essential for them for reasons of health, safety or
protection of cultural heritage or is critical for the functioning
of society, and where there are no available technically and
economically
are
alternatives or
acceptable from the standpoint of environment and health.

substitutes

feasible

that

Applications shall be accompanied by a document stating the
reasons and justifications.

2.
The applications referred to in paragraph 1 shall be
forwarded by the Commission to the other Member States
and shall be made publicly available by electronic means.

5. Member States may at any time review the approvals of
biocidal products for which the period of placing on the market
has been extended in accordance with paragraph 3. Whenever
there is reason to believe that any of the conditions set in
points (a) to (e) of that paragraph are no longer satisfied, the
Member States concerned shall without undue delay take steps
to remedy the situation or if that is not possible, withdraw the
approvals of the biocidal products concerned.

Article 6

Food and Feed

Member States or any person may for a period of 60 days
following reception of an application submit comments in
writing to the Commission.

By way of derogating from Article 4(1), Member States may
the placing on the
allow until 14 May 2010 at
market of active substances consisting solely of food or feed
that are intended for use as repellents or attractants of product
type 19.

the latest

of

the

Taking

account

the
3.
Commission may grant
a derogation from Article 4(1)
allowing the placing of the substance on the market of the
requesting Member States until 14 May 2010 at the latest,
provided that the Member States:

comments

received,

(a) ensure that continued use is possible only if products
containing the substance are approved for the intended
essential use;

‘food or feed’ means any
For the purposes of this derogation,
edible substance or product of plant or animal origin, whether
processed, partially processed or unprocessed, which is intended
or reasonably expected to be ingested by humans or animals;
this
individual
comprise
substances isolated from food or feed.

category does not

extracts or

(b) conclude that, taking into account all available information,
it is reasonable to assume that continued use does not have
any unacceptable effect on human or animal health or on
the environment;

(c)

impose all appropriate risk reduction measures when
granting approval;

Article 7

Examination of existing active substances under the review
programme

The review of an active substance listed in Annex II, in
1.
respect of the product types specified, shall be undertaken by
the Rapporteur Member State designated for that purpose on
the basis of the complete dossier for that substance/product
type combination, provided that:

(d) ensure that such approved biocidal products remaining on
the market after 1 September 2006 are relabelled in order
to match the use conditions laid down by the Member
States in accordance with this paragraph; and

(a)

the dossier complies with the requirements set out in Annex
III to this Regulation;

(e) ensure that, where appropriate, alternatives for such uses are
being sought by the holders of the approvals or the Member
States concerned, or a dossier
is being prepared for
submission in accordance with the procedure laid down
in Article 11 of Directive 98/8/EC by 14 May 2008 at
the latest.

(b) the

is

complete dossier

submitted within the period
specified in Article 9 of this Regulation for the product
type
summary dossier
together with the
referred to in Article 11(1)(b) of Directive 98/8/EC and
defined in Annex III to this Regulation.

concerned,

L 325/8

EN

Official Journal of the European Union

11.12.2007

An active substance listed in Annex II to this Regulation shall
be reviewed exclusively in relation to the product types specified
therein.

(d) when informed by the Rapporteur Member State that
another participant has notified plans to carry out
the
same tests, make all reasonable efforts to cooperate with
that participant in the performance of common testing.

For the active substance/product type combinations referred to
in Article 3(2)(c), with the exception of product types 8 and 14,
the evaluation of the dossiers shall commence at the same time
as the evaluation of dossiers for active substances contained in
the same product types.

Advice given by Rapporteur Member States in accordance with
point (b) of the first subparagraph shall not predetermine the
outcome of the completeness check under Article 13(1).

A Member State which has

2.
in
supporting the inclusion of an active substance in Annex I,
IA or IB to the Directive shall not be designated as Rapporteur
Member State in respect of that substance.

indicated an interest

3. Without prejudice to Articles 10, 11 and 12 of this Regu-
lation, persons other than participants may apply, in accordance
with Article 11 of Directive 98/8/EC, for the inclusion in Annex
I, IA or IB thereto of an existing active substance/product type
combination that is listed in Annex II to this Regulation. These
persons shall submit in that case a complete dossier within the
time period specified in Article 9 for that substance/product
type combination.

Article 8

Preparation of the complete dossier

1.
In the preparation of the complete dossier, all reasonable
efforts shall be made, inter alia, to avoid duplication of testing
on vertebrate animals and, where appropriate, to establish a
collective complete dossier.

3.
A Rapporteur Member State may make available the
reference to any test carried out on vertebrate animals in
respect of an active substance listed in Annex II to this Regu-
lation, save where that reference is to be treated as confidential
in accordance with Article 19 of Directive 98/8/EC. Such
reference may include the name of
the active substance
concerned,
the tests, and the contact
address of the data owner.

the end points of

4. Where a Rapporteur Member State is aware that more
than one participant is seeking review of a particular active
substance, it shall inform those participants accordingly.

Participants seeking review of the same active substance
5.
for the same product types shall undertake all reasonable efforts
to submit a collective complete dossier, while fully respecting
the Community rules on competition.

Where,
is not
in those circumstances, a collective dossier
submitted, each individual dossier shall detail the efforts made
to secure cooperation and the reasons for non-participation.

Before commencing compilation of the complete dossier,

2.
a participant shall:

Details shall be given in the complete dossier and in the
6.
summary dossier of the efforts made to avoid duplication of
testing on vertebrate animals.

(a)

inform the Rapporteur Member State of any testing on
vertebrate animals that it has already carried out;

(b) contact the Rapporteur Member State for advice as to the
acceptability of justifications for waiving certain studies;

7.
In order to provide information on the costs entailed in
applying for review and on the need for animal testing for the
purposes of compiling the complete dossier, participants may
submit
to the Rapporteur Member State together with the
complete dossiers a breakdown of the costs of the respective
actions and studies carried out.

(c)

inform the Rapporteur Member State of any intention to
carry out
further testing on vertebrate animals for the
purposes of the complete dossier;

The Rapporteur Member State shall communicate that infor-
mation to the Commission when submitting the competent
authority report in accordance with Article 14(4).

11.12.2007

EN

Official Journal of the European Union

L 325/9

Information on the costs entailed in compiling the
8.
complete dossier and on the animal testing carried out for
that purpose shall be included in the report referred to in
Article 18(5) of Directive 98/8/EC together with any appro-
concerning modifications of data
priate
requirements in order to reduce to a minimum the need for
testing on vertebrate animals, and to ensure cost-effectiveness
and proportionality.

recommendations

Article 9

Submission of the complete dossier

Unless otherwise indicated by the Rapporteur Member
1.
State, a participant shall submit to the Rapporteur Member
State one paper and one electronic copy of
the complete
dossier.

The participant shall also,
in accordance with Article 13(3),
submit one paper and one electronic copy of the summary
dossier to the Commission and to each of the other Member
States. However, any Member State wishing to receive copies
only in electronic format or additional copies shall inform the
Commission, which shall make that
information publicly
available by electronic means. If the Member State subsequently
inform the Commission without
decides otherwise,
undue delay, whereupon the Commission shall update
accordingly the information made publicly available.

it shall

For the existing active substances listed in Annex II,
competent
State within the

2.
complete dossiers must be
authority of
following periods:

the Rapporteur Member

received by

the

(a)

for product types 8 and 14, until 28 March 2004;

(b) for product types 16, 18, 19 and 21, from 1 November

2005 until 30 April 2006;

(c)

for product types 1, 2, 3, 4, 5, 6 and 13, from 1 February
2007 until 31 July 2007;

(d) for product types 7, 9, 10, 11, 12, 15, 17, 20, 22 and 23,

from 1 May 2008 until 31 October 2008.

Article 10

Joining and replacing of participants

Where, by mutual agreement, a producer, formulator or as-
sociation joins or replaces a participant for the purposes of
submitting the complete dossier, all parties to the agreement

jointly inform the Commission and the Rapporteur
letter of

shall
Member State accordingly, attaching any relevant
access.

The Commission shall inform accordingly any other participant
seeking review of the same active substance in relation to the
same product types.

Article 11

Withdrawal of participants

review programme,

1. Where a participant intends to discontinue participation in
the
relevant
Rapporteur Member State and the Commission accordingly, in
writing and without delay, stating the reasons.

inform the

shall

they

The Commission shall
inform accordingly the other Member
States and any other participant seeking review of the same
active substance in relation to the same product type(s).

2. Where all the participants have withdrawn as regards a
particular existing active substance/product type combination,
inform the Member States thereof and
the Commission shall
shall publish that information electronically.

Article 12

Taking over the role of participant

1. Within three months of the electronic publication of the
information referred to in Article 11(2), a producer, formulator,
association or other person may inform the Commission of
their intention to take over the role of participant as regards
the existing active substance/product type combination.

Within the time period referred to in the first subparagraph, a
Member State may also indicate to the Commission an interest
in taking over the role of participant in order to support the
IA or IB to Directive 98/8/EC of the
inclusion in Annex I,
existing active substance/product
type combination, where
there are uses which the Member State considers essential, in
particular for the protection of human health, animal health or
the environment.

The person or Member State wishing to take over the role
the participant who has withdrawn shall, within three
intention,
that work to compile a complete

2.
of
months of
provide evidence to it
dossier has been commissioned.

informing the Commission of

their

L 325/10

EN

Official Journal of the European Union

11.12.2007

On the basis of the evidence referred to in paragraph 2,
3.
the Commission shall decide whether or not
to allow the
interested person or Member State to take over the role of
participant.

delay communicate its concerns to the Rapporteur Member
State, the Commission and the other Member States.

Where the Commission allows the interested person or Member
State to take over the role of participant,
it may decide to
extend, if necessary, the relevant period for the submission of
a complete dossier specified in Article 9.

The taking over of the role of participant for a given
type combination may be

4.
existing active substance/product
allowed only once.

5. Where the Commission receives no response pursuant to
paragraph 1, it shall take a decision not to include the existing
IA or IB to Directive 98/8/EC
active substance in Annex I,
the
within the framework of
product type(s) concerned.

the review programme for

Article 13

Completeness check of dossiers

1. Within three months of receiving the dossier for an
type combination and no
existing active substance/product
time
later than three months after the end of
period specified in Article 9(2) of
the
Rapporteur Member State shall verify whether the dossier is
to be accepted as
in accordance with Article
11(1)(b) of Directive 98/8/EC.

the relevant
this Regulation,

complete

Where the Rapporteur Member State has initiated consultations
with other Member States and the Commission in relation to
the acceptability of a dossier, the period may be prolonged until
consultations have been finalised, up to a maximum of six
months from receipt of the dossier.

2.
A Rapporteur Member State may require, as a condition
for considering a dossier to be complete, proof of advance
payment,
the charges payable under
Article 25 of Directive 98/8/EC to be provided in the dossier.

in full or in part, of

the
is considered to be complete,
3. Where a dossier
the
Rapporteur Member State shall confirm acceptance of
dossier
to the participant
forwarding the summary dossier to the Commission and the
other Member States within one month of receiving the confir-
mation.

to the participant

and agree

The Rapporteur Member State shall immediately take up consul-
tations with that Member State and the Commission in order to
discuss the concern expressed and resolve divergent opinions.

In exceptional circumstances,

4.
the Rapporteur Member
State may establish a new deadline for the submission of infor-
mation which, for reasons duly substantiated, the participant
was unable to submit in due time.

The participant shall, within three months of being informed of
the new deadline, provide evidence to the Rapporteur Member
State that work to provide the missing information has been
commissioned.

If the Rapporteur Member State considers that it has received
sufficient evidence, it shall carry out its evaluation in accordance
with Article 14 as if the dossier were complete. Otherwise, the
evaluation shall not commence until the missing information is
submitted.

5. Where a complete dossier is not received within the
period specified in Article 9 or by a new deadline established
in accordance with paragraph 4, the Rapporteur Member State
shall inform the Commission, giving the reasons put forward by
the participant by way of justification.

also

shall

The Rapporteur Member
inform the
State
Commission in cases where a participant fails to provide the
evidence required in accordance with the second subparagraph
of paragraph 4. In the cases referred to in the first and second
subparagraphs and if no other dossier concerns the same
existing active substance/product type combination, all parti-
cipants shall be deemed to have withdrawn and Articles 11(2)
and 12 shall apply mutatis mutandis.

Article 14

Evaluation of dossiers by the Rapporteur Member State

1. Where the Rapporteur Member State considers a dossier
to be complete, it shall carry out the evaluation within twelve
months of accepting the dossier in accordance with Article
11(2) of Directive 98/8/EC and shall prepare a report on that
evaluation, hereinafter ‘the competent authority report’.

If a Member State in receipt of a summary dossier has legitimate
reason to believe that the dossier is incomplete, it shall without

Without prejudice to Article 12 of Directive 98/8/EC,
Rapporteur Member State may take
relevant
scientific
properties of the active substance, metabolites or residues.

the
into account other
information regarding the

technical or

11.12.2007

EN

Official Journal of the European Union

L 325/11

At the request of a participant, the Rapporteur Member
2.
State may take into account additional information relating to
an active substance for which the dossier has been accepted as
complete only if the following conditions are fulfilled:

A Rapporteur Member State may decide to withhold the
5.
competent authority report if the charges payable under Article
25 of Directive 98/8/EC have not been paid in full, in which
case it
inform the participant and the Commission
accordingly.

shall

(a)

the participant informed the Rapporteur Member State, at
the time of submission of the dossier, that preparation of
the additional information was under way;

(b) the additional information is submitted no later than nine
months after acceptance of the dossier in accordance with
Article 13(3);

(c) by comparison with the data originally submitted, the ad-
ditional information is equally or more reliable owing to the
application of the same or higher quality standards;

(d) by comparison with the data originally submitted, the ad-
ditional
conclusion
concerning the active substance for the purposes of the
recommendation under paragraph 6.

information supports

different

a

The Rapporteur Member State shall take into account additional
information submitted by persons other than the participant
in
only if
points (b), (c) and (d) of the first subparagraph.

information satisfies the conditions set out

that

in the application of paragraph 1,

in
3. Where relevant
particular when additional information has been requested by
a deadline established by the Rapporteur Member State, the
latter may request
submit updated
summary dossiers to the Commission and the other Member
States when the additional information is received.

the participant

that

All participants shall be deemed to have withdrawn and Articles
11(2) and 12 shall apply mutatis mutandis if:

(a)

the additional information is not received by the deadline;

(b) the participant

fails to provide adequate justification for

further postponing the deadline;

(c) no other dossier concerns the same existing active sub-

stance/product type combination.

The Rapporteur Member State shall, without undue delay,
4.
send a copy of
to the
Commission, the other Member States and to the participant.

the competent authority report

All participants shall be deemed to have withdrawn and Articles
11(2) and 12 shall apply mutatis mutandis if:

(a)

full payment is not received within three months of the date
of receipt of that information;

(b) no other dossier concerns the same existing active sub-

stance/product type combination.

The competent authority report shall be presented in a
to be recommended by the Commission and shall

6.
format
include one of the following:

(a) a recommendation to include the existing active substance
in Annex I, IA or IB to Directive 98/8/EC, stating, where
appropriate, conditions for inclusion;

(b) a recommendation not
substance in Annex I,
stating the reasons.

to include the existing active
IB to Directive 98/8/EC,
IA or

Article 15

Commission procedures

1. When the Commission receives a competent authority
to Article 14(4) of this Regulation it shall,
report pursuant
without undue delay, prepare the draft decision referred to in
Article 27 of Directive 98/8/EC.

Before preparing the draft decision referred to in
2.
paragraph 1,
the Commission shall, when necessary in the
light of the comments received on the competent authority
report, consult with experts
to
address any problems remaining unresolved. Where necessary
and upon a request
the Rapporteur
Member State shall prepare an updated competent authority
report.

from the Member States

from the Commission,

L 325/12

EN

Official Journal of the European Union

11.12.2007

3. Where an existing active substance, despite a recommen-
dation for inclusion pursuant to Article 14(6) of this Regulation,
still gives rise to concern, as referred to in Article 10(5) of
Directive 98/8/EC, the Commission may, without prejudice to
Article 12 of that Directive, take into account the finalisation of
the evaluation of other existing active substances applied for the
same use.

the first part of which shall

On the basis of the documents and information referred
4.
to in Article 27(2) of Directive 98/8/EC,
the Rapporteur
Member State shall prepare an updated competent authority
report,
form the assessment
report. The assessment report shall be reviewed within the
Standing Committee on Biocidal Products. Where several
dossiers have been submitted for the same active substance/
product type combination, the Rapporteur Member State shall
prepare one assessment
report based on the information
contained in those dossiers.

Article 16

Access to information

a Rapporteur Member State has

submitted the
Where
competent authority report in accordance with Article 14(4)
of this Regulation, or where an assessment report has been
finalised or updated in the Standing Committee on Biocidal
the Commission shall make the report or any
Products,
updates thereof publicly available by electronic means, except
for
in
is
accordance with Article 19 of Directive 98/8/EC.

to be treated as confidential

information that

Article 17

Suspension of procedures

the Commission presents a proposal

Where, in respect of an active substance listed in Annex II to
for
this Regulation,
amending Directive 76/769/EEC or, with effect from 1 June
2009, Annex XVII of Regulation (EC) No 1907/2006 in order
to prohibit its placing on the market or its use, including use
for biocidal purposes,
the
procedures provided for in this Regulation concerning that
substance for use in the product
types concerned may be
suspended pending a decision on that proposal.

in certain or all product

types,

Article 18

Repeal

Regulation (EC) No 2032/2003 is repealed.

References to the repealed Regulation shall be construed as
references to this Regulation.

Article 19

Entry into force

This Regulation shall enter into force on the 20th day following
its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 4 December 2007.

For the Commission

Stavros DIMAS
Member of the Commission

11.12.2007

EN

Official Journal of the European Union

L 325/13

ANNEX I

ACTIVE SUBSTANCES IDENTIFIED AS EXISTING

Name (EINECS and/or others)

EC number

CAS number

Formaldehyde

Ergocalciferol/Vitamin D2

Lactic acid

Clofenotane/DDT

Ascorbic acid

2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide

2,4-dinitrophenol

2-imidazol-4-ylethylamine

Bronopol

Trichlorfon

Sodium salicylate

Fenthion

Glycerol trinitrate

Bis(tributyltin) oxide

Tributyltin acetate

Coumaphos

Glycerol

Chlorhexidine diacetate

Allyl isothiocyanate

Cetrimonium bromide/Hexadecyltrimethylammonium bromide

Urea

Strychnine

Propane-1,2-diol

Ethinylestradiol

Caffeine

Diphenoxarsin-10-yl oxide

Gamma-HCH or Gamma-BHC/Lindane/1,2,3,4,5,6-hexachlorocyclohexane

Sulfaquinoxaline

Chlorocresol

2-phenylethanol

Dimethoate

Methylthioninium chloride

Thiourea

Dichlorvos

Carbaryl

Ethanol

Formic acid

Acetic acid

200-001-8

200-014-9

200-018-0

200-024-3

200-066-2

200-076-7

200-087-7

200-100-6

200-143-0

200-149-3

200-198-0

200-231-9

200-240-8

200-268-0

200-269-6

200-285-3

200-289-5

200-302-4

200-309-2

200-311-3

200-315-5

200-319-7

200-338-0

200-342-2

200-362-1

200-377-3

200-401-2

200-423-2

200-431-6

200-456-2

200-480-3

200-515-2

200-543-5

200-547-7

200-555-0

200-578-6

200-579-1

200-580-7

50-00-0

50-14-6

50-21-5

50-29-3

50-81-7

51-03-6

51-28-5

51-45-6

52-51-7

52-68-6

54-21-7

55-38-9

55-63-0

56-35-9

56-36-0

56-72-4

56-81-5

56-95-1

57-06-7

57-09-0

57-13-6

57-24-9

57-55-6

57-63-6

58-08-2

58-36-6

58-89-9

59-40-5

59-50-7

60-12-8

60-51-5

61-73-4

62-56-6

62-73-7

63-25-2

64-17-5

64-18-6

64-19-7

L 325/14

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Benzoic acid

Propan-2-ol

Chloroform/Trichloromethane

Colecalciferol

Salicylic acid

Hexachlorophene

Propan-1-ol

Butan-1-ol

Methoxychlor

Bromomethane/Methyl bromide

Hydrogen cyanide

Metaldehyde

Carbon disulfide

Ethylene oxide

Iodoform/Triiodomethane

Tert-butyl hydroperoxide

Trichloronitromethane

Bornan-2-one/Campher

(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-
2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo[de,g]chromene-1,5,11-trione/
Quassin

1,3-dibromo-5,5-dimethylhydantoin

3-beta-hydroxyurs-12-en-28-oic acid/Ursolic acid

Citric acid

Citric acid monohydrate

1,3,4,5-tetrahydroxycyclohexanecarboxylic acid

Linalool

2-methylpropan-1-ol

2-chloroacetamide

Bromoacetic acid

Propionic acid

Chloroacetic acid

Glycollic acid

Peracetic acid

L-(+)-lactic acid

p-(1,1-dimethylpropyl)phenol

Pin-2(3)-ene

Sennoside A

Warfarin

Coumachlor

Diphacinone

Ethyl quinine carbonate

200-618-2

200-661-7

200-663-8

200-673-2

200-712-3

200-733-8

200-746-9

200-751-6

200-779-9

200-813-2

200-821-6

65-85-0

67-63-0

67-66-3

67-97-0

69-72-7

70-30-4

71-23-8

71-36-3

72-43-5

74-83-9

74-90-8

200-836-8

9002-91-9

200-843-6

200-849-9

200-874-5

200-915-7

200-930-9

200-945-0

200-985-9

201-030-9

201-034-0

201-069-1

75-15-0

75-21-8

75-47-8

75-91-2

76-06-2

76-22-2

76-78-8

77-48-5

77-52-1

77-92-9

201-069-1

5949-29-1

201-072-8

201-134-4

201-148-0

201-174-2

201-175-8

201-176-3

201-178-4

201-180-5

201-186-8

201-196-2

201-280-9

201-291-9

201-339-9

201-377-6

201-378-1

201-434-5

201-500-3

77-95-2

78-70-6

78-83-1

79-07-2

79-08-3

79-09-4

79-11-8

79-14-1

79-21-0

79-33-4

80-46-6

80-56-8

81-27-6

81-81-2

81-82-3

82-66-6

83-75-0

11.12.2007

EN

Official Journal of the European Union

L 325/15

Name (EINECS and/or others)

EC number

CAS number

(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxy-
chromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone

201-501-9

83-79-4

Anthraquinone

Dibutyl phthalate

Salicylanilide

(+)-tartaric acid

Pentachlorophenol

Symclosene

Chloroxylenol

2,4,6-trichlorophenol

Menthol

Isopulegol

Thymol

Guaiacol/2-methoxyphenol

Biphenyl-2-ol

Naphthalene

Propyl 4-hydroxybenzoate

Butyl 4-hydroxybenzoate

Dibenzoyl peroxide

2-ethylhexane-1,3-diol

Benzotriazole

3-chloropropane-1,2-diol

Dichlorophen

Eugenol

Allantoin

Methyl 4-hydroxybenzoate

Benzyl alcohol

2,2′-[(1,1,3-trimethylpropane-1,3-diyl)bis(oxy)]bis[4,4,6-trimethyl-1,3,2-dioxa-
borinane]

Methenamine/Hexamethylenetetramine

Triclocarban

Chlorpropham

1,1′,1″,1‴!-ethylenedinitrilotetrapropan-2-ol

2,2′,2″-nitrilotriethanol

Chlorphenesin

Anethole

Cinnamaldehyde/3-phenyl-propen-2-al

2-ethylhexan-1-ol/Isooctanol

Citronellol

Citronellal

Geraniol

1,4-dichlorobenzene

201-549-0

201-557-4

201-727-8

201-766-0

201-778-6

201-782-8

201-793-8

201-795-9

201-939-0

201-940-6

201-944-8

201-964-7

201-993-5

202-049-5

202-307-7

202-318-7

202-327-6

202-377-9

202-394-1

202-492-4

202-567-1

202-589-1

202-592-8

202-785-7

202-859-9

202-899-7

202-905-8

202-924-1

202-925-7

203-041-4

203-049-8

203-192-6

203-205-5

203-213-9

203-234-3

203-375-0

203-376-6

203-377-1

203-400-5

84-65-1

84-74-2

87-17-2

87-69-4

87-86-5

87-90-1

88-04-0

88-06-2

89-78-1

89-79-2

89-83-8

90-05-1

90-43-7

91-20-3

94-13-3

94-26-8

94-36-0

94-96-2

95-14-7

96-24-2

97-23-4

97-53-0

97-59-6

99-76-3

100-51-6

100-89-0

100-97-0

101-20-2

101-21-3

102-60-3

102-71-6

104-29-0

104-46-1

104-55-2

104-76-7

106-22-9

106-23-0

106-24-1

106-46-7

L 325/16

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Ethylendiamine

Chloro-acetaldehyde

Ethane-1,2-diol

Glyoxal

Methyl formate

Butane-1,3-diol

Vinyl acetate

Acetic anhydride

m-Cresol

Resorcinol

Cyanuric acid

Phenol

Ethyl formate

Succinic acid

Hexa-2,4-dienoic acid/Sorbic acid

Pyridine

Morpholine

Glutaral

2-Butoxyethanol

203-468-6

107-15-3

203-472-8

107-20-0

203-473-3

107-21-1

203-474-9

107-22-2

203-481-7

107-31-3

203-529-7

107-88-0

203-545-4

108-05-4

203-564-8

108-24-7

203-577-9

108-39-4

203-585-2

108-46-3

203-618-0

108-80-5

203-632-7

108-95-2

203-721-0

109-94-4

203-740-4

110-15-6

203-768-7

110-44-1

203-809-9

110-86-1

203-815-1

110-91-8

203-856-5

111-30-8

203-905-0

111-76-2

Cetrimonium chloride/Hexadecyl-trimethylammoniumchloride

203-928-6

112-02-7

Nonanoic acid

Undecan-2-one/Methyl-nonyl-ketone

2,2′-(ethylenedioxy)diethanol/Triethylene-glycol

Undec-10-enoic acid

Oleic acid

(Z)-docos-13-enoic acid

203-931-2

112-05-0

203-937-5

112-12-9

203-953-2

112-27-6

203-965-8

112-38-9

204-007-1

112-80-1

204-011-3

112-86-7

N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide

204-029-1

113-48-4

Propoxur

Endosulfan

1,7,7-trimethylbicyclo[2.2.1]hept-2-yl thiocyanatoacetate

Dicofol

Linalyl acetate

3,3′,4′,5,7-pentahydroxyflavone

1,3-dichloro-5,5-dimethylhydantoin

Methyl salicylate

Clorophene

Ethyl 4-hydroxybenzoate

Benzyl benzoate

Piperonal

Indole

204-043-8

114-26-1

204-079-4

115-29-7

204-081-5

115-31-1

204-082-0

115-32-2

204-116-4

115-95-7

204-187-1

117-39-5

204-258-7

118-52-5

204-317-7

119-36-8

204-385-8

120-32-1

204-399-4

120-47-8

204-402-9

120-51-4

204-409-7

120-57-0

204-420-7

120-72-9

11.12.2007

EN

Official Journal of the European Union

L 325/17

Name (EINECS and/or others)

EC number

CAS number

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-
methyl-3-oxoprop-1-enyl)-cyclopropanecarboxylate/Cinerin II

204-454-2

121-20-0

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)],3.beta.]]-
chrysanthemate/Pyrethrin I

204-455-8

121-21-1

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)](3.beta.)-
3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate/
Pyrethrin II

204-462-6

121-29-9

Benzethonium chloride

5-nitrothiazol-2-ylamine

Malathion

Fenitrothion

Cetalkonium chloride

Benzyldimethyl(octadecyl)ammonium chloride

Simazine

Propham

4-Phenylbutanone

2-Phenoxyethanol

Cetylpyridinium chloride

204-479-9

204-490-9

204-497-7

204-524-2

204-526-3

204-527-9

204-535-2

204-542-0

204-555-1

204-589-7

204-593-9

121-54-0

121-66-4

121-75-5

122-14-5

122-18-9

122-19-0

122-34-9

122-42-9

122-57-6

122-99-6

123-03-5

Cetylpyridinium chloride monohydrate

204-593-9

6004-24-6

2-Ethylhexanal

Pyridazine-3,6-diol/Maleic hydrazide

Adipic acid

Octanoic acid

Dodecylamine/Laurylamine

Carbon dioxide

Sodium dimethylarsinate

Exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol

Nitromethylidynetrimethanol

Sodium acetate

Sodium N-chlorobenzenesulphonamide

Tosylchloramide sodium

Bis(2,3,3,3-tetrachloropropyl) ether

Potassium dimethyldithiocarbamate

Sodium dimethyldithiocarbamate

N-bromosuccinimide

N-chlorosuccinimide

2,6-di-tert-butyl-p-cresol

Warfarin sodium

Dimethyl phthalate

Sodium pentachlorophenolate

Sodium 2-biphenylate

Sodium 2-biphenylate tetrahydrate

Captan

204-596-5

204-619-9

204-673-3

204-677-5

204-690-6

204-696-9

204-708-2

204-712-4

204-769-5

204-823-8

204-847-9

204-854-7

204-870-4

204-875-1

204-876-7

204-877-2

204-878-8

204-881-4

204-929-4

205-011-6

205-025-2

205-055-6

123-05-7

123-33-1

124-04-9

124-07-2

124-22-1

124-38-9

124-65-2

124-76-5

126-11-4

127-09-3

127-52-6

127-65-1

127-90-2

128-03-0

128-04-1

128-08-5

128-09-6

128-37-0

129-06-6

131-11-3

131-52-2

132-27-4

205-055-6

6152-33-6

205-087-0

133-06-2

L 325/18

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

N-(trichloromethylthio)phthalimide/Folpet

2,4-Dichloro-3,5-xylenol

Methyl anthranilate

Bis(8-hydroxyquinolinium) sulphate

N,N-diethyl-m-toluamide

Dipropyl pyridine-2,5-dicarboxylate

Zinc bis(2-ethylhexanoate)

6-methylbenzotriazole

Thiram

Ziram

Sodium propionate

Potassium methyldithiocarbamate

Metam-sodium

Dipentene

Disodium cyanodithiocarbamate

Benzododecinium chloride

Miristalkonium chloride

Nitrilo triacetic acid

p-tolyl acetate

1,3-bis(hydroxymethyl)urea

Sodium formate

2,3-dihydroxypropyl laurate

Nabam

Hexanoic acid

Lauric acid

Potassium oleate

Sodium hydrogencarbonate

Oxalic acid

Quinolin-8-ol

Thiabendazole

Benzothiazole-2-thiol

Monuron

Rutoside

Glyoxylic acid

Fenchlorphos

Naled

5-chlorosalicylic acid

Diuron

Potassium thiocyanate

Diazinon

Decanoic acid

Cyanamide

205-088-6

205-109-9

205-132-4

205-137-1

205-149-7

205-245-9

205-251-1

205-265-8

205-286-2

205-288-3

205-290-4

205-292-5

205-293-0

205-341-0

205-346-8

205-351-5

205-352-0

205-355-7

205-413-1

205-444-0

205-488-0

205-526-6

205-547-0

205-550-7

205-582-1

205-590-5

205-633-8

205-634-3

205-711-1

205-725-8

205-736-8

205-766-1

205-814-1

206-058-5

206-082-6

206-098-3

206-283-9

206-354-4

206-370-1

206-373-8

206-376-4

206-992-3

133-07-3

133-53-9

134-20-3

134-31-6

134-62-3

136-45-8

136-53-8

136-85-6

137-26-8

137-30-4

137-40-6

137-41-7

137-42-8

138-86-3

138-93-2

139-07-1

139-08-2

139-13-9

140-39-6

140-95-4

141-53-7

142-18-7

142-59-6

142-62-1

143-07-7

143-18-0

144-55-8

144-62-7

148-24-3

148-79-8

149-30-4

150-68-5

153-18-4

298-12-4

299-84-3

300-76-5

321-14-2

330-54-1

333-20-0

333-41-5

334-48-5

420-04-2

11.12.2007

EN

Official Journal of the European Union

L 325/19

Name (EINECS and/or others)

EC number

CAS number

Metronidazole

Cineole

7,8-dihydroxycoumarin

Sodium carbonate

2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one

Carvacrol

6.beta.-acetoxy-3beta-(beta.-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-
trienolide/Scilliroside

Barium carbonate

3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione

Osalmid

2,6-Dimethoxy-p-benzoquinone

Acridine-3,6-diamine dihydrochloride

Sodium benzoate

Dazomet

Trisodium hydrogendicarbonate/Sodium sesquicarbonate

Silver carbonate

Crimidine

Calcium diformate

Myristic acid

1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one

1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-
7,14-dione/Hypericum perforatum

[4-[4,4′-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]
dimethylammonium chloride

Zinc dibenzoate

Methyl isothiocyanate

4,4′-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride

[4-[alpha-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]
dimethylammonium chloride/Malachite green chloride

Potassium benzoate

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-
(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio: 1:1:1:1:1:1:1:1)/
Allethrin

Sodium 3-(p-anilinophenylazo)benzenesulphonate/Metanil yellow

DL-lactic acid

BHC or HCH/Hexachlorocyclohexane

DL-malic acid

N-(hydroxymethyl)acetamide

Succinaldehyde

2-fluoroacetamide

Phthalaldehyde

2-hydroxyethanesulphonic acid, compound with 4,4′-[hexane-1,6-diylbis(oxy)]bis
[benzenecarboxamidine] (2:1)

207-136-1

207-431-5

207-632-8

207-838-8

207-880-7

207-889-6

208-077-4

208-167-3

208-293-9

208-385-9

208-484-7

208-515-4

208-534-8

208-576-7

208-580-9

208-590-3

208-622-6

208-863-7

208-875-2

208-912-2

208-941-0

443-48-1

470-82-6

486-35-1

497-19-8

499-44-5

499-75-2

507-60-8

513-77-9

520-45-6

526-18-1

530-55-2

531-73-7

532-32-1

533-74-4

533-96-0

534-16-7

535-89-7

544-17-2

544-63-8

546-80-5

548-04-9

208-953-6

548-62-9

209-047-3

209-132-5

209-321-2

209-322-8

209-481-3

209-542-4

209-608-2

209-954-4

210-168-9

210-514-9

210-897-2

211-333-8

211-363-1

211-402-2

211-533-5

553-72-0

556-61-6

569-61-9

569-64-2

582-25-2

584-79-2

587-98-4

598-82-3

608-73-1

617-48-1

625-51-4

638-37-9

640-19-7

643-79-8

659-40-5

Tetrahydro-2,5-dimethoxyfuran

211-797-1

696-59-3

L 325/20

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

N-[(dichlorofluoromethyl)thio]phthalimide

Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/
Tolylfluanid

Levonorgestrel

Hydroxyl-2-pyridone

2,6-dimethyl-1,3-dioxan-4-yl acetate

Terbutryn

Proflavine hydrochloride

N′1-quinoxalin-2-ylsulphanilamide, sodium salt

Norbormide

(hydroxymethyl)urea

Dichlofluanid

Copper thiocyanate

Dodecyltrimethylammonium bromide

Tetradonium bromide

(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-
3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin

4,5-dichloro-3H-1,2-dithiol-3-one

Xylenol

Bentonite

Diarsenic pentaoxide

Diboron trioxide

211-952-3

211-986-9

212-349-8

212-506-0

212-579-9

212-950-5

213-459-9

213-526-2

213-589-6

719-96-0

731-27-1

797-63-7

822-89-9

828-00-2

886-50-0

952-23-8

967-80-6

991-42-4

213-674-8

1000-82-4

214-118-7

1085-98-9

214-183-1

1111-67-7

214-290-3

1119-94-4

214-291-9

1119-97-7

214-619-0

1166-46-7

214-754-5

1192-52-5

215-089-3

1300-71-6

215-108-5

1302-78-9

215-116-9

1303-28-2

215-125-8

1303-86-2

Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime

215-137-3

1305-62-0

Calcium oxide/lime/burnt lime/quicklime

Potassium hydroxide

Sodium hydroxide

Silicic acid, potassium salt/Potassium silicate

Zinc oxide

Trizinc diphosphide

Zinc sulphide

Trimanganese tetraoxide

Copper oxide

Dicopper oxide

Cresol

Aluminum chloride, basic

Disodium tetraborate, anhydrous

Disodium tetraborate decahydrate

Dicopper chloride trihydroxide

Chromium trioxide

Sodium hydrogendifluoride

Naphthenic acids, copper salts

2-Butanone, peroxide

215-138-9

1305-78-8

215-181-3

1310-58-3

215-185-5

1310-73-2

215-199-1

1312-76-1

215-222-5

1314-13-2

215-244-5

1314-84-7

215-251-3

1314-98-3

215-266-5

1317-35-7

215-269-1

1317-38-0

215-270-7

1317-39-1

215-293-2

1319-77-3

215-477-2

1327-41-9

215-540-4

1330-43-4

215-540-4

1303-96-4

215-572-9

1332-65-6

215-607-8

1333-82-0

215-608-3

1333-83-1

215-657-0

1338-02-9

215-661-2

1338-23-4

11.12.2007

EN

Official Journal of the European Union

L 325/21

Name (EINECS and/or others)

EC number

CAS number

Naphthenic acids

Ammonium hydrogendifluoride

Silicic acid, sodium salt

Copper(II) chloride

N,N″-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine
dihydrochloride

Monolinuron

2,4-dichlorobenzyl alcohol

Ethacridine lactate

4,4′-(2-ethyl-2-nitropropane-1,3-diyl)bismorpholine

Chlorothalonil

Dodecylammonium acetate

Fluometuron

Allyl propyl disulphide

4-(2-nitrobutyl)morpholine

N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine

Didecyldimethylammonium bromide

Tolnaftate

Bis[[4-[4-(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethyl-
ammonium] oxalate, dioxalate

Dodine

2-bromo-1-(4-hydroxyphenyl)ethan-1-one

2,2′-dithiobis[N-methylbenzamide]

2,2′-[methylenebis(oxy)]bisethanol

Phenthoate

1,2-benzisothiazol-3(2H)-one

215-662-8

1338-24-5

215-676-4

1341-49-7

215-687-4

1344-09-8

215-704-5

1344-67-8

216-994-6

1715-30-6

217-129-5

1746-81-2

217-210-5

1777-82-8

217-408-1

1837-57-6

217-450-0

1854-23-5

217-588-1

1897-45-6

217-956-1

2016-56-0

218-500-4

2164-17-2

218-550-7

2179-59-1

218-748-3

2224-44-4

219-145-8

2372-82-9

219-234-1

2390-68-3

219-266-6

2398-96-1

219-441-7

2437-29-8

219-459-5

2439-10-3

219-655-0

2491-38-5

219-768-5

2527-58-4

219-891-4

2565-36-8

219-997-0

2597-03-7

220-120-9

2634-33-5

2,2′-[(1-methylpropane-1,3-diyl)bis(oxy)]bis[4-methyl-1,3,2-dioxaborinane]

220-198-4

2665-13-6

2-methyl-2H-isothiazol-3-one

Sulphuryl difluoride

2-Amino-3-chloro-1,4-naphthoquinone

2-chloro-N-(hydroxymethyl)acetamide

Troclosene sodium

Sodium dichloroisocyanurate dihydrate

Chlorpyrifos

Mecetronium ethyl sulphate

Dodecylethyldimethylammonium ethyl sulphate

Bis(trichloromethyl) sulphone

Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate

4-isopropyl-m-cresol

Copper dinitrate

Triclosan

Temephos

220-239-6

2682-20-4

220-281-5

2699-79-8

220-529-2

2797-51-5

220-598-9

2832-19-1

220-767-7

2893-78-9

220-767-7

51580-86-0

220-864-4

2921-88-2

221-106-5

3006-10-8

221-108-6

3006-13-1

221-310-4

3064-70-8

221-416-0

3088-31-1

221-761-7

3228-02-2

221-838-5

3251-23-8

222-182-2

3380-34-5

222-191-1

3383-96-8

L 325/22

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Thuj-4(10)-ene

Oct-1-ene-3-ol

Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]
phenoxy]benzenesulphonate

(ethylenedioxy)dimethanol

Chlorophacinone

Dipyrithione

Chlorhexidine dihydrochloride

Denatonium benzoate

Sodium 2,4,6-trichlorophenolate

Pyridine-2-thiol 1-oxide, sodium salt

Hexahydro-1,3,5-tris(3-methoxypropyl)-1,3,5-triazine

222-212-4

3387-41-5

222-226-0

3391-86-4

222-654-8

3567-25-7

222-720-6

3586-55-8

223-003-0

3691-35-8

223-024-5

3696-28-4

223-026-6

3697-42-5

223-095-2

3734-33-6

223-246-2

3784-03-0

223-296-5

3811-73-2

223-563-6

3960-05-2

4-oxo-4-[(tributylstannyl)oxy]but-2-enoic acid/Tributyltin maleate

223-701-5

4027-18-3

Methenamine 3-chloroallylochloride

N-ethylheptadecafluorooctanesulphonamide

Isobutyl 4-hydroxybenzoate/Isobutyl parabene

Tributylstannyl salicylate/Tributyltin salicylate

Tributylstannyl benzoate/Tributyltin benzoate

223-805-0

4080-31-3

223-980-3

4151-50-2

224-208-8

4247-02-3

224-397-7

4342-30-7

224-399-8

4342-36-3

Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethanolate

224-580-1

4418-26-2

Diethylammonium salicylate

Dimethyl dicarbonate

Farnesol

2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol

Octylphosphonic acid

Sodium 4-(methoxycarbonyl)phenolate

Sulphamidic acid

Citral

Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-
dione

224-586-4

4419-92-5

224-859-8

4525-33-1

225-004-1

4602-84-0

225-208-0

4719-04-4

225-218-5

4724-48-5

225-714-1

5026-62-0

226-218-8

5329-14-6

226-394-6

5392-40-5

226-408-0

5395-50-6

1-benzyl-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride

226-445-2

5400-93-1

Dimethyldioctylammonium chloride

N-dodecylpropane-1,3-diamine

Chlorpyrifos-methyl

N,N′-methylenebismorpholine

Coumatetralyl

Terbuthylazine

(R)-p-mentha-1,8-diene

4-methoxybenzene-1,3-diamine sulphate

Methylene dithiocyanate

226-901-0

5538-94-3

226-902-6

5538-95-4

227-011-5

5598-13-0

227-062-3

5625-90-1

227-424-0

5836-29-3

227-637-9

5915-41-3

227-813-5

5989-27-5

228-290-6

6219-67-6

228-652-3

6317-18-6

1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione

229-222-8

6440-58-0

Dodicin

Malic acid

229-930-7

6843-97-6

230-022-8

6915-15-7

11.12.2007

EN

Official Journal of the European Union

L 325/23

Name (EINECS and/or others)

EC number

CAS number

(2-bromo-2-nitrovinyl)benzene

Didecyldimethylammonium chloride

(Z)-N-9-octadecenylpropane-1,3-diamine

Benzyldodecyldimethylammonium bromide

Prometryn

Silver

Boron

Copper

Zinc

Sulphur dioxide

Dithallium sulphate

Calcium dihexa-2,4-dienoate

Quinine monohydrochloride dihydrate

Iodine

Iodine in the form of iodophor

Iodine complex in solution with non-ionic detergents

Polyvinylpyrrolidone iodine

Alkylaryl polyether alcohol-iodine complex

Iodine complex with ethylene-propylene block co-Polymer (pluronic)

Iodine complex with poly alkylenglycol

Iodinated Resin/Polyiodide Anion Resin

Trisodium orthophosphate (TSP)

Silicon dioxide — amorphous

Sodium hydrogensulphite

Sodium nitrite

Sodium peroxometaborate/Sodium perborate hydrate

Hydrogen chloride/Hydrochloric acid

Sodium chloride

Sodium bromide

Orthophosphoric acid

Hydrogen fluoride

Ammonia, anhydrous

Sulphuric acid

Potassium iodide

Sodium hydrogensulphate

Sodium fluoride

Sodium hypochlorite

Disodium disulphite

Tetramethrin

Sulphur

Iron sulphate

230-515-8

7166-19-0

230-525-2

7173-51-5

230-528-9

7173-62-8

230-698-4

7281-04-1

230-711-3

7287-19-6

231-131-3

7440-22-4

231-151-2

7440-42-8

231-159-6

7440-50-8

231-175-3

7440-66-6

231-195-2

7446-09-5

231-201-3

7446-18-6

231-321-6

7492-55-9

231-437-7

6119-47-7

231-442-4

7553-56-2

39392-86-4

25655-41-8

Mixture

Mixture

Polymer

Polymer

Polymer

Polymer

Polymer

231-509-8

7601-54-9

231-545-4

7631-86-9

231-548-0

7631-90-5

231-555-9

7632-00-0

231-556-4

7632-04-4

231-595-7

7647-01-0

231-598-3

7647-14-5

231-599-9

7647-15-6

231-633-2

7664-38-2

231-634-8

7664-39-3

231-635-3

7664-41-7

231-639-5

7664-93-9

231-659-4

7681-11-0

231-665-7

7681-38-1

231-667-8

7681-49-4

231-668-3

7681-52-9

231-673-0

7681-57-4

231-711-6

7696-12-0

231-722-6

7704-34-9

231-753-5

7720-78-7

Iron vitriol/Ferrous sulphate heptahydrate/Iron sulphate heptahydrate

231-753-5

7782-63-0

L 325/24

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Potassium permanganate

Hydrogen peroxide

Bromine

Dipotassium peroxodisulphate

Nitrogen

Zinc sulphate heptahydrate

7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole

Sodium sulphite

Sodium chlorite

Copper chloride

Copper sulphate

Copper sulphate pentahydrate

Silver nitrate

Sodium thiosulphate pentahydrate

Sodium chlorate

Disodium peroxodisulphate/Sodium persulphate

Potassium dichromate

Calcium hypochlorite

Hexahydro-1,3,5-triethyl-1,3,5-triazine

Chlorine

Ammonium sulphate

Silver chloride

Aluminium ammonium bis(sulphate)

Manganese sulphate

Manganese sulphate tetrahydrate

Iodine monochloride

Terpineol

Soybean oil

Linseed oil

Corn oil

Coconut oil

Creosote

Castor oil

Bone oil/Animal oil

Rape oil

Pyrethrins and Pyrethroids

Terpinol

Turpentine oil

Garlic ext.

Tar, pine/Pine wood tar

Beeswax

Paraffin oils

231-760-3

7722-64-7

231-765-0

7722-84-1

231-778-1

7726-95-6

231-781-8

7727-21-1

231-783-9

7727-37-9

231-793-3

7446-20-0

231-810-4

7747-35-5

231-821-4

7757-83-7

231-836-6

7758-19-2

231-842-9

7758-89-6

231-847-6

7758-98-7

231-847-6

7758-99-8

231-853-9

7761-88-8

231-867-5

10102-17-7

231-887-4

7775-09-9

231-892-1

7775-27-1

231-906-6

7778-50-9

231-908-7

7778-54-3

231-924-4

7779-27-3

231-959-5

7782-50-5

231-984-1

7783-20-2

232-033-3

7783-90-6

232-055-3

7784-25-0

232-089-9

7785-87-7

232-089-9

10101-68-5

232-236-7

7790-99-0

232-268-1

8000-41-7

232-274-4

8001-22-7

232-278-6

8001-26-1

232-281-2

8001-30-7

232-282-8

8001-31-8

232-287-5

8001-58-9

232-293-8

8001-79-4

232-294-3

8001-85-2

232-299-0

8002-13-9

232-319-8

8003-34-7

—

8006-39-1

232-350-7

8006-64-2

232-371-1

8008-99-9

232-374-8

8011-48-1

232-383-7

8012-89-3

232-384-2

8012-95-1

11.12.2007

EN

Official Journal of the European Union

L 325/25

Name (EINECS and/or others)

EC number

CAS number

Oils, avocado

Orange, sweet, ext.

White mineral oil (petroleum)

Saponins

Tall-oil rosin

Asphalt/Bitumen

Copals

Lignin

Aluminium sulphate

Boric acid

Aluminium potassium bis(sulphate)/Alum

Chlorine dioxide

Potassium sulphite

Sodium hydrogen 2,2′methylenebis[4-chlorophenolate]

2,2-dibromo-2-cyanoacetamide

Disilver(1+) sulphate

Sodium metaphosphate

Oxine-copper

Resmethrin

N,N′-ethylenebis[N-acetylacetamide]

Sodium dichromate

Carbendazim

Tridecasodium hypochloritetetrakis(phosphate)

Natural boric acid

Sodium perborate tetrahydrate

Perboric acid, sodium salt

Naphthenic acids, zinc salts

Disodium octaborate

Disodium octaborate tetrahydrate

[2H4]ammonium chloride

Dialuminium chloride pentahydroxide

Trimagnesium diphosphide

Sodium toluenesulphonate

Copper(II) carbonate-copper(II) hydroxide (1:1)

Zineb

Ammonium bromide

Tetraboron disodium heptaoxide, hydrate

Maneb

Hexaboron dizinc undecaoxide/Zinc borate

N-(hydroxymethyl)formamide

2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine

Nifurpirinol

232-428-0

8024-32-6

232-433-8

8028-48-6

232-455-8

8042-47-5

232-462-6

8047-15-2

232-484-6

8052-10-6

232-490-9

8052-42-4

232-527-9

9000-14-0

232-682-2

9005-53-2

233-135-0

10043-01-3

233-139-2

10043-35-3

233-141-3

10043-67-1

233-162-8

10049-04-4

233-321-1

10117-38-1

233-457-1

10187-52-7

233-539-7

10222-01-2

233-653-7

10294-26-5

233-782-9

10361-03-2

233-841-9

10380-28-6

233-940-7

10453-86-8

234-123-8

10543-57-4

234-190-3

10588-01-9

234-232-0

10605-21-7

234-307-8

11084-85-8

234-343-4

11113-50-1

234-390-0

10486-00-7

234-390-0

11138-47-9

234-409-2

12001-85-3

234-541-0

12008-41-2

234-541-0

12280-03-4

234-607-9

12015-14-4

234-933-1

12042-91-0

235-023-7

12057-74-8

235-088-1

12068-03-0

235-113-6

12069-69-1

235-180-1

12122-67-7

235-183-8

12124-97-9

235-541-3

12267-73-1

235-654-8

12427-38-2

235-804-2

12767-90-7

235-938-1

13052-19-2

236-035-5

13108-52-6

236-503-9

13411-16-0

L 325/26

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Pyrithione zinc

Titanium dioxide

Dodecylguanidine monohydrochloride

Barium diboron tetraoxide

Potassium 2-biphenylate

Ammonium tetrafluoroborate

Lithium hypochlorite

Orthoboric acid, sodium salt

Bromine chloride

Zinc bis(diethyldithiocarbamate)

(benzyloxy)methanol

2,2′-oxybis[4,4,6-trimethyl-1,3,2-dioxaborinane]

Phoxim

Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper

Bis(8-hydroxyquinolyl) sulphate, monopotassium salt

Dibromopropionamide

Sodium perborate monohydrate

2,2′-methylenebis(6-bromo-4-chlorophenol)

Chlorotoluron

236-671-3

13463-41-7

236-675-5

13463-67-7

237-030-0

13590-97-1

237-222-4

13701-59-2

237-243-9

13707-65-8

237-531-4

13826-83-0

237-558-1

13840-33-0

237-560-2

13840-56-7

237-601-4

13863-41-7

238-270-9

14324-55-1

238-588-8

14548-60-8

238-749-2

14697-50-8

238-887-3

14816-18-3

238-984-0

14915-37-8

239-133-6

15077-57-3

239-153-5

15102-42-8

239-172-9

10332-33-9

239-446-8

15435-29-7

239-592-2

15545-48-9

Disodium carbonate, compound with hydrogen peroxide (2:3)

239-707-6

15630-89-4

Sodium p-chloro-m-cresolate

Chloralose

1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione

(R)-2-(4-chloro-2-methylphenoxy)propionic acid

Dipotassium disulphite

Methomyl

Disodium hexafluorosilicate

Hexafluorosilicic acid

Benomyl

D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-
2,4,11,13-tetraazatetradecanediamidine (2:1)

O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate

Benzoxonium chloride

Methyl hydroxymethoxyacetate

p-[(diiodomethyl)sulphonyl]toluene

Copper dihydroxide

Disilver oxide

2-butene-1,4-diyl bis(bromoacetate)

Aluminium phosphide

(benzothiazol-2-ylthio)methyl thiocyanate

Tetrachlorvinphos

Bendiocarb

239-825-8

15733-22-9

240-016-7

15879-93-3

240-230-0

16079-88-2

240-539-0

16484-77-8

240-795-3

16731-55-8

240-815-0

16752-77-5

240-934-8

16893-85-9

241-034-8

16961-83-4

241-775-7

17804-35-2

242-354-0

18472-51-0

242-624-8

18854-01-8

243-008-1

19379-90-9

243-271-2

19757-97-2

243-468-3

20018-09-1

243-815-9

20427-59-2

243-957-1

20667-12-3

243-962-9

20679-58-7

244-088-0

20859-73-8

244-445-0

21564-17-0

244-865-4

22248-79-9

245-216-8

22781-23-3

11.12.2007

EN

Official Journal of the European Union

L 325/27

Name (EINECS and/or others)

EC number

CAS number

2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-
1-enyl)cyclopropanecarboxylate/Prallethrin

245-387-9

23031-36-9

Potassium (E,E)-hexa-2,4-dienoate

2-tert-Butyl-4-methoxyphenol

Bis(hydroxymethyl)urea

246-376-1

24634-61-5

246-563-8

25013-16-5

246-679-9

25155-29-7

.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol

246-764-0

25254-50-6

2,2′-(octadec-9-enylimino)bisethanol

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-
enyl)cyclopropanecarboxylate/Cinerin I

246-807-3

25307-17-9

246-948-0

25402-06-6

3-phenoxybenzyl 2-dimethyl-3-(methylpropenyl)cyclopropanecarboxylate/
Phenothrin

247-404-5

26002-80-2

5-chloro-2-methyl-2H-isothiazol-3-one

2-octyl-2H-isothiazol-3-one

Dodecylbenzenesulphonic acid

Lauric acid, monoester with glycerol

Zinc neodecanoate

Dodecyl(ethylbenzyl)dimethylammonium chloride

Cis-tricos-9-ene

247-500-7

26172-55-4

247-761-7

26530-20-1

248-289-4

27176-87-0

248-337-4

27215-38-9

248-370-4

27253-29-8

248-486-5

27479-28-3

248-505-7

27519-02-4

Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride

248-595-8

27668-52-6

N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine

(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-
1-enyl)-cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin

Bioresmethrin

3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-
benzopyrone/Bromadiolone

Pirimiphos-methyl

Lithium heptadecafluorooctanesulphonate

5-bromo-5-nitro-1,3-dioxane

248-872-3

28159-98-0

249-013-5

28434-00-6

249-014-0

28434-01-7

249-205-9

28772-56-7

249-528-5

29232-93-7

249-644-6

29457-72-5

250-001-7

30007-47-7

Trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate

250-517-2

31218-83-4

(Z,E)-tetradeca-9,12-dienyl acetate

Decyldimethyloctylammonium chloride

Bromochloro-5,5-dimethylimidazolidine-2,4-dione

Amitraz

3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon

2-(hydroxymethylamino)ethanol

N-[3-(dodecylamino)propyl]glycine

2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione, mono-
sodium salt

Sodium 4-ethoxycarbonylphenoxide

Sodium 4-propoxycarbonylphenoxide

250-753-6

30507-70-1 (1)

251-035-5

32426-11-2

251-171-5

32718-18-6

251-375-4

33089-61-1

251-835-4

34123-59-6

251-974-0

34375-28-5

251-993-4

34395-72-7

252-204-6

34769-44-3

252-487-6

35285-68-8

252-488-1

35285-69-9

N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide

252-529-3

35367-38-5

1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil

252-615-0

35554-44-0

(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil

Plant protection
product

73790-28-0

L 325/28

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiopho-
sphate/Azamethiphos

252-626-0

35575-96-3

2-bromo-2-(bromomethyl)pentanedinitrile

Benzyldimethyloleylammonium chloride

Calcium magnesium oxide/dolomitic lime

Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated
dolomitic lime

2-phosphonobutane-1,2,4-tricarboxylic acid

4-methoxy-m-phenylenediammonium sulphate

252-681-0

35691-65-7

253-363-4

37139-99-4

253-425-0

37247-91-9

254-454-1

39445-23-3

253-733-5

37971-36-1

254-323-9

39156-41-7

N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]

254-372-6

39236-46-9

Dinocap

alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropa-
necarboxylate

254-408-0

39300-45-3

254-484-5

39515-40-7

Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate/Methoprene

254-993-2

40596-69-8

Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride

255-451-8

41591-87-1

Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol

4,4-dimethyloxazolidine

(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-cis)-2,2-dimethyl-3-
(2-methylprop-1-enyl)cyclopropanecarboxylate

255-953-7

42822-86-6

257-048-2

51200-87-4

257-144-4

51348-90-4

Cyano (3-phenoxybenzyl)-2-(4-chlorophenyl)-3-methylbutyrate/Fenvalerate

257-326-3

51630-58-1

ethyl N-acetyl-N-butyl-.beta.-alaninate

.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-
carboxylate/Cypermethrin

257-835-0

52304-36-6

257-842-9

52315-07-8

m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/
Permethrin

258-067-9

52645-53-1

.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-
2,2-dimethylcyclopropanecarboxylate/Deltamethrin

258-256-6

52918-63-5

bis(2-ethylhexanoato-O)-.mu.-oxodizinc

1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropa-
necarboxylate/Empenthrin

3-iodo-2-propynyl butylcarbamate

Tetrakis(hydroxymethyl)phosphonium sulphate(2:1)

259-049-3

54262-78-1

259-154-4

54406-48-3

259-627-5

55406-53-6

259-709-0

55566-30-8

3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum

259-978-4

56073-07-5

4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/
Brodifacoum

259-980-5

56073-10-0

[2-(2-butoxyethoxy)ethoxy]methanol

2-ethoxyethyl bromoacetate

N-octyl-N′-[2-(octylamino)ethyl]ethylenediamine

1,2-benzisothiazol-3(2H)-one, sodium salt

Azaconazole

1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/
Propiconazole

N,N-bis(2-hydroxyethyl)undec-10-enamide

2-chloro-3-(phenylsulphonyl)acrylonitrile

Tetradecyldimethylbenzylammonium fluoride

[1,1′-Biphenyl]-2-ol, chlorinated

260-097-2

56289-76-0

260-240-9

56521-73-4

260-725-5

57413-95-3

261-184-8

58249-25-5

262-102-3

60207-31-0

262-104-4

60207-90-1

262-114-9

60239-68-1

262-395-8

60736-58-5

—

61134-95-0

262-974-5

61788-42-9

11.12.2007

EN

Official Journal of the European Union

L 325/29

Name (EINECS and/or others)

EC number

CAS number

Amines, coco alkyl

Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl,
chlorides

262-977-1

61788-46-3

263-005-9

61788-78-1

Quaternary ammonium compounds, coco alkyltrimethyl, chlorides

263-038-9

61789-18-2

Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), chlorides

263-078-7

61789-68-2

Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides

263-080-8

61789-71-7

Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides

263-087-6

61789-77-3

Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl,
chlorides

263-090-2

61789-80-8

Quaternary ammonium compounds, trimethylsoya alkyl, chlorides

263-134-0

61790-41-8

Ethanol, 2,2′-iminobis-, N-coco alkyl derivs.

263-163-9

61791-31-9

1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs.

263-171-2

61791-39-7

Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl,
chlorides

263-185-9

61791-52-4

Amines, N-tallow alkyldipropylenetri-

Amines, N-coco alkyltrimethylenedi-

Amines, N-coco alkyltrimethylenedi-, acetates

263-191-1

61791-57-9

263-195-3

61791-63-7

263-196-9

61791-64-8

Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides

264-151-6

63449-41-2

4,5-dichloro-2-octyl-2H-isothiazol-3-one

264-843-8

64359-81-5

2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide

264-980-3

64628-44-0

Distillates (petroleum), solvent-refined light naphthenic

Distillates (petroleum), hydrotreated light

N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1,3-dimethyl-2,4-dioxopyri-
midine-5-carboxamide

265-098-1

64741-97-5

265-149-8

64742-47-8

265-732-7

65400-98-8

.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dichlorovinyl)-
2,2-dimethylcyclopropanecarboxylate

265-898-0

65731-84-2

Tar acids, coal, crude

Glass powder

3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin

N-cyclopropyl-1,3,5-triazine-2,4,6-triamine

Betaines, C12-C14-alkyl dimethyl

.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopro-
panecarboxylate/Tralomethrin

266-019-3

65996-85-2

266-046-0

65997-17-3

266-235-8

66204-44-2

266-257-8

66215-27-8

266-368-1

66455-29-6

266-493-1

66841-25-6

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0

67129-08-2

Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine

266-719-9

67564-91-4

N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide

266-994-5

67747-09-5

Fatty acids, C16-18 and C18-unsatd., Me esters

.alpha-cyano-3-phenoxybenzyl 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-
dimethyl cyclopropanecarboxylate/Cyhalothrin

Dodecylethyldimethylammonium bromide/Laudacit

Shale oils

.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclo-
propanecarboxylate/Cyfluthrin

267-015-4

67762-38-3

268-450-2

68085-85-8

269-249-2

68207-00-1

269-646-0

68308-34-9

269-855-7

68359-37-5

Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides

269-919-4

68391-01-5

Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides

269-925-7

68391-06-0

L 325/30

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts

270-115-0

68411-30-3

Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides

270-324-7

68424-84-0

Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides

270-325-2

68424-85-1

Betaines, coco alkyldimethyl

270-329-4

68424-94-2

Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides

270-331-5

68424-95-3

Fatty acids, coco, reaction products with diethanolamine

270-430-3

68440-04-0

1-Propanaminium, 3-amino-N,N,N-trimethyl-, N-C12-18 acyl derivs., Me sulfates

271-063-1

68514-93-2

Amides, coco, N,N-bis(2-hydroxyethyl)

Quaternary ammonium compounds, (oxydi-2,1-ethanediyl)bis[coco alkyldimethyl,
dichlorides

9-Octadecenoic acid (Z)-, sulfonated, potassium salts

Urea, reaction products with formaldehyde

Imidazolium compounds, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-
dihydro-2-norcoco alkyl, hydroxides, sodium salts

bis(tetraamminecopper) carbonatedihydroxide

1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with
2-aminoethanol (1:1)

Amines, N-tallowalkyl trimethylenedi-, diacetates

Quassia, ext.

Fatty acids, C8-10

Sulfuric acid, mono-C12-18-alkyl esters, sodium salts

Quaternary ammonium compounds, C12-18-alkyl[(ethylphenyl)methyl]dimethyl,
chlorides

271-657-0

68603-42-9

271-761-6

68607-28-3

271-843-1

68609-93-8

271-898-1

68611-64-3

272-043-5

68650-39-5

272-415-7

68833-88-5

272-574-2

68890-66-4

272-786-5

68911-78-4

272-809-9

68915-32-2

273-086-2

68937-75-7

273-257-1

68955-19-1

273-318-2

68956-79-6

Didecylmethyl[3-(trimethoxysilyl)propyl]ammonium chloride

273-403-4

68959-20-6

Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides

273-544-1

68989-00-4

Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-
benzisothiazol-3(2H)-one 1,1-dioxide (1:1)

273-545-7

68989-01-5

Sodium N-(hydroxymethyl)glycinate

Amines, C10-16-alkyldimethyl, N-oxides

Pentapotassium bis(peroxymonosulphate) bis(sulphate)

274-357-8

70161-44-3

274-687-2

70592-80-2

274-778-7

70693-62-8

N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride

274-861-8

70775-75-6

1,3-didecyl-2-methyl-1H-imidazolium chloride

ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb

274-948-0

70862-65-6

276-696-7

72490-01-8

Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides

277-453-8

73398-64-8

1-[(hydroxymethyl)amino]propan-2-ol

1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxy-
methyl)urea/Diazolidinylurea

278-534-0

76733-35-2

278-928-2

78491-02-8

Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-)

279-013-0

78948-87-5

Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate

279-013-0

114915-85-4

Tributyltetradecylphosphonium chloride

(2-Butoxyethoxy)methanol

Zinc, isodecanoate isononanoate complexes, basic

Juniper, Juniperus communis, ext.

Laurus nobilis, ext.

279-808-2

81741-28-8

281-648-3

84000-92-0

282-786-7

84418-73-5

283-268-3

84603-69-0

283-272-5

84603-73-6

11.12.2007

EN

Official Journal of the European Union

L 325/31

Name (EINECS and/or others)

EC number

CAS number

Rosemary, ext.

Eucalyptus globulus, ext.

Cinnamomum zeylanicum, ext.

Margosa ext.

Lavender, Lavandula angustifolia angustifolia, ext.

Thyme, Thymus serpyllum, ext.

Formaldehyde, reaction products with diethylene glycol

Formamide, reaction products with formaldehyde
Glycine, N-(3-aminopropyl)-, N′-C10-16-alkyl derivs.

Lemon, ext.

Thyme, Thymus vulgaris, ext.

Clove, ext.

Tar acids, polyalkylphenol fraction

Melaleuca alternifolia, ext./Australian Tea Tree Oil

2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-
oxide, sodium salt

Formaldehyde, reaction products with propylene glycol

Stannane, tributyl-, mono(naphthenoyloxy) derivs.

283-291-9

84604-14-8

283-406-2

84625-32-1

283-479-0

84649-98-9

283-644-7

84696-25-3

283-994-0

84776-65-8

284-023-3

84776-98-7

284-062-6

84777-35-5

284-064-7

84777-37-7

284-065-2

84777-38-8

284-515-8

84929-31-7

284-535-7

84929-51-1

284-638-7

84961-50-2

284-893-4

84989-05-9

285-377-1

85085-48-9

286-344-4

85209-91-2

286-695-3

85338-22-3

287-083-9

85409-17-2

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

287-089-1

85409-22-9

Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl,
chlorides

287-090-7

85409-23-0

[R-(Z)]-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]propyltrimethylammonium
methyl sulphate

287-462-9

85508-38-9

Benzenesulfonic acid, 4-C10-13-sec-alkyl derives.

Guanidine, N,N‴-1,3-propanediylbis-, N-coco alkyl derivs., diacetates

Sulfonic acids, C13-17-sec-alkane, sodium salts

.alpha.-cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlor-
ovinyl)-2,2-dimethylcyclopropanecarboxylate

Chrysanthemum cinerariaefolium, ext.

Cymbopogon nardus, ext.

Lavender, Lavandula angustifolia, ext.

Litsea cubeba, ext.

Mentha arvensis, ext.

Pelargonium graveolens, ext.

Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with Me 1H-benzi-
midazol-2-ylcarbamate

Copper, EDTA-complexes

Formaldehyde, reaction products with propanolamine

Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxy
ethoxy)ethanol, ethylene glycol and formaldehyde

287-494-3

85536-14-7

288-198-7

85681-60-3

288-330-3

85711-69-9

289-244-9

86560-93-2

289-699-3

89997-63-7

289-753-6

89998-15-2

289-995-2

90063-37-9

290-018-7

90063-59-5

290-058-5

90063-97-1

290-140-0

90082-51-2

290-651-9

90194-41-5

290-989-7

90294-99-8

291-325-9

90387-52-3

292-348-7

90604-54-9

Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides

293-522-5

91080-29-4

Fir, Abies sibirica, ext.

Juniper, Juniperus mexicana, ext.

Lavender, Lavandula hybrida, ext./Lavandin oil

294-351-9

91697-89-1

294-461-7

91722-61-1

294-470-6

91722-69-9

L 325/32

EN

Official Journal of the European Union

11.12.2007

Amines, N-(3-aminopropyl)-N′-coco alkyltrimethylenedi-, monoacrylated

294-702-6

91745-32-3

Name (EINECS and/or others)

EC number

CAS number

Cymbopogon winterianus, ext.

Lemongrass (Cymbopogon flexuosus)

White mineral oil (petroleum), light

N-[3-(dodecylamino)propyl]glycine hydrochloride

Bis(2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandionato-
O2,O3)copper

Citrus, ext.

Pine ext.

294-954-7

91771-61-8

295-161-9

91844-92-7

295-550-3

92062-35-6

298-216-5

93778-80-4

304-146-9

94246-73-8

304-454-3

94266-47-4

304-455-9

94266-48-5

Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate

304-990-8

94313-91-4

Peppermint, American, ext.

Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)
amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts

Corn cob, powdered

Natural lemon juice (filtered)

Hedera helix

Onion Oil

Thuja occidentalis

Salvia officinalis

Hyssopus officinalis

Chrysanthemum vulgare

Artemisia absinthium

Achillea millefolium

Origanum vulgare

Majorana hortensis

Origanum majorano

Rosmarinus officinalis

Satureja hortensis

Uritica dioica

Aesculus hippocastanum

Symphytum officinale

Equisetum arvense

Sambucus nigra

1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/
Hexaflumuron

1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione

1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/
Tebuconazole

308-770-2

98306-02-6

309-206-8

100085-64-1

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

310-127-6

999999-99-4

401-400-1

86479-06-3

401-570-7

89415-87-2

403-640-2

107534-96-3

Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine

403-950-8

164907-72-6

Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)pho-
sphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate

404-690-8

68132-19-4

(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane

405-020-7

105024-66-6

2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropane-
carboxylate/Transfluthrin

405-060-5

118712-89-3

11.12.2007

EN

Official Journal of the European Union

L 325/33

Name (EINECS and/or others)

EC number

CAS number

5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-
(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon

405-090-9

67485-29-4

3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox

407-980-2

80844-07-1

6-(phthalimido)peroxyhexanoic acid

Lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide

Methyl neodecanamide

Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-
trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-
phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-
dimethylcyclopropanecarboxylate/Lambda cyhalothrin

410-850-8

128275-31-0

411-690-1

111337-53-2

414-460-9

105726-67-8

415-130-7

91465-08-6

1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)
urea/Flufenoxuron

417-680-3

101463-69-8

2-butyl-benzo[d]isothiazol-3-one

Tetrachlorodecaoxide complex

Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)-
phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-
trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen

420-590-7

04299-07-4

420-970-2

92047-76-2

421-960-0

90035-08-8

sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine

423-210-8

119515-38-7

N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide

Fipronil

423-990-1

149118-66-1

424-610-5

120068-37-3

cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride

426-020-3

51229-78-8

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid

428-040-8

138261-41-3

Thiamethoxam

[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/
Imiprothrin

428-650-4

153719-23-4

428-790-6

72963-72-5

5-chloro-2-(4-chlorphenoxy)phenol

429-209-0

3380-30-1

2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen

429-800-1

95737-68-1

3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide

431-030-6

163269-30-5

Reaction products of diisopropanolamine with formaldehyde(1:4)

432-440-8

220444-73-5

Chloromethyl n-octyl disulfide

432-680-3

180128-56-7

Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with
hydrogen peroxide/Perestane

432-790-1

Bis(3-aminopropyl)octylamine

433-340-7

86423-37-2

(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine

433-460-1

210880-92-5

(E)-2-Octadecenal

(E,Z)-2,13-Octadecadienal

Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-
containing

Silver sodium hydrogen zirconium phosphate

Paraformaldehyde

Peroxyoctanoic acid

Bromomyristyl isoquinoline

9-Aminoacridine hydrochloride monohydrate

Not yet
allocated

Not yet
allocated

Not yet
allocated

Not yet
allocated

51534-37-3

99577-57-8

398477-47-9

30525-89-4

33734-57-5

51808-87-8

52417-22-8

L 325/34

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Chlorinated trisodium phosphate

Cyclohexylhydroxydiazene 1-oxide, potassium salt

(1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol

Silica, amorphous, crystalline-free

Denatonium Capsaicinate

Tris(N-cyclohexyldiazeniumdioxy)aluminium

Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper

Reaction product of essential oils and ozone in-situ (Open Air Factor (OAF))

Silver zeolite A

Silver sodium borosilicate

5-Chloro-2-(4-chlorophenoxy)phenol

56802-99-4

66603-10-9

104870-56-6

112945-52-5

192327-95-0

312600-88-7

312600-89-8

Benzyl-lauryl-dimethyl-myristylammonium chloride/Lauryl-myristyl dimethyl
benzyl ammonium chloride

((1,2-Ethanediylbis(carbamodithioato))(2-))manganese mixture with ((1,2-ethan-
diylbis(carbamodithioate))(2-))zinc/Mancozeb

Plant protection
product

8018-01-7

Chlorosulfamic acid

2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl phosphate/bromfenvinfos

Ethyl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate/Hydroprene

Silicium dioxide/Kieselguhr

Plant protection
product

Plant protection
product

Plant protection
product

Plant protection
product

17172-27-9

33399-00-7

41096-46-2

61790-53-2

.alpha.,.alpha.,.alpha.-Trifluoro-N-methyl-4,6-dinitro-N-(2,4,6-tribromophenyl)-o-
toluidine/Bromethalin

Plant protection
product

63333-35-7

S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate

S-Hydroprene/Ethyl (S-(E,E))-3,7,11-trimethyldodeca-2,4-dienoate

Plant protection
product

Plant protection
product

65733-16-6

65733-18-8

Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methyl-
butyrate

Plant protection
product

66230-04-4

[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloro-
ethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-Cyper-
methrin

Plant protection
product

67375-30-8

Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Aver-
mectin B1b; < 20 % EINECS 265-611-9)

265-610-3

71751-41-2

Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-
dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/
Biphenate

Plant protection
product

82657-04-3

N-(2-((2,6-Dimethyl)phenyl)amino)-2-oxoethyl)-N,N-diethyl benzenemethan-
aminiumsaccharide/Denatonium Saccharide

Plant protection
product

90823-38-4

.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/
Cyproconazole

Plant protection
product

94361-06-5

3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxy-
benzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-
tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone

Plant protection
product

104653-34-1

Guazatine triacetate

Plant protection
product

115044-19-4

4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-
carbonitrile/Chlorfenapyr

Plant protection
product

122453-73-0

11.12.2007

EN

Official Journal of the European Union

L 325/35

Name (EINECS and/or others)

EC number

CAS number

Aluminium sodium silicate-silver complex/Silver zeolite

Aluminium sodium silicate-silver copper complex/Silver Copper Zeolite

Aluminium sodium silicate-silver zinc complex/Silver-Zinc-Zeolite

N-Isononyl-N,N-dimethyl-N-decylammonium chloride

N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/Acetamiprid

3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)
cyclopropanecarboxylate/d-Phenothrin

Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS
59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS
229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabi-
cyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %)

130328-18-6

130328-19-7

130328-20-0

138698-36-9

160430-64-8

188023-86-1

Plant protection
product

Plant protection
product

Plant protection
Product

Plant protection
product

Plant protection
product

Plant protection
product

Plant protection
product

[1.alpha.(S*),3.alpha.]-(.alpha.)-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloro-
ethenyl)-2,2-dichlorovinyl)-2,2-dimenthylcyclopropanecarboxylate

Plant protection
product

S-Cyphenothrin

(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-
methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS
only 1:1)/Bioallethrin/d-trans-Allethrin

Plant protection
product

Plant protection
product

(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-
methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R:
1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-Allethrin

Plant protection
product

(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-
methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S
only 1:3)/Esbiothrin

Plant protection
product

Spinosad: fermentation product of soil micro-organism containing Spinosyn A
and Spinosyn D

Plant protection
product

Butoxy polypropylene glycol

Polydimethylsiloxane

Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloro
methyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride

Polymer of N,N,N,N-tetramethyl-ethane-1,2-diamine and (chloromethyl)oxirane

Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4)

Polymer of formaldehyde and acrolein

Monohydro chloride of polymer of N,N‴-1,6-hexanediylbis[N′-cyanoguanidine]
(EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexa-
methylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium mono-
hydrochloride)

Polymer of N,N,N′,N′-tetramethyl-1,6-hexanediamine and 1,6-dichlorohexane

Poly(hexamethylendimethylammonium chloride)/Poly[(dimethylimino)-1,6-hexa-
nediyl-chloride]

N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymer

Poly(hexamethylendiamine guanidinium chloride)

Poly(hexamethylenebiguanide)

Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-
hydroxy-, propanoate (salt)

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

9003-13-8

9016-00-6

25988-97-0

25988-98-1

26716-20-1

26781-23-7

27083-27-8/
32289-58-0

27789-57-7

28728-61-2

31075-24-8

57028-96-3

91403-50-8

94667-33-1

N,N-Didecyl(-N-methyl-poly(oxyethyl)ammoniumpropionate/1-Decanaminium, N-
decyl-N-(2-hydroxyethyl)-N-methyl-, propanoate (salt)

Polymer

107879-22-1

L 325/36

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Copolymer of 2-propenal and propane-1,2-diol

N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium
borate

Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)

Tributyltin coPolymer (TBT-coPolymer)

Fat alcohol polyglycol ether

Poly(vinyl chloride-co-isobutyl vinyl ether-co-N-vinyl, N′-dimethyl octyl bromide
propyl diamine)

Polyglycolpolyamine resin

Sodium lignosulfonate

Neem/Neem-Vital

Pinus pumilio oil

Cedarwood oil

Lavender oil

Citronella oil

Essential oil of eugenia caryophyllus

Geranium oil

Eucalyptus Oil

Orange oil

Pine oil

Black pepper oil

Peppermint oil

Lemongrass oil

Penny Royal Oil

Thyme oil

Coriander oil

Spearmint oil

Valeriana officinalis oil

Cajuput Oil

Juniperberry oil

Cypress Oil

Patchouli oil

Cumin Oil

Palmarosa oil

Rue oil

Basilicum Ocimum basilium oil

Bois de rose oil/Rosewood oil

Celery oil

Chamomile oil

Clove leaf oil (Eugenia caryophyllus)

Melaleuca oil

Litsea cubeba oil

191546-07-3

214710-34-6

374572-91-5

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Polymer

Natural Polymer

8061-51-6

Natural oil

5945-86-8

Natural oil

8000-26-8

Natural oil

8000-27-9

Natural oil

8000-28-0

Natural oil

8000-29-1

Natural oil

8000-34-8

Natural oil

8000-46-2

Natural oil

8000-48-4

Natural oil

8000-57-9

Natural oil

8002-09-3

Natural oil

8006-82-4

Natural oil

8006-90-4

Natural oil

8007-02-1

Natural oil

8007-44-1

Natural oil

8007-46-3

Natural oil

8008-52-4

Natural oil

8008-75-5

Natural oil

8008-88-6

Natural oil

8008-98-8

Natural oil

8012-91-7

Natural oil

8013-86-3

Natural oil

8014-09-3

Natural oil

8014-13-9

Natural oil

8014-19-5

Natural oil

8014-29-7

Natural oil

8015-73-4

Natural oil

8015-77-8

Natural oil

8015-90-5

Natural oil

8015-92-7

Natural oil

8015-97-2

Natural oil

68647-73-4

Natural oil

68855-99-2

11.12.2007

EN

Official Journal of the European Union

L 325/37

Name (EINECS and/or others)

EC number

CAS number

Cornmint oil

Natural oil

68917-18-0

Cedar Oil (Cedarwood oil Texas, Juniperus mexicana oil, 22 %)

Natural oil

68990-83-0

Citrus extract of seeds of tabebuia avellanedae

Essential oil of cymbopogon winterianus

Allium sativum and Allium cepa

Essential oil of cinnamomum zeylanicum

Clove oil (main components: Eugenol (83,8 %), Caryophyllene (12,4 %), Eugenol
acetate (0,4 %))

Fir needle perfume oil: (Ethereal oil, main components: Turpentine oil (30-37,5 %),
Terpineol (15-20 %), Isobornyl acetate (15-20 %), Pinene beta (12,5-15 %), Pinene
alpha (7-10 %), Coumarin (1-3 %), Terpineol-fraction (1-3%)

Perfume oil Spring Fresh: ethereal oil: main components: Citral-diethylacetal
(Citrathal) (1-3 %), Citronellol (1-3 %), Ylanat (1-3 %), Hivertal (1-3 %), Allylca-
pronate (1-3 %)

Rosas oil

Natural Pyrethrins

Peat extract

Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chloride

Cetrimide

Mixture of 3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8;) and
3,6-acridinediamine/Acriflavine

Natural oil

Natural oil

Natural oil

Natural oil

Natural oil

Natural oil

Natural oil

Natural oil

Natural extract

Natural extract

Mixture

Mixture

Mixture

8001-54-5

8044-71-1

8048-52-0

Mixture of ((3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8) and
3,6-acridinediamine) hydrochloride)/Acriflavine HCl

Mixture

8063-24-9

Benzalkonium saccharinate/Benzalkonium o-sulfobenzimidate

Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-
methyl-2H-isothiazol-3-one (EINECS 220-239-6)

Mixture

Mixture

39387-42-3

55965-84-9

Siloxanes and Silicones, di-Me, reaction products with silica/Treated Fumed Silica

Mixture

67762-90-7

Reaction mixture of fatty acids mixed esters (C6-18, derived from coconut oil) with
acetic acid and 2,2′-methylenebis(4-chlorophenol)

Mixture

106523-52-8

139734-65-9

308074-50-2

Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid

Quaternary ammonium iodides

Reaction products of 5,5-dimethylhydantoin and formaldehyde

Reaction products of 2-(2-butoxyethoxy)ethanol and formaldehyde

Reaction products of ethylene glycol and formaldehyde

Reaction products of urea, ethylene glycol and formaldehyde

Reaction products of chloroacetamide, 2(2-butoxyethoxy)ethanol and formal-
dehyde

Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol
(EINECS 224-027-4)

Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium
hypochlorite produced in situ

Potassium salts of fatty acids (C15-21)

Acypetacs copper

Acypetacs zinc

Webbing clothes moths pheromone: components: E,Z-Octadecadi-2,13-enal
(75 %) and E-Octadec-2-enal (25 %)

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

Mixture

L 325/38

EN

Official Journal of the European Union

11.12.2007

Name (EINECS and/or others)

EC number

CAS number

Mixture of chromium trioxide (EINECS 215-607-8; 34,2 %), diarsenic pentoxide
(EINECS 215-116-9; 24,1 %), copper(II)oxide (EINECS 215-269-1; 13,7 %), water
(EINECS 231-791-2; 28 %)

Mixture of chlormethylisothiazolinon, ethandiylbisoxybismethanol, methylisothia-
zolinon

Mixture of bromine (EINECS 231-778-1) and hypobromous acid (CAS-No.:
13517-11-8) manufactured in situ

Products of natural fermentation of plants in water, sulphur-containing

Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22,
saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides,
bromides, or hydroxides)/BKC

Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated
and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides,
or methylsulphates)/DDAC

Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated
and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides,
or methylsulphates)/TMAC

Mixture

Mixture

Mixture

Mixture

Mixture of
EINECS listed
substances

Mixture of
EINECS listed
substances

Mixture of
EINECS listed
substances

Bacillus thuringiensis

Bacillus sphaericus

Bacillus thuringiensis +D381is subsp. Israelensis

Bacillus thuringiensis Var. Kurstaky

Bacillus thuringiensis subsp. Israelensis Serotype H14

Bacillus thuringiensis var. israelensis

Bacillus subtilis

Micro-organism

68038-71-1

Micro-organism

143447-72-7

Micro-organism

Micro-organism

Micro-organism

Micro-organism

Micro-organism

(1) This substance also has a different CAS number (31654-77-0) according to the ESIS registry.

11.12.2007

EN

Official Journal of the European Union

L 325/39

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

I
I

X
E
N
N
A

E
M
M
A
R
G
O
R
P
W
E
I
V
E
R

E
H
T

R
E
D
N
U

I

D
E
N
M
A
X
E

E
B

O
T

S
E
C
N
A
T
S
B
U
S

E
V
I
T
C
A

9
1

8
1

3
2

2
2

0
2

3
1

2
1

1
1

2
2

3
1

2
1

1
1

0
1

8
1

3
1

0
1

9

9

9

9

6

5

4

3

2

1

0
-
0
0
-
0
5

8
-
1
0
0
-
0
0
2

6
-
3
0
-
1
5

7
-
6
7
0
-
0
0
2

7

6

4

3

2

1

7
-
1
5
-
2
5

0
-
3
4
1
-
0
0
2

6

4

3

2

1

7
-
0
5
-
9
5

6
-
1
3
4
-
0
0
2

6
-
6
3
-
8
5

3
-
7
7
3
-
0
0
2

0
2

0
2

8
1

4
1

8

2
1

1
1

3
1

2
1

1
1

9

1
1

2
1

1
1

0
1

9

6

6

6

6

5

5

4

4

4

4

4

4

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

7
-
3
7
-
2
6

7
-
7
4
5
-
0
0
2

5
-
7
1
-
4
6

6
-
8
7
5
-
0
0
2

6
-
8
1
-
4
6

1
-
9
7
5
-
0
0
2

0
-
5
8
-
5
6

2
-
8
1
6
-
0
0
2

0
-
3
6
-
7
6

7
-
1
6
6
-
0
0
2

7
-
2
7
-
9
6

3
-
2
1
7
-
0
0
2

8
-
3
2
-
1
7

9
-
6
4
7
-
0
0
2

8
-
0
9
-
4
7

6
-
1
2
8
-
0
0
2

8
-
1
2
-
5
7

9
-
9
4
8
-
0
0
2

5
-
8
4
-
7
7

9
-
0
3
0
-
1
0
2

1

9
-
2
9
-
7
7

1
-
9
6
0
-
1
0
2

E
D

L
E

S
E

R
F

R
F

T
I

L
E

E
B

E
D

E
D

T
L

E
D

Z
C

N

L
N

E
B

-
l
y
p
o
r
p
-
6

l
y
h
t
e
)
y
x
o
h
t
e
y
x
o
t
u
b
-
2
(
-
2

e
d
i
x
o
t
u
b

l
y
n
o
r
e
p
i
P
/
r
e
h
t
e

l
y
n
o
r
e
p
p

i

e
d
y
h
e
d
l
a
m
r
o
F

e
d
i
x
o

l
y
-
0
1
-
n
i
s
r
a
x
o
n
e
h
p
D

i

l

o
p
o
n
o
r
B

l

o
s
e
r
c
o
r
o
h
C

l

s
o
v
r
o
h
c
i
D

l

l

o
n
a
h
t
E

d
i
c
a

c
i
m
r
o
F

d
i
c
a

c
i
o
z
n
e
B

l

o
-
2
-
n
a
p
o
r
P

d
i
c
a

c
i
l
y
c
i
l
a
S

l

o
-
1
-
n
a
p
o
r
P

i

e
d
n
a
y
c

n
e
g
o
r
d
y
H

e
d
i
x
o

e
n
e
l
y
h
t
E

i

i

n
o
t
n
a
d
y
h
l
y
h
t
e
m
d
-
5
5
-
o
m
o
r
b
d
-
3
1

i

,

,

d
i
c
a

c
i
r
t
i

C

l

o
o
l
a
n
i
L

9
1

6
-
0
7
-
8
7

4
-
4
3
1
-
1
0
2

K
D

L 325/40

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

0
2

7
1

4
1

2
1

2
1

1
1

3
1

0
1

9

2
1

1
1

9

7

7

6

6

6

6

6

5

5

5

3
1

1
1

0
1

9

7

6

9
1

9
1

8
1

3
1

2
1

1
1

0
1

9

7

6

4

4

4

4

4

4

4

4

4

2
1

6

4

3

3

3

3

3

3

3

3

3

3

2

2

2

2

2

2

2

2

2

2

2

2
-
7
0
-
9
7

2
-
4
7
1
-
1
0
2

3
-
8
0
-
9
7

8
-
5
7
1
-
1
0
2

1
-
4
1
-
9
7

5
-
0
8
1
-
1
0
2

1

0
-
1
2
-
9
7

8
-
6
8
1
-
1
0
2

E
E

S
E

T
L

I
F

i

e
d
m
a
t
e
c
a
o
r
o
h
c
-
2

l

d
i
c
a

c
i
t
e
c
a
o
m
o
r
B

d
i
c
a

c
i
l
l

o
c
y
l
G

d
i
c
a

c
i
t
e
c
a
r
e
P

4
-
3
3
-
9
7

2
-
6
9
1
-
1
0
2

E
D

d
i
c
a

c
i
t
c
a
l
-
)
+
(
-
L

2
-
1
8
-
1
8

6
-
7
7
3
-
1
0
2

E
I

n
i
r
a
f
r
a

W

1

1

0
-
4
0
-
8
8

8
-
3
9
7
-
1
0
2

7
-
3
4
-
0
9

5
-
3
9
9
-
1
0
2

E
B

S
E

1

2
-
0
2
-
1
0
1

1
-
4
2
9
-
2
0
2

4
-
3
2
-
7
9

1
-
7
6
5
-
2
0
2

E
I

K
S

3
-
0
2
-
1
9

5
-
9
4
0
-
2
0
2

K
U

1
-
0
9
-
7
8

8
-
2
8
7
-
1
0
2

K
U

4
-
9
7
-
3
8

9
-
1
0
5
-
1
0
2

K
U

,

i

-
h
t
e
m
d
-
9
8
-
l
y
n
e
p
o
r
p
o
s
i
-
2
-
o
r
d
y
h
a
x
e
h

e
n
o
n
e
t
o
R
/
e
n
o
-
6
-
n
e
m
o
r
h
c
]
h
-
3
2
[
o
r
u
f

,

,

]
b
-
4
3
[
o
n
e
m
o
r
h
c
y
x
o

e
n
e
s
o
l
c
m
y
S

l

o
n
e
l
y
x
o
r
o
h
C

l

l

o
-
2
-
l
y
n
e
h
p
B

i

e
n
e
l
a
h
t
h
p
a
N

n
e
h
p
o
r
o
h
c
i
D

l

n
a
b
r
a
c
o
l
c
i
r
T

,

,

,

,

-
a
2
1
2
1
,
a
6
6
2
1
-
)
S
a
2
1
S
a
6
R
2

,

,

(

2
-
5
5
-
4
0
1

9
-
3
1
2
-
3
0
2

K
U

l
a
-
2
-
n
e
p
o
r
p
-
l
y
n
e
h
p
-
3
/
e
d
y
h
e
d
l
a
m
a
n
n
C

i

1
-
4
2
-
6
0
1

1
-
7
7
3
-
3
0
2

2
-
2
2
-
7
0
1

9
-
4
7
4
-
3
0
2

4
-
9
3
-
8
0
1

9
-
7
7
5
-
3
0
2

R
F

R
F

R
F

l

i

o
n
a
r
e
G

l
a
x
o
y
l
G

l

o
s
e
r
C
-
m

11.12.2007

EN

Official Journal of the European Union

L 325/41

2
2

3
1

2
1

1
1

0
1

0
1

9

9

8

7

7

6

6

5

5

4

4

3

3

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

9
1

9
1

8
1

8
1

8
1

8
1

0
2

8
1

0
2

9
1

8
1

5
1

4
1

2
1

1
1

0
1

6

4

3

2

2

2

2

2

2

1

1

1
-
4
4
-
0
1
1

7
-
8
6
7
-
3
0
2

E
D

d
i
c
a

c
i
b
r
o
S
/
d
i
c
a

c
i
o
n
e
i
d
-
4
2
-
a
x
e
H

,

8
-
0
3
-
1
1
1

5
-
6
5
8
-
3
0
2

I
F

l
a
r
a
t
u
G

l

0
-
5
0
-
2
1
1

2
-
1
3
9
-
3
0
2

T
A

d
i
c
a

c
i
o
n
a
n
o
N

9
-
2
1
-
2
1
1

5
-
7
3
9
-
3
0
2

1
-
6
2
-
4
1
1

8
-
3
4
0
-
4
0
2

S
E

E
B

5
-
2
5
-
8
1
1

7
-
8
5
2
-
4
0
2

L
N

e
n
o
t
e
k
-
l
y
n
o
n
-
l
y
h
t
e
M
/
e
n
o
-
2
-
n
a
c
e
d
n
U

r
u
x
o
p
o
r
P

i

i

n
o
t
n
a
d
y
h
l
y
h
t
e
m
d
-
5
5
-
o
r
o
h
c
i
d
-
3
1

l

,

,

1

1
-
2
3
-
0
2
1

8
-
5
8
3
-
4
0
2

N

e
n
e
h
p
o
r
o
C

l

4
-
1
5
-
0
2
1

9
-
2
0
4
-
4
0
2

K
U

e
t
a
o
z
n
e
b

l
y
z
n
e
B

1

0
-
4
5
-
1
2
1

9
-
9
7
4
-
4
0
2

E
B

e
d
i
r
o
h
c

l

i

m
u
n
o
h
t
e
z
n
e
B

5
-
4
1
-
2
2
1

2
-
4
2
5
-
4
0
2

K
U

i

n
o
h
t
o
r
t
i
n
e
F

9
-
8
1
-
2
2
1

3
-
6
2
5
-
4
0
2

)
1
(

e
d
i
r
o
h
c

l

i

m
u
n
o
k
l
a
t
e
C

3
1

1
1

0
1

9

7

7

6

6

5

4

4

4

3

3

2

2

1

1

0
-
9
1
-
2
2
1

9
-
7
2
5
-
4
0
2

i

m
u
n
o
m
m
a
)
l
y
c
e
d
a
t
c
o
(
l
y
h
t
e
m
d
l
y
z
n
e
B

i

6
-
9
9
-
2
2
1

7
-
9
8
5
-
4
0
2

K
U

l

o
n
a
h
t
e
y
x
o
n
e
h
P
-
2

)
1
(

e
d
i
r
o
h
c

l

5
-
3
0
-
3
2
1

9
-
3
9
5
-
4
0
2

K
U

e
d
i
r
o
h
c

l

i

i

m
u
n
d
i
r
y
p
l
y
t
e
C

2
-
7
0
-
4
2
1

5
-
7
7
6
-
4
0
2

T
A

d
i
c
a

c
i
o
n
a
t
c
O

9
-
8
3
-
4
2
1

9
-
6
9
6
-
4
0
2

2
-
5
6
-
4
2
1

2
-
8
0
7
-
4
0
2

R
F

T
P

e
t
a
n
i
s
r
a
l
y
h
t
e
m
d

i

i

m
u
d
o
S

e
d
i
x
o
d

i

n
o
b
r
a
C

3
1

2
1

1
1

6

3

2

4
-
1
1
-
6
2
1

5
-
9
6
7
-
4
0
2

K
U

l

o
n
a
h
t
e
m

i
r
t
e
n
y
d

i
l
y
h
t
e
m
o
r
t
i

N

L 325/42

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

2
2

9
1

9
1

0
2

3
1

2
1

1
1

0
1

3
1

2
1

1
1

0
1

1
1

0
1

4
1

3
1

0
1

0
1

0
1

3
1

2
1

1
1

2
1

1
1

2
1

1
1

2
1

1
1

0
1

2
1

1
1

0
1

3
1

2
1

1
1

3
1

2
1

1
1

0
1

9

9

9

9

9

9

9

9

9

9

9

9

9

6

6

6

6

6

6

6

6

6

6

6

7

7

7

7

7

4

3

2

1

4
-
7
2
-
2
3
1

6
-
5
5
0
-
5
0
2

6
-
6
0
-
9
2
1

4
-
9
2
9
-
4
0
2

5

5

4

4

4

3

3

2

2

2

1

1
-
5
6
-
7
2
1

7
-
4
5
8
-
4
0
2

S
E

i

m
u
d
o
s

i

e
d
m
a
r
o
h
c
l
y
s
o
T

l

0
-
3
0
-
8
2
1

1
-
5
7
8
-
4
0
2

K
U

1
-
4
0
-
8
2
1

7
-
6
7
8
-
4
0
2

K
U

i

e
t
a
m
a
b
r
a
c
o
h
t
i
d
l
y
h
t
e
m
d

i

m
u
i
s
s
a
t
o
P

i

e
t
a
m
a
b
r
a
c
o
h
t
i
d
l
y
h
t
e
m
d

i

i

m
u
d
o
S

4

4

2

2

2

2

2

2

2

2
-
6
0
-
3
3
1

0
-
7
8
0
-
5
0
2

3
-
7
0
-
3
3
1

6
-
8
8
0
-
5
0
2

3
-
0
2
-
4
3
1

4
-
2
3
1
-
5
0
2

3
-
2
6
-
4
3
1

7
-
9
4
1
-
5
0
2

8
-
6
2
-
7
3
1

2
-
6
8
2
-
5
0
2

4
-
0
3
-
7
3
1

3
-
8
8
2
-
5
0
2

E
I

S
E

T
I

T
I

R
F

E
S

E
B

E
B

/
e
d
m

i

i

i
l
a
h
t
h
p
)
o
h
t
l
y
h
t
e
m
o
r
o
h
c
i
r
t
(
-

l

N

i

e
d
m
a
u
o
t
-

l

m

-
l
y
h
t
e
i
d
-
N
N

,

m
a
r
i
h
T

m
a
r
i
Z

e
t
a
l
i

n
a
r
h
t
n
a

l
y
h
t
e
M

t
e
p
o
F

l

e
t
a
l
y
n
e
h
p
b
-
2

i

i

m
u
d
o
S

i

m
u
d
o
s

n
i
r
a
f
r
a

W

n
a
t
p
a
C

7
-
1
4
-
7
3
1

5
-
2
9
2
-
5
0
2

Z
C

e
t
a
m
a
b
r
a
c
o
h
t
i
d
l
y
h
t
e
m

i

m
u
i
s
s
a
t
o
P

8
-
2
4
-
7
3
1

0
-
3
9
2
-
5
0
2

E
B

i

m
u
d
o
s
-

m
a
t
e
M

2
-
3
9
-
8
3
1

8
-
6
4
3
-
5
0
2

Z
C

e
t
a
m
a
b
r
a
c
o
h
t
i
d
o
n
a
y
c

i

i

m
u
d
o
s
i
D

1
-
7
0
-
9
3
1

5
-
1
5
3
-
5
0
2

)
1
(

e
d
i
r
o
h
c

l

i

m
u
n
i
c
e
d
o
d
o
z
n
e
B

2
-
8
0
-
9
3
1

0
-
2
5
3
-
5
0
2

)
1
(

e
d
i
r
o
h
c

l

i

m
u
n
o
k
l
a
t
s
i
r
i

M

4
-
5
9
-
0
4
1

0
-
4
4
4
-
5
0
2

U
H

a
e
r
u
)
l
y
h
t
e
m
y
x
o
r
d
y
h
(
s
i
b
-
3
1

,

6
-
9
5
-
2
4
1

0
-
7
4
5
-
5
0
2

L
P

m
a
b
a
N

11.12.2007

EN

Official Journal of the European Union

L 325/43

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

0
2

9
1

8
1

8
1

9
1

8
1

8
1

1
2

1
2

0
2

3
1

2
1

1
1

3
1

2
1

1
1

0
1

9

9

8

7

7

6

2

2

8
-
9
7
-
8
4
1

8
-
5
2
7
-
5
0
2

4
-
0
3
-
9
4
1

8
-
6
3
7
-
5
0
2

5
-
6
7
-
0
0
3

3
-
8
9
0
-
6
0
2

S
E

N

R
F

0
1

7

6

1
-
4
5
-
0
3
3

4
-
4
5
3
-
6
0
2

K
D

5
-
1
4
-
3
3
3

8
-
3
7
3
-
6
0
2

T
P

l

i

o
h
t
-
2
-
e
l
o
z
a
i
h
t
o
z
n
e
B

e
l
o
z
a
d
n
e
b
a
i
h
T

d
e
l
a
N

n
o
r
u
D

i

n
o
n
i
z
a
i
D

7
-
7
0
-
3
4
1

1
-
2
8
5
-
5
0
2

E
D

d
i
c
a

c
i
r
u
a
L

4

5
-
8
4
-
4
3
3

4
-
6
7
3
-
6
0
2

T
A

d
i
c
a

c
i
o
n
a
c
e
D

3

2
-
4
0
-
0
2
4

3
-
2
9
9
-
6
0
2

E
D

i

e
d
m
a
n
a
y
C

1
1

0
1

2
1

1
1

0
1

9

0
1

8

8

3
1

2
1

1
1

3
1

2
1

1
1

0
1

9

0
1

9

0
1

8

7

7

7

7

6

6

6

6

2

1

1
-
2
3
-
2
3
5

8
-
4
3
5
-
8
0
2

E
D

e
t
a
o
z
n
e
b

i

m
u
d
o
S

e
n
o
-
1
-
n
e
i
r
t
a
t
p
e
h

4
-
4
7
-
3
3
5

7
-
6
7
5
-
8
0
2

E
B

1
-
7
2
-
1
3
7

9
-
6
8
9
-
1
1
2

I
F

i

l

-
o
h
p
u
s
)
o
n
m
a
l
y
h
t
e
m
d
(
[
-

i

t
e
m
o
z
a
D

N
-
o
r
o
h
c
i
D

l

l

-
e
h
p
u
s
e
n
a
h
t
e
m

)
l
y
l
o
t
-
p
(
-

N
-
o
r
o
u
l
f
]
l
y
n

i

d
n
a
u
l
f
l
y
l
o
T
/
e
d
m
a
n

i

5
-
4
4
-
9
9
4

7
-
0
8
8
-
7
0
2

K
S

,

,

-
o
l
c
y
c
-
6
4
2
-
l
y
p
o
r
p
o
s
i
-
4
-
y
x
o
r
d
y
h
-
2

2

2

9
-
9
8
-
2
2
8

0
-
6
0
5
-
2
1
2

R
F

e
n
o
d
i
r
y
p
-
2
-
l
y
x
o
r
d
y
H

2
-
0
0
-
8
2
8

9
-
9
7
5
-
2
1
2

T
A

e
t
a
t
e
c
a

,

i

l
y
-
4
-
n
a
x
o
d
-
3
1
-
l
y
h
t
e
m
d
-
6
2

i

,

0
-
0
5
-
6
8
8

5
-
0
5
9
-
2
1
2

K
S

n
y
r
t
u
b
r
e
T

9
-
8
9
-
5
8
0
1

7
-
8
1
1
-
4
1
2

K
U

i

d
n
a
u
l
f
o
h
c
i
D

l

L 325/44

EN

Official Journal of the European Union

11.12.2007

1
2

2
2

1
2

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

1

7
-
7
9
-
9
1
1
1

9
-
1
9
2
-
4
1
2

7
-
7
6
-
1
1
1
1

1
-
3
8
1
-
4
1
2

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

R
F

N

e
c
n
a
t
s
b
u
S

e
t
a
n
a
y
c
o
h
t

i

r
e
p
p
o
C

i

e
d
m
o
r
b

i

m
u
n
o
d
a
r
t
e
T

8
1

7
-
6
4
-
6
6
1
1

0
-
9
1
6
-
4
1
2

E
D

-

,

i

H
2
-
o
x
o
d
-
3
1
-
o
r
d
y
h
a
x
e
h
-
7
6
5
4
3
1

,

,

,

,

,

(

3
1

1
1

0
1

3
1

2
1

0
1

0
1

9

9

9

9

8

8

7

7

7

6

6

6

3

2

2

2

2

1

1

0
-
8
3
-
7
1
3
1

1
-
9
6
2
-
5
1
2

1
-
9
3
-
7
1
3
1

7
-
0
7
2
-
5
1
2

R
F

R
F

e
d
i
x
o

r
e
p
p
o
C

e
d
i
x
o

r
e
p
p
o
c
i
D

4
-
3
4
-
0
3
3
1

4
-
0
4
5
-
5
1
2

L
N

s
u
o
r
d
y
h
n
a

,
e
t
a
r
o
b
a
r
t
e
t

i

m
u
d
o
s
i
D

4
-
3
2
-
8
3
3
1

2
-
1
6
6
-
5
1
2

U
H

e
d
i
x
o
r
e
p

,
e
n
o
n
a
t
u
B
-
2

2
-
1
8
-
6
4
7
1

5
-
9
2
1
-
7
1
2

K
U

n
o
r
u
n

i
l

o
n
o
M

8
-
2
8
-
7
7
7
1

5
-
0
1
2
-
7
1
2

Z
C

l

o
h
o
c
l
a

l
y
z
n
e
b
o
r
o
h
c
i
d
-
4
2

l

,

6
-
5
4
-
7
9
8
1

1
-
8
8
5
-
7
1
2

L
N

l
i

n
o
l
a
h
t
o
r
o
h
C

l

0
1

9

7

3
-
8
9
-
4
1
3
1

3
-
1
5
2
-
5
1
2

K
U

i

e
d
h
p
u
s

l

c
n
Z

i

8

2
-
6
8
-
3
0
3
1

8
-
5
2
1
-
5
1
2

L
N

e
d
i
x
o
i
r
t

n
o
r
o
b
D

i

3

2

0
-
2
6
-
5
0
3
1

3
-
7
3
1
-
5
1
2

K
U

/
e
m

i
l

d
e
t
a
r
d
y
h
/
e
m

i
l

c
i
t
s
u
a
c
/
e
d
i
x
o
r
d
y
h

m
u
i
c
l
a
c
/
e
d
i
x
o
r
d
y
h
d

i

m
u
i
c
l
a
C

e
m

i
l

d
e
k
a
l
s

3

2

8
-
8
7
-
5
0
3
1

9
-
8
3
1
-
5
1
2

K
U

/
e
m

i
l

t
n
r
u
b
/
e
m

i
l
/
e
d
i
x
o

m
u
i
c
l
a
C

e
m

i
l

k
c
i
u
q

2
1

1
1

9

6

2

5
-
2
5
-
2
9
1
1

5
-
4
5
7
-
4
1
2

L
P

,

i

e
n
o
-
3
-
l
o
h
t
i
d
-
2
1
-
H
3
-
o
r
o
h
c
i
d
-
5
4

l

,

-
o
l
c
y
c
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m
-
2
(
-
3
-
l
y
h
t
e
m
d

i

,

-
2
2
-
)
s
n
a
r
t
-
R
1

(

l
y
h
t
e
m

)
l
y
-
2
-
l
o
d
n
o
s
i

i

-
a
r
t
e
T
-
s
n
a
r
t
-
d
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

n
i
r
h
t
e
m

11.12.2007

EN

Official Journal of the European Union

L 325/45

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

3
1

3
1

2
1

1
1

0
1

9

8

3
1

2
1

1
1

0
1

9

7

2
2

2
2

2
2

8
1

9
1

3
1

2
1

3
1

2
1

1
1

0
1

3
1

2
1

1
1

0
1

2
1

1
1

2
1

1
1

2
1

1
1

0
1

4
1

3
1

2
1

1
1

9

9

9

9

9

9

9

9

9

9

8

7

7

7

6

6

6

6

6

6

6

6

6

4

3

2

1

9
-
2
8
-
2
7
3
2

8
-
5
4
1
-
9
1
2

T
P

-
e
n
a
p
o
r
p
l
y
c
e
d
o
d
-
N

-
)
l
y
p
o
r
p
o
n
m
a
-
3
(
-

i

N

2
-
7
1
-
4
6
1
2

4
-
0
0
5
-
8
1
2

L
E

n
o
r
u
t
e
m
o
u
l
F

4
-
4
4
-
4
2
2
2

3
-
8
4
7
-
8
1
2

K
U

e
n

i
l

o
h
p
r
o
m

)
l
y
t
u
b
o
r
t
i
n
-
2
(
-
4

i

e
n
m
a
i
d
-
3
1

,

5

5

4

4

4

3

3

2

2

2

2

2

1

1

1

1
-
6
9
-
8
9
3
2

6
-
6
6
2
-
9
1
2

4
-
8
5
-
7
2
5
2

5
-
8
6
7
-
9
1
2

5
-
3
3
-
4
3
6
2

9
-
0
2
1
-
0
2
2

4
-
0
2
-
2
8
6
2

6
-
9
3
2
-
0
2
2

8
-
9
7
-
9
9
6
2

5
-
1
8
2
-
0
2
2

L
P

L
P

S
E

I
S

E
S

i

]
e
d
m
a
z
n
e
b
l
y
h
t
e
m
N
[
s
i
b
o
h
t
i
d
-

-

i

′
2
2

,

e
t
a
t
f
a
n
o
T

l

e
n
o
-
)

(

H
2
3
-
l
o
z
a
i
h
t
o
s
i
z
n
e
b
-
2
1

,

e
n
o
-
3
-
l
o
z
a
i
h
t
o
s
i
-

H
2
-
l
y
h
t
e
m
-
2

e
d
i
r
o
u
l
f
i
d

l
y
r
u
h
p
u
S

l

9
-
8
7
-
3
9
8
2

7
-
7
6
7
-
0
2
2

K
U

i

m
u
d
o
s

e
n
e
s
o
l
c
o
r
T

0
-
6
8
-
0
8
5
1
5

7
-
7
6
7
-
0
2
2

K
U

e
t
a
r
d
y
h
d

i

e
t
a
r
u
n
a
y
c
o
s
i
o
r
o
h
c
i
d

l

i

m
u
d
o
S

8
-
0
1
-
6
0
0
3

5
-
6
0
1
-
1
2
2

8
-
0
7
-
4
6
0
3

4
-
0
1
3
-
1
2
2

L
P

T
L

e
t
a
h
p
u
s

l

l
y
h
t
e

i

m
u
n
o
r
t
e
c
e
M

e
n
o
h
p
u
s

l

)
l
y
h
t
e
m
o
r
o
h
c
i
r
t
(
s
i
B

l

3
-
8
6
-
0
9
3
2

1
-
4
3
2
-
9
1
2

)
2
(

i

e
d
m
o
r
b

i

m
u
n
o
m
m
a
l
y
h
t
e
m
d
l
y
c
e
d
D

i

i

7

3

2

1

5
-
4
3
-
0
8
3
3

2
-
2
8
1
-
2
2
2

K
D

6

4

3

2

8
-
5
5
-
6
8
5
3

6
-
0
2
7
-
2
2
2

4
-
6
8
-
1
9
3
3

0
-
6
2
2
-
2
2
2

8
-
5
3
-
1
9
6
3

0
-
3
0
0
-
3
2
2

4
-
8
2
-
6
9
6
3

5
-
4
2
0
-
3
2
2

N

L
P

S
E

E
S

l

i

o
n
a
h
t
e
m
d
)
y
x
o
d
e
n
e
l
y
h
t
e
(

i

e
n
o
n
i
c
a
h
p
o
r
o
h
C

l

l

o
-
3
-
e
n
e
-
1
-
t
c
O

n
a
s
o
l
c
i
r
T

i

e
n
o
h
t
i
r
y
p
D

i

L 325/46

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

2
2

3
1

2
1

1
1

0
1

9

7

3
1

2
1

1
1

3
1

2
1

1
1

3
1

2
1

1
1

0
1

9

8

7

3
1

2
1

3
1

2
1

1
1

3
1

2
1

1
1

0
1

9

9

9

9

3
1

2
1

1
1

0
1

9

7

4
1

3
1

1
1

9

2
1

2
1

1
1

6

6

6

6

6

6

6

6

6

6

4

3

3

2

2

0
-
3
0
-
4
8
7
3

2
-
6
4
2
-
3
2
2

2
-
3
7
-
1
1
8
3

5
-
6
9
2
-
3
2
2

3
-
1
3
-
0
8
0
4

0
-
5
0
8
-
3
2
2

4

3

2

4
-
4
0
-
9
1
7
4

0
-
8
0
2
-
5
2
2

E
I

E
S

L
P

L
P

4

3

2

6
-
0
5
-
5
9
3
5

0
-
8
0
4
-
6
2
2

S
E

t
l
a
s

i

m
u
d
o
s

,
e
d
i
x
o
-
1

l

i

o
h
t
-
2
-
e
n
d
i
r
y
P

i

l

e
d
i
r
o
h
c
o
l
y
l
l
a
o
r
o
h
c
-
3

l

i

e
n
m
a
n
e
h
t
e
M

e
t
a
l
o
n
e
h
p
o
r
o
h
c
i
r
t
-
6
4
2

l

,

,

i

m
u
d
o
S

,

,

-
5
3
1
-
e
n
i
z
a
i
r
t
-
5
3
1
-
o
r
d
y
h
a
x
e
h
(
-

,

,

,

″
2
′
2
2

,

-
y
x
o
r
d
y
h
(
s
i
k
a
r
t
e
t
-
6
4
3
1
-
o
r
d
y
h
a
r
t
e
T

,

,

,

l

o
n
a
h
t
e
i
r
t
)
l
y
i
r
t

3
-
4
9
-
8
3
5
5

0
-
1
0
9
-
6
2
2

)
2
(

e
d
i
r
o
h
c

l

i

m
u
n
o
m
m
a
l
y
t
c
o
d
l
y
h
t
e
m
D

i

i

1
-
0
9
-
5
2
6
5

3
-
2
6
0
-
7
2
2

T
A

e
n

i
l

o
h
p
r
o
m

s
i
b
e
n
e
l
y
h
t
e
m

-

′

N
N

,

-
e
l
o
z
a
d
m

i

,

i
]
d
-
5
4
[
o
z
a
d
m

i

i
)
l
y
h
t
e
m

e
n
o
d
-
)

i

,

H
3
H
1
5
2

(

,

2

3
-
1
4
-
5
1
9
5

9
-
7
3
6
-
7
2
2

3
-
9
2
-
6
3
8
5

0
-
4
2
4
-
7
2
2

2

0
-
8
5
-
0
4
4
6

8
-
2
2
2
-
9
2
2

5
-
7
2
-
9
8
9
5

5
-
3
1
8
-
7
2
2

6
-
8
1
-
7
1
3
6

3
-
2
5
6
-
8
2
2

4

3

2

1

5
-
1
5
-
3
7
1
7

2
-
5
2
5
-
0
3
2

0
-
9
1
-
6
6
1
7

8
-
5
1
5
-
0
3
2

1
-
4
0
-
1
8
2
7

4
-
8
9
6
-
0
3
2

K
D

K
U

T
P

R
F

L
P

K
S

T
I

T
P

E
S

,

i

-
l
y
h
t
e
m
d
-
5
5
-
)
l
y
h
t
e
m
y
x
o
r
d
y
h
(
s
i
b
-
3
1

,

e
d
i
r
o
h
c

l

i

m
u
n
o
m
m
a
l
y
h
t
e
m
d
l
y
c
e
d
D

i

i

e
n
e
z
n
e
b
)
l
y
n
i
v
o
r
t
i
n
-
2
-
o
m
o
r
b
-
2

(

i

m
u
n
o
m
m
a
l
y
h
t
e
m
d
l
y
c
e
d
o
d
l
y
z
n
e
B

i

)
1
(

i

e
d
m
o
r
b

n
y
r
t
e
m
o
r
P

r
e
v
l
i
S

i

e
n
o
d
-
4
2
-
e
n
d

i

,

i
l

o
z
a
d
m

i

i

,

e
n
e
i
d
-
8
1
-
a
h
t
n
e
m
-
p
-
)
R

(

e
t
a
n
a
y
c
o
h
t
i
d

i

e
n
e
l
y
h
t
e
M

l
y
l
a
r
t
e
t
a
m
u
o
C

e
n
i
z
a
l
y
h
t
u
b
r
e
T

3
1

2
1

1
1

0
1

1
1

9

9

7

6

6
-
9
1
-
7
8
2
7

3
-
1
1
7
-
0
3
2

5

4

2

4
-
2
2
-
0
4
4
7

3
-
1
3
1
-
1
3
2

11.12.2007

EN

Official Journal of the European Union

L 325/47

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

2
2

2
2

2
2

1
2

0
2

0
2

0
2

0
2

8
1

3
1

2
1

1
1

1
1

3
1

2
1

1
1

1
1

0
1

9

9

9

9

7

7

6

6

6

5

5

4

4

5

4

6

5

4

2
2

0
2

3
1

2
1

1
1

9

2
1

1
1

8
1

8
1

3
1

2
1

1
1

2
1

1
1

6

6

6

6

3
1

2
1

1
1

9

7

6

5

5

5

5

5

4

4

4

4

3

3

3

3

2

2

2

2

2

2

2

2

1

1

1

8
-
0
5
-
0
4
4
7

6
-
9
5
1
-
1
3
2

5
-
9
0
-
6
4
4
7

2
-
5
9
1
-
1
3
2

9
-
5
5
-
2
9
4
7

6
-
1
2
3
-
1
3
2

2
-
6
5
-
3
5
5
7

4
-
2
4
4
-
1
3
2

9
-
6
8
-
1
3
6
7

4
-
5
4
5
-
1
3
2

R
F

E
D

E
D

E
S

R
F

e
t
a
o
n
e
i
d
-
4
2
-
a
x
e
h
d

i

,

m
u
i
c
l
a
C

i

e
n
d
o
I

s
u
o
h
p
r
o
m
a

—

e
d
i
x
o
d

i

n
o
c
i
l
i
S

e
d
i
x
o
d

i

r
u
h
p
u
S

l

r
e
p
p
o
C

1

5
-
0
9
-
1
3
6
7

0
-
8
4
5
-
1
3
2

E
D

l

e
t
i
h
p
u
s
n
e
g
o
r
d
y
h

i

m
u
d
o
S

0
-
1
0
-
7
4
6
7

7
-
5
9
5
-
1
3
2

5
-
4
1
-
7
4
6
7

3
-
8
9
5
-
1
3
2

V
L

T
P

d
i
c
a

l

c
i
r
o
h
c
o
r
d
y
H
/
e
d
i
r
o
h
c

l

n
e
g
o
r
d
y
H

e
d
i
r
o
h
c

l

i

m
u
d
o
S

6
-
5
1
-
7
4
6
7

9
-
9
9
5
-
1
3
2

L
N

i

e
d
m
o
r
b

i

m
u
d
o
S

4

3

2

1

1
-
4
8
-
2
2
7
7

0
-
5
6
7
-
1
3
2

9
-
7
3
-
7
2
7
7

9
-
3
8
7
-
1
3
2

1

1

9
-
2
5
-
1
8
6
7

3
-
8
6
6
-
1
3
2

4
-
7
5
-
1
8
6
7

0
-
3
7
6
-
1
3
2

2
-
8
3
-
4
6
6
7

2
-
3
3
6
-
1
3
2

0
-
2
1
-
6
9
6
7

6
-
1
1
7
-
1
3
2

7
-
4
6
-
2
2
7
7

3
-
0
6
7
-
1
3
2

T
P

T
I

E
D

E
D

K
S

I
F

E
I

d
i
c
a

c
i
r
o
h
p
s
o
h
p
o
h
t
r

O

l

e
t
i
r
o
h
c
o
p
y
h

i

m
u
d
o
S

e
t
i
h
p
u
s
i
d

l

i

m
u
d
o
s
i
D

n
i
r
h
t
e
m
a
r
t
e
T

e
t
a
n
a
g
n
a
m
r
e
p

m
u
i
s
s
a
t
o
P

e
d
i
x
o
r
e
p

n
e
g
o
r
d
y
H

n
e
g
o
r
t
i

N

2
2

0
2

3
1

2
1

1
1

9

6

5

4

2

1

7
-
3
8
-
7
5
7
7

4
-
1
2
8
-
1
3
2

E
D

e
t
i
h
p
u
s

l

i

m
u
d
o
S

e
l
o
z
a
x
o
]
c
-
4
3
[

,

5
-
5
3
-
7
4
7
7

4
-
0
1
8
-
1
3
2

L
P

,

,

l

o
o
z
a
x
o
-
H
5
H
3
H
1
-
o
r
d
y
h
d
l
y
h
t
e
-
a
7

i

L 325/48

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

0
2

2
1

1
1

2
1

1
1

2
1

1
1

1
1

1
1

5

5

5

5

4

4

4

3

4

3

2

2

2

2

2

1

1

7
-
8
9
-
8
5
7
7

6
-
7
4
8
-
1
3
2

8
-
8
8
-
1
6
7
7

9
-
3
5
8
-
1
3
2

2
-
9
1
-
8
5
7
7

6
-
6
3
8
-
1
3
2

9
-
9
0
-
5
7
7
7

4
-
7
8
8
-
1
3
2

1
-
7
2
-
5
7
7
7

1
-
2
9
8
-
1
3
2

1

3
-
4
5
-
8
7
7
7

7
-
8
0
9
-
1
3
2

5
-
0
5
-
2
8
7
7

5
-
9
5
9
-
1
3
2

T
P

R
F

E
S

T
P

T
P

T
I

T
I

i

m
u
d
o
S
/
e
t
a
h
p
u
s
i
d
o
x
o
r
e
p

l

i

m
u
d
o
s
i
D

l

e
t
i
r
o
h
c
o
p
y
h

m
u
i
c
l
a
C

e
t
a
h
p
u
s
r
e
p

l

e
n
i
r
o
h
C

l

e
t
i
r
o
h
c

l

i

m
u
d
o
S

e
t
a
h
p
u
s

l

r
e
p
p
o
C

e
t
a
r
t
i
n

r
e
v
l
i
S

e
t
a
r
o
h
c

l

i

m
u
d
o
S

2
-
0
2
-
3
8
7
7

1
-
4
8
9
-
1
3
2

K
U

e
t
a
h
p
u
s

l

i

m
u
n
o
m
m
A

9
1

8
1

9
1

8
1

2
2

2
2

0
2

0
2

8
1

3
1

2
1

1
1

0
1

3
1

2
1

1
1

0
1

3
1

2
1

1
1

2
1

1
1

3
1

2
1

1
1

0
1

9

9

9

9

8

8

7

7

7

6

6

6

6

5

5

5

4

4

4

4

4

3

3

3

3

3

2

2

2

2

2

1

1

9
-
8
5
-
1
0
0
8

5
-
7
8
2
-
2
3
2

7
-
4
3
-
3
0
0
8

8
-
9
1
3
-
2
3
2

9
-
9
9
-
8
0
0
8

1
-
1
7
3
-
2
3
2

2
-
3
5
-
5
0
0
9

2
-
2
8
6
-
2
3
2

3
-
5
3
-
3
4
0
0
1

2
-
9
3
1
-
3
3
2

4
-
4
0
-
9
4
0
0
1

8
-
2
6
1
-
3
3
2

1

1
-
8
3
-
7
1
1
0
1

1
-
1
2
3
-
3
3
2

7
-
2
5
-
7
8
1
0
1

1
-
7
5
4
-
3
3
2

3
1

1
1

0
1

9

7

6

5

4

3

2

1

6
-
0
9
-
3
8
7
7

3
-
3
3
0
-
2
3
2

E
S

E
S

S
E

L
P

L
E

L
N

T
P

E
D

V
L

i

s
d
o
r
h
t
e
r
y
P

d
n
a

s
n
i
r
h
t
e
r
y
P

e
d
i
r
o
h
c

l

r
e
v
l
i
S

e
t
o
s
o
e
r
C

e
d
i
x
o
d

i

e
n
i
r
o
h
C

l

e
t
i
h
p
u
s

l

m
u
i
s
s
a
t
o
P

.
t
x
e

c
i
l
r
a
G

d
i
c
a

c
i
r
o
B

i

n
n
g
i
L

-
4
[
s
i
b
e
n
e
l
y
h
t
e
m
′
2
2

,

n
e
g
o
r
d
y
h

i

m
u
d
o
S

]
e
t
a
l
o
n
e
h
p
o
r
o
h
c

l

3
1

2
1

1
1

0
1

9

7

6

5

4

3

2

1

2
-
1
0
-
2
2
2
0
1

7
-
9
3
5
-
3
3
2

K
D

i

e
d
m
a
t
e
c
a
o
n
a
y
c
-
2
-
o
m
o
r
b
d
-
2
2

i

,

11.12.2007

EN

Official Journal of the European Union

L 325/49

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

1
2

1
2

1
2

2
2

3
2

0
2

8
1

3
1

2
1

1
1

0
1

3
1

2
1

1
1

0
1

2
1

1
1

3
1

3
1

2
1

1
1

0
1

0
1

0
1

2
1

1
1

3
1

1
1

0
1

3
1

2
1

1
1

0
1

3
1

0
1

3
2

5
1

4
1

2
2

0
2

3
1

2
1

1
1

9

9

9

9

9

9

9

9

9

9

9

9

8

8

7

7

6

6

7

6

4

7

7

7

6

6

6

6

6

6

3

2

1

4
-
3
0
-
0
8
2
2
1

0
-
1
4
5
-
4
3
2

7
-
1
2
-
5
0
6
0
1

0
-
2
3
2
-
4
3
2

2

2

2

2

2

8
-
4
7
-
7
5
0
2
1

7
-
3
2
0
-
5
3
2

1
-
9
6
-
9
6
0
2
1

6
-
3
1
1
-
5
3
2

7
-
7
6
-
2
2
1
2
1

1
-
0
8
1
-
5
3
2

9
-
7
9
-
4
2
1
2
1

8
-
3
8
1
-
5
3
2

7
-
0
9
-
7
6
7
2
1

2
-
4
0
8
-
5
3
2

1

1
-
7
9
-
0
9
5
3
1

0
-
0
3
0
-
7
3
2

8
-
5
6
-
7
0
7
3
1

9
-
3
4
2
-
7
3
2

7
-
1
4
-
3
6
4
3
1

3
-
1
7
6
-
6
3
2

E
D

L
N

E
D

R
F

E
I

E
S

S
E

E
S

S
E

S
E

e
t
a
r
d
y
h
a
r
t
e
t

e
t
a
r
o
b
a
t
c
o

i

m
u
d
o
s
i
D

m
i
z
a
d
n
e
b
r
a
C

)
I
I
(
r
e
p
p
o
c
-
e
t
a
n
o
b
r
a
c

)
I
I
(
r
e
p
p
o
C

i

e
d
h
p
s
o
h
p
d

i

m
u
i
s
e
n
g
a
m

i
r
T

)

1
1

:

(

e
d
i
x
o
r
d
y
h

b
e
n
Z

i

i

c
n
Z
/
e
d
i
x
o
a
c
e
d
n
u

c
n
i
z
i
d

n
o
r
o
b
a
x
e
H

e
t
a
r
o
b

i

e
d
m
o
r
b

i

m
u
n
o
m
m
A

c
n
i
z

i

e
n
o
h
t
i
r
y
P

l

e
d
i
r
o
h
c
o
r
d
y
h
o
n
o
m

i

i

e
n
d
n
a
u
g
l
y
c
e
d
o
D

e
t
a
l
y
n
e
h
p
b
-
2

i

m
u
i
s
s
a
t
o
P

4

3

2

1

9
-
2
2
-
3
3
7
5
1

8
-
5
2
8
-
9
3
2

9
-
8
4
-
5
4
5
5
1

2
-
2
9
5
-
9
3
2

3
-
3
9
-
9
7
8
5
1

7
-
6
1
0
-
0
4
2

S
E

R
F

T
P

8
-
7
3
-
5
1
9
4
1

0
-
4
8
9
-
8
3
2

E
S

i

i

-
o
t
a
n
o
h
t
-
2
-
e
n
d
i
r
y
p
-
H
1
-
y
x
o
r
d
y
h
-
1
(
s
i
B

r
e
p
p
o
c
)
S
O

,

e
t
a
l
o
s
e
r
c
-
m
-
o
r
o
h
c
-
p

l

i

m
u
d
o
S

e
s
o
l
a
r
o
h
C

l

l

n
o
r
u
o
t
o
r
o
h
C

l

7
-
1
4
-
3
6
8
3
1

4
-
1
0
6
-
7
3
2

L
N

e
d
i
r
o
h
c

l

i

e
n
m
o
r
B

8
-
0
6
-
8
4
5
4
1

8
-
8
8
5
-
8
3
2

K
U

l

o
n
a
h
t
e
m
)
y
x
o
l
y
z
n
e
b
(

6

5

4

2

1

8
-
5
5
-
1
3
7
6
1

3
-
5
9
7
-
0
4
2

E
D

e
t
i
h
p
u
s
i
d

l

m
u
i
s
s
a
t
o
p
D

i

L 325/50

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

6

4

3

2

1

0
-
1
5
-
2
7
4
8
1

0
-
4
5
3
-
2
4
2

T
P

-

″

N
N

,

h
t
i

w

d
n
u
o
p
m
o
c

,

d
i
c
a

c
i
n
o
c
u
l
g
-
D

-
o
n
m

i

i
i

,

d
-
2
1
3
-
)
l
y
n
e
h
p
o
r
o
h
c
-
4
(
s
i
b

l

i

i

e
n
d
m
a
i
d
e
n
a
c
e
d
a
r
t
e
t
a
z
a
a
r
t
e
t
-
3
1
1
1
4
2

,

,

,

3
2

0
2

8
1

4
1

8
-
3
7
-
9
5
8
0
2

0
-
8
8
0
-
4
4
2

E
D

i

e
d
h
p
s
o
h
p

i

i

m
u
n
m
u
A

l

8
1

8
1

3
1

2
1

1
1

0
1

9

7

6

4

2

0
-
7
1
-
4
6
5
1
2

0
-
5
4
4
-
4
4
2

N

-
o
h
t

i

i

l
y
h
t
e
m
)
o
h
t
l
y
-
2
-
l
o
z
a
i
h
t
o
z
n
e
b
(

3
-
3
2
-
1
8
7
2
2

8
-
6
1
2
-
5
4
2

K
U

b
r
a
c
o
d
n
e
B

i

e
t
a
n
a
y
c

9
-
6
3
-
1
3
0
3
2

9
-
7
8
3
-
5
4
2

L
E

)
l
y
n
y
-
2
-
p
o
r
p
(
-
3
-
o
x
o
-
4
-
l
y
h
t
e
m
-
2

-
3
-
l
y
h
t
e
m
d
-
2
2

i

,

l
y
-
1
-
n
e
-
2
-
t
n
e
p
o
l
c
y
c

-
e
n
a
p
o
r
p
o
l
c
y
c
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m
-
2

(

n
i
r
h
t
e
l
l
a
r
P
/
e
t
a
l
y
x
o
b
r
a
c

3
1

2
1

0
1

1
1

9

9

8

7

6

1
-
9
0
-
8
1
0
0
2

3
-
8
6
4
-
3
4
2

K
U

l

e
n
e
u
o
t
]
l
y
n
o
h
p
u
s
)
l
y
h
t
e
m
o
d
o

l

i
i

d
(
[
-
p

1

9
-
0
9
-
9
7
3
9
1

1
-
8
0
0
-
3
4
2

Y
C

e
d
i
r
o
h
c

l

i

m
u
n
o
x
o
z
n
e
B

)

1
2

:

(

2
-
9
5
-
7
2
4
0
2

9
-
5
1
8
-
3
4
2

3
-
2
1
-
7
6
6
0
2

1
-
7
5
9
-
3
4
2

R
F

E
S

e
d
i
x
o
r
d
y
h
d

i

r
e
p
p
o
C

e
d
i
x
o

r
e
v
l
i
s
i
D

1
2

0
1

9

0
1

9

7

7

2

6
-
2
5
-
8
6
6
7
2

8
-
5
9
5
-
8
4
2

S
E

)
l
y
l
i
s
y
x
o
h
t
e
m

i
r
t
(
-
3
[
l
y
c
e
d
a
t
c
o
l
y
h
t
e
m
D

i

e
d
i
r
o
h
c

l

i

m
u
n
o
m
m
a
]
l
y
p
o
r
p

0
-
8
9
-
9
5
1
8
2

3
-
2
7
8
-
8
4
2

L
N

-
6
-
l
y
p
o
r
p
o
l
c
y
c
-
N

-
l
y
t
u
b
-
t
r
e
t
-

′

N

,

i

e
n
m
a
i
d
-
4
2
-
e
n
i
z
a
i
r
t
-
5
3
1
-
)
o
h
t
l
y
h
t
e
m

i

,

,

(

9
1

8
1

4
-
2
0
-
9
1
5
7
2

7
-
5
0
5
-
8
4
2

3
1

2
1

1
1

0
1

9

7

6

4

1
-
0
2
-
0
3
5
6
2

7
-
1
6
7
-
7
4
2

3
1

1
1

0
1

9

9

8

7

6

6

5

4

3

2

2

1

5
-
1
6
-
4
3
6
4
2

1
-
6
7
3
-
6
4
2

6
-
0
5
-
4
5
2
5
2

0
-
4
6
7
-
6
4
2

E
D

T
A

K
U

T
A

,

,

-
5
3
1
-
l
y
h
t
e
m

i
r
t
-

″

.
a
h
p
l
a
.
,

′

.
a
h
p
l
a
.
,
.
a
h
p
l
a

.

l

o
n
a
h
t
e
i
r
t
-
)

,

,

(

H
6
H
4
H
2
5
3
1
-
e
n
i
z
a
i
r
t

,

,

e
n
o
-
3
-
l
o
z
a
i
h
t
o
s
i
-

H
2
-
l
y
t
c
o
-
2

e
n
e
-
9
-
s
o
c
i
r
t
-
s
i
C

,

e
t
a
o
n
e
i
d
-
4
2
-
a
x
e
h
-
)
E
E
(

,

m
u
i
s
s
a
t
o
P

11.12.2007

EN

Official Journal of the European Union

L 325/51

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

4
1

7
-
6
5
-
2
7
7
8
2

9
-
5
0
2
-
9
4
2

E
S

-
3
-
)
l
y
-
4
-
]
l
y
n
e
h
p
b
-

i

,

′
1
1
[
o
m
o
r
b
-

′
4
(
-
3
[
-
3

-
2
-
y
x
o
r
d
y
h
-
4
-
]
l
y
p
o
r
p
l
y
n
e
h
p
-
1
-
y
x
o
r
d
y
h

i

l

e
n
o
o
d
a
m
o
r
B
/
e
n
o
r
y
p
o
z
n
e
b

0
2

8
1

8
1

3
1

2
1

1
1

0
1

9

7

6

6
-
9
5
-
3
2
1
4
3

4
-
5
3
8
-
1
5
2

E
D

5
-
8
3
-
7
6
3
5
3

3
-
9
2
5
-
2
5
2

E
S

3
1

4

3

2

0
-
4
4
-
4
5
5
5
3

0
-
5
1
6
-
2
5
2

E
D

3
-
6
9
-
5
7
5
5
3

0
-
6
2
6
-
2
5
2

K
U

,

i

/
a
e
r
u
l
y
h
t
e
m
d
-
1
1
-
)
l
y
n
e
h
p
l
y
p
o
r
p
o
s
i
-
4
(
-
3

n
o
r
u
t
o
r
p
o
s
I

i

-
]
l
y
n
o
b
r
a
c
]
o
n
m
a
)
l
y
n
e
h
p
o
r
o
h
c
-
4
(
[
[
-

l

N

i

e
d
m
a
z
n
e
b
o
r
o
u
l
f
i
d
-
6
2

,

l
i
l
a
z
a
m

I
/
e
l
o
z
a
d
m

i

i
-

H
1
-
]
l
y
h
t
e
)
l
y
n
e
h
p

,

l

-
o
r
o
h
c
i
d
-
4
2
(
-
2
-
)
y
x
o
l
y
l
l
a
(
-
2
[
-
1

,

l

-
5
4
[
o
o
z
a
x
o
o
x
o
-
2
-
o
r
o
h
c
-
6
(
[
-
S

l

3
1

1
1

0
1

9

7

6

7
-
5
6
-
1
9
6
5
3

0
-
1
8
6
-
2
5
2

Z
C

-
e
n
a
t
n
e
p
)
l
y
h
t
e
m
o
m
o
r
b
(
-
2
-
o
m
o
r
b
-
2

e
l
i
r
t
i
n
d

i

i

s
o
h
p
h
t
e
m
a
z
A
/
e
t
a
h
p
s
o
h
p
o
h
t

i

l
y
h
t
e
m
d

i

-

O
O

,

]
l
y
h
t
e
m

)
l
y
-
)

i

(

H
2
3
-
n
d
i
r
y
p
]
b

3

2

9
-
1
9
-
7
4
2
7
3

0
-
5
2
4
-
3
5
2

K
U

4
-
9
9
-
9
3
1
7
3

4
-
3
6
3
-
3
5
2

c
i
t
i

l

m
o
o
d
/
e
d
i
x
o

m
u
i
s
e
n
g
a
m

m
u
i
c
l
a
C

e
m

i
l

)
1
(

e
d
i
r
o
h
c

l

i

m
u
n
o
m
m
a
l
y
e
l
o
l
y
h
t
e
m
d
l
y
z
n
e
B

i

3

2

3
-
3
2
-
5
4
4
9
3

1
-
4
5
4
-
4
5
2

K
U

d
e
t
a
r
d
y
h
/
e
d
i
x
o
r
d
y
h
m
u
i
s
e
n
g
a
m
m
u
i
c
l
a
c

/
e
d
i
x
o
r
d
y
h
a
r
t
e
t

m
u
i
s
e
n
g
a
m

m
u
i
c
l
a
C

e
m

i
l

c
i
t
i

m
o
o
d

l

i

e
n
o
d
-
4
2
-
e
n
d

i

,

i
l

3
1

2
1

1
1

9

6

5

4

3

2

6
-
8
1
-
8
1
7
2
3

5
-
1
7
1
-
1
5
2

L
N

-
o
z
a
d
m

i

,

i

i
l
y
h
t
e
m
d
-
5
5
-
o
r
o
h
c
o
m
o
r
B

l

2
-
1
1
-
6
2
4
2
3

5
-
5
3
0
-
1
5
2

i

m
u
n
o
m
m
a
l
y
t
c
o
l
y
h
t
e
m
d
l
y
c
e
D

i

)
2
(

e
d
i
r
o
h
c

l

9
1

8
1
-
0
7
-
7
0
5
0
3

6
-
3
5
7
-
0
5
2

T
A

e
t
a
t
e
c
a

,

l
y
n
e
i
d
-
2
1
9
-
a
c
e
d
a
r
t
e
t
-
)
E
Z

,

(

L 325/52

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

2
2

9
1

9
1

8
1

8
1

8
1

8
1

8
1

3
1

2
1

1
1

6

4
-
7
8
-
0
0
2
1
5

2
-
8
4
0
-
7
5
2

K
U

e
n
d

i

i
l

o
z
a
x
o
l
y
h
t
e
m
d
-
4
4

i

,

9

1
-
7
8
-
1
9
5
1
4

8
-
1
5
4
-
5
5
2

L
P

-
)
l
y
l
i
s
y
x
o
h
t
e
m

i
r
t
(
-
3
[
l
y
c
e
d
a
r
t
e
t
l
y
h
t
e
m
D

i

e
d
i
r
o
h
c

l

i

m
u
n
o
m
m
a
]
l
y
p
o
r
p

2

1

6
-
6
8
-
2
2
8
2
4

7
-
3
5
9
-
5
5
2

K
U

-
e
n
a
h
t
n
e
m
-
p
-
s
n
a
r
t

d
n
a

-
s
i
c

f
o

e
r
u
t
x
i
M

l

i

o
d
o
i
r
t
i

C

/
l
o
d

i

8
3

,

7
-
0
4
-
5
1
5
9
3

5
-
4
8
4
-
4
5
2

L
E

-
o
l
c
y
c
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m
-
2
(
-
3
-
l
y
h
t
e
m
d

i

-
2
2

,

l
y
z
n
e
b
y
x
o
n
e
h
p
-
3
-
o
n
a
y
c
-
.
a
h
p
l
a

.

e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

9

8

8
-
7
0
-
5
1
3
2
5

9
-
2
4
8
-
7
5
2

6
-
6
3
-
4
0
3
2
5

0
-
5
3
8
-
7
5
2

E
B

E
B

9

8

5

3

2

1
-
3
5
-
5
4
6
2
5

9
-
7
6
0
-
8
5
2

E
I

i

e
t
a
n
n
a
l
a
-
.
a
t
e
b
.
-
l
y
t
u
b
-
N

-
l
y
t
e
c
a
-
N

l
y
h
t
e

,

-
2
2
(
-
3

l
y
z
n
e
b
y
x
o
n
e
h
p
-
3
-
o
n
a
y
c
-
.
a
h
p
l
a

.

i

-
o
l
c
y
c
l
y
h
t
e
m
d
-
2
2
-
)
l
y
n
i
v
o
r
o
h
c
i
d

l

,

l

-
)
l
y
n
i
v
o
r
o
h
c
i
d
-
2
2
(
-
3

,

l
y
z
n
e
b
y
x
o
n
e
h
p
-
m

n
i
r
h
t
e
m
r
e
p
y
C
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

5
-
3
6
-
8
1
9
2
5

6
-
6
5
2
-
8
5
2

E
S

-
R
1
[

l
y
z
n
e
b
y
x
o
n
e
h
p
-
3
-
o
n
a
y
c
-
.
a
h
p
l
a

.

n
i
r
h
t
e
m
r
e
P

,

i

-
o
r
b
d
-
2
2
(
-
3
-
]
]
.
a
h
p
l
a
.
3

,
)
*
S
(
.
a
h
p
l
a
.
1
[

/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p
o
l
c
y
c
l
y
h
t
e
m
d
-
2
2

i

,

3
1

1
1

0
1

2
1

1
1

9

9

8

7

6

6

2

8
-
0
3
-
6
6
5
5
5

0
-
9
0
7
-
9
5
2

T
M

i

m
u
n
o
h
p
s
o
h
p
)
l
y
h
t
e
m
y
x
o
r
d
y
h
(
s
i
k
a
r
t
e
T

6
-
3
5
-
6
0
4
5
5

5
-
7
2
6
-
9
5
2

K
D

e
t
a
m
a
b
r
a
c
l
y
t
u
b

l
y
n
y
p
o
r
p
-
2
-
o
d
o
i
-
3

3
-
8
4
-
6
0
4
4
5

4
-
4
5
1
-
9
5
2

E
B

-
o
l
c
y
c
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m
-
2
(
-
3
-
l
y
h
t
e
m
d

i

-
2
2

,

l
y
n
e
-
2
-
t
n
e
p
l
y
h
t
e
m
-
2
-
l
y
n
y
h
t
e
-
1

n
i
r
h
t
n
e
p
m
E
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

n
i
r
h
t
e
m
a
t
l
e
D
/
e
t
a
l
y
x
o
b
r
a
c

-
e
n
a
p
o
r
p
o
l
c
y
c
l
y
h
t
e
m
d
-
2
2
-
)
l
y
n
i
v
o
m

i

,

)

:

1
2
(
e
t
a
h
p
u
s

l

4
1

5
-
7
0
-
3
7
0
6
5

4
-
8
7
9
-
9
5
2

I
F

,

,

,

-
1
-
o
r
d
y
h
a
r
t
e
t
-
4
3
2
1
-
l
y
-
4
-
l
y
n
e
h
p
b
-
3
(
-
3

i

/
n
i
r
a
m
u
o
c
y
x
o
r
d
y
h
-
4
-
)
l
y
h
t
h
p
a
n

m
u
o
c
a
n
e
f
i

D

11.12.2007

EN

Official Journal of the European Union

L 325/53

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

4
1

0
-
0
1
-
3
7
0
6
5

5
-
0
8
9
-
9
5
2

T
I

-
4
-
o
m
o
r
b
-

′
4
(
-
3
(
-
3
-
y
x
o
r
d
y
h
-
4

1
2

2
1

1
1

0
1

9

8

7

6

5
-
1
8
-
9
5
3
4
6

8
-
3
4
8
-
4
6
2

N

-
3
-
l
o
z
a
i
h
t
o
s
i
-

H
2
-
l
y
t
c
o
-
2
-
o
r
o
h
c
i
d
-
5
4

l

,

2
-
8
1
-
9
8
7
1
6

9
-
8
3
0
-
3
6
2

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

)
3
(

s
e
d
i
r
o
h
c

l

,
l
y
h
t
e
m

i
r
t
l
y
k
l
a

o
c
o
c

7
-
1
7
-
9
8
7
1
6

8
-
0
8
0
-
3
6
2

)
1
(

s
e
d
i
r
o
h
c

l

,
l
y
h
t
e
m
d
l
y
k
l
a

i

o
c
o
c
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

3
-
7
7
-
9
8
7
1
6

6
-
7
8
0
-
3
6
2

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

)
2
(

s
e
d
i
r
o
h
c

l

,
l
y
h
t
e
m
d

i

l
y
k
l
a
o
c
o
c
i
d

8
-
0
8
-
9
8
7
1
6

2
-
0
9
0
-
3
6
2

,
l
y
h
t
e
m
d
)
l
y
k
l
a

i

w
o

l
l
a
t

d
e
t
a
n
e
g
o
r
d
y
h
(
s
i
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

)
2
(

s
e
d
i
r
o
h
c

l

2
-
1
4
-
9
4
4
3
6

6
-
1
5
1
-
4
6
2

)
1
(

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
8
1
-
8
C
-
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

e
l
o
z
a
n
o
c
i
p
o
r
P
/
e
l
o
z
a
i
r
t

0
2

3
1

2
1

0
1

9

8

7

4

2

1

1
-
0
9
-
7
0
2
0
6

4
-
4
0
1
-
2
6
2

I
F

-
l
y
p
o
r
p
-
4
-
)
l
y
n
e
h
p
o
r
o
h
c
i
d
-
4
2
(
-
2
[
[
-
1

l

,

m
u
o
c
a
f
i
d
o
r
B
/
n
i
r
a
m
u
o
c
)
l
y
h
t
h
p
a
n

,

,

-
4
2
1
-
H
1
-
]
l
y
h
t
e
m

]
l
y
-
2
-
n
a
l
o
x
o
d
-
3
1

i

,

8
1

8
1

3
1

2
1

1
1

0
1

6

2

2
-
4
4
-
4
0
2
6
6

8
-
5
3
2
-
6
6
2

T
A

-
o
z
a
x
o
l
y
h
t
e
m
-
5
[
s
i
b
e
n
e
l
y
h
t
e
m

-

′
3
3

,

0
-
4
4
-
8
2
6
4
6

3
-
0
8
9
-
4
6
2

T
I

-
e
h
p
)
y
x
o
h
t
e
m
o
r
o
u
l
f
i
r
t
(
-
4
[
[
[
-

N
-
o
r
o
h
c
-
2

l

e
n
o

i

e
d
m
a
z
n
e
b
]
l
y
n
o
b
r
a
c
]
o
n
m
a
]
l
y
n

i

n
d

i

i
l

o
z
a
x
O

/
]
e
n
d

i

i
l

3
1

2
1

0
1

9

8

7

6

4
-
1
9
-
4
6
5
7
6

9
-
9
1
7
-
6
6
2

S
E

-
l
y
h
t
e
m
-
2
-
)
l
y
n
e
h
p
l
y
t
u
b
-
t
r
e
t
-
p
(
-
3
[
-
4
-
s
i
C

i

e
n
m
a
i
r
t

/
e
n

i
l

o
h
p
r
o
m
l
y
h
t
e
m
d
-
6
2
-
]
l
y
p
o
r
p

i

,

i

h
p
r
o
m
p
o
r
p
n
e
F

8
-
7
2
-
5
1
2
6
6

8
-
7
5
2
-
6
6
2

L
E

,

,

,

-
6
4
2
-
e
n
i
z
a
i
r
t
-
5
3
1
-
l
y
p
o
r
p
o
l
c
y
c
-
N

,

,

-
1
-
o
r
d
y
h
a
r
t
e
t
-
4
3
2
1
-
)
l
y
l
y
n
e
h
p
b

i

,

,

L 325/54

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

8
1

5
-
7
3
-
9
5
3
8
6

7
-
5
5
8
-
9
6
2

E
D

l
y
z
n
e
b
y
x
o
n
e
h
p
-
3
-
o
r
o
u
l
f
-
4
-
o
n
a
y
c
-
.
a
h
p
l
a

.

2
2

7
1

3
1

2
1

1
1

0
1

9

7

6

5

4

3

2

1

5
-
1
0
-
1
9
3
8
6

4
-
9
1
9
-
9
6
2

T
I

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
8
1
-
2
1
C
-
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

n
i
r
h
t
u
l
f
y
C
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

2
2

3
1

2
1

1
1

0
1

9

7

6

5

4

3

2

1

3
-
5
9
-
4
2
4
8
6

5
-
1
3
3
-
0
7
2

T
I

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
0
1
-
8
C
-
i
d

3
1

2
1

1
1

0
1

9

8

7

6

4

3

2

1

1
-
5
8
-
4
2
4
8
6

2
-
5
2
3
-
0
7
2

T
I

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
6
1
-
2
1
C
-
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

3

0
-
4
0
-
0
4
4
8
6

3
-
0
3
4
-
0
7
2

U
H

s
t
c
u
d
o
r
p

n
o
i
t
c
a
e
r

,

o
c
o
c

,
s
d
i
c
a

i

e
n
m
a
l
o
n
a
h
t
e
i
d

y
t
t
a
F

h
t
i

w

4
-
0
0
-
9
8
9
8
6

1
-
4
4
5
-
3
7
2

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

0
-
6
0
-
1
9
3
8
6

7
-
5
2
9
-
9
6
2

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

)
2
(

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
2
1
-
6
C
-
i
d

0
-
4
8
-
4
2
4
8
6

7
-
4
2
3
-
0
7
2

)
1
(

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
6
1
-
8
C
-
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

,

i

-
o
l
c
y
c
l
y
h
t
e
m
d
-
2
2
-
)
l
y
n
i
v
o
r
o
h
c
i
d
-
2
2
(
-
3

l

,

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
6
1
-
0
1
C
-
l
y
z
n
e
b

)
1
(

s
e
d
i
r
o
h
c

l

2
1

1
1

4

2

5
-
1
0
-
9
8
9
8
6

7
-
5
4
5
-
3
7
2

T
M

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

h
t
i

w

s
t
l
a
s

-
1
1

,

e
n
o
-
)

(

H
2
3
-
l
o
z
a
i
h
t
o
s
i
z
n
e
b
-
2
1

,

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
8
1
-
2
1
C
-
l
y
z
n
e
b

2
1

1
1

5

4

3

2

1

8
-
2
6
-
3
9
6
0
7

7
-
8
7
7
-
4
7
2

I
S

-
o
n
o
m
y
x
o
r
e
p
(
s
i
b

m
u
i
s
s
a
t
o
p
a
t
n
e
P

)
e
t
a
h
p
u
s
(
s
i
b

l

)
e
t
a
h
p
u
s

l

7

6

3
-
4
4
-
1
6
1
0
7

8
-
7
5
3
-
4
7
2

T
A

e
t
a
n
i
c
y
l
g
)
l
y
h
t
e
m
y
x
o
r
d
y
h
(
-

N

i

m
u
d
o
S

2

1

2
-
0
8
-
2
9
5
0
7

2
-
7
8
6
-
4
7
2

T
P

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
6
1
-
0
1
C

,
s
e
n
m
A

i

s
e
d
i
x
o
-
N

)

1
1

:

(

e
d
i
x
o
d

i

11.12.2007

EN

Official Journal of the European Union

L 325/55

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

1

6
-
5
7
-
5
7
7
0
7

8
-
1
6
8
-
4
7
2

U
H

-
l
y
d
i
r
y
p
-
)

(

H
4
1
-
i
d
l
y
i
d
-
0
1
1
-
e
n
a
c
e
d
(
-

,

′

,

N
N

)

i

m
u
n
o
m
m
a
l
y
t
c
o
(
s
i
b
)
e
n
e
d

i
l
y
-
4

e
d
i
r
o
h
c
i
d

l

2
2

2
2

9
1

8
1

8
1

7
1

7
1

3
1

2
1

1
1

0
1

7

6

4

3

2

6
-
5
6
-
2
6
8
0
7

0
-
8
4
9
-
4
7
2

Z
C

m
u

i
l

o
z
a
d
m

i

i
-

H
1
-
l
y
h
t
e
m
-
2
-
l
y
c
e
d
d
-
3
1

i

,

2
1

1
1

9

4

3

3

2

2

2

3
-
5
2
-
6
9
6
4
8

7
-
4
4
6
-
3
8
2

E
D

.
t
x
e

a
s
o
g
r
a
M

9
-
5
0
-
9
8
9
4
8

4
-
3
9
8
-
4
8
2

U
H

n
o
i
t
c
a
r
f

l

o
n
e
h
p
l
y
k
l
a
y
l
o
p

,
s
d
i
c
a

r
a
T

1

9
-
8
4
-
5
8
0
5
8

1
-
7
7
3
-
5
8
2

S
E

n
a
i
l
a
r
t
s
u
A

/
.
t
x
e

,
a
i
l

o
f
i
n
r
e
t
l
a

a
c
u
e
l
a
l
e
M

l
i

O

e
e
r
T

a
e
T

8
-
8
2
-
1
4
7
1
8

2
-
8
0
8
-
9
7
2

L
P

l

i

e
d
i
r
o
h
c
m
u
n
o
h
p
s
o
h
p
l
y
c
e
d
a
r
t
e
t
l
y
t
u
b
i
r
T

3
1

2
1

1
1

0
1

9

7

6

5

4

3

2

1

9
-
2
2
-
9
0
4
5
8

1
-
9
8
0
-
7
8
2

3
1

2
1

1
1

9

6

5

4

3

2

1

0
-
3
2
-
9
0
4
5
8

7
-
0
9
0
-
7
8
2

T
I

T
I

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
4
1
-
2
1
C
-
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

8

8
-
1
0
-
0
9
4
2
7

7
-
6
9
6
-
6
7
2

E
D

-
r
a
c
]
l
y
h
t
e
)
y
x
o
n
e
h
p
y
x
o
n
e
h
p
-
4
(
-
2
[

l
y
h
t
e

b
r
a
c
y
x
o
n
e
F
/
e
t
a
m
a
b

8
-
4
6
-
8
9
3
3
7

8
-
3
5
4
-
7
7
2

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

)
2
(

s
e
d
i
r
o
h
c

l

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
8
1
-
8
C
-
i
d

e
d
i
r
o
h
c

l

7

6

8
-
2
0
-
1
9
4
8
7

2
-
8
2
9
-
8
7
2

T
L

4

3

2

4
-
5
8
-
5
1
9
4
1
1

L
P

,

i

-
i
o
x
o
d
-
5
2
-
)
l
y
h
t
e
m
y
x
o
r
d
y
h
(
s
i
b
-
3
1
[
-
1

,

)
-
2
(
e
t
a
s
e
n
g
a
m
]
1
O
O
1
O

,

-
)
-
2
(
o
t
a
l
a
h
t
h
p
y

-
x
o
r
e
p
o
n
o
m

[
s
i
b

n
e
g
o
r
d
y
h
D

i

e
t
a
r
d
y
h
a
x
e
h

a
e
r
u
l
y
n
d

i

i
l

o
z
a
i
D
/
a
e
r
u
)
l
y
h
t
e
m

-
y
x
o
r
d
y
h
(
s
i
b
-
3
1
-
]
l
y
-
4
-
n
d

i

,

i
l

o
z
a
d
m

i

-
i
d
]
l
y
h
t
e
m

)
l
y
n
e
h
p
l
y
h
t
e
(
[
l
y
k
l
a
-
4
1
-
2
1
C

s
e
d
i
r
o
h
c

l

,
l
y
h
t
e
m

7
-
3
6
-
7
9
9
9
8

3
-
9
9
6
-
9
8
2

S
E

.
t
x
e

,

m
u
i
l
o
f
e
a
i
r
a
r
e
n
i
c

m
u
m
e
h
t
n
a
s
y
r
h
C

L 325/56

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

9
1

9
-
9
6
-
2
2
7
1
9

6
-
0
7
4
-
4
9
2

T
P

/
.
t
x
e

,
a
d
i
r
b
y
h

a
l
u
d
n
a
v
a
L

,
r
e
d
n
e
v
a
L

3
1

2
1

1
1

6

2

9
-
4
5
-
4
0
6
0
9

7
-
8
4
3
-
2
9
2

L
P

-
y
x
o
t
u
b
-
2
(
-
2

h
t
i

w

s
t
c
u
d
o
r
p

n
o
i
t
c
a
e
r

d
n
a

l

o
c
y
l
g

e
n
e
l
y
h
t
e

,
l

o
n
a
h
t
e
)
y
x
o
h
t
e

,
-
)
l
y
h
t
e
m
y
x
o
r
d
y
h
(
s
i
b
-

′

N
N

,

,
a
e
r
U

e
d
y
h
e
d
l
a
m
r
o
f

4
-
9
2
-
0
8
0
1
9

5
-
2
2
5
-
3
9
2

)
1
(

i

s
e
d
m
o
r
b

i

,
l
y
h
t
e
m
d
l
y
k
l
a
-
8
1
-
8
C
-
l
y
z
n
e
b

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

8
1

4
1

4
-
9
9
-
9
9
9
9
9
9

6
-
7
2
1
-
0
1
3

3
-
6
0
-
9
7
4
6
8

1
-
0
0
4
-
1
0
4

3
1

2
1

1
1

0
1

7

6

4

3

2

1

1
-
4
6
-
5
8
0
0
0
1

8
-
6
0
2
-
9
0
3

0
1

5
-
8
4
-
6
6
2
4
9

9
-
5
5
4
-
4
0
3

V
L

T
L

L
E

T
P

)
l
y
h
t
e
y
x
o
r
d
y
h
-
2

(
)
l
y
h
t
e
y
x
o
b
r
a
c
-
2
(
[
-
2
[
[
-
2
[

,
s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

l
i

o

i

n
d
n
a
v
a
L

.
t
x
e

e
n
i
P

o
c
o
c
]
l
y
h
t
e
o
x
o
-
2
-
]
o
n
m
a
]
l
y
h
t
e
]
o
n
m
a

i

i

s
t
l
a
s

r
e
n
n

i

,
s
e
d
i
x
o
r
d
y
h

,
l
y
h
t
e
m
d
l
y
k
l
a

i

d
e
r
e
d
w
o
p

,

b
o
c

n
r
o
C

,

,

,

-
o
r
o
u
l
f
a
r
t
e
t
-
2
2
1
1
(
-
4
-
o
r
o
h
c
i
d
-
5
3
(
-
1

l

,

2
1

1
1

2

2
-
7
8
-
5
1
4
9
8

7
-
0
7
5
-
1
0
4

L
N

-
o
z
a
d
m

i

i
l
y
h
t
e
m
-
5
-
l
y
h
t
e
-
5
-
o
r
o
h
c
i
d
-
3
1

l

,

,

-
o
r
o
u
l
f
i
d
-
6
2
(
-
3
-
)
l
y
n
e
h
p
)
y
x
o
h
t
e

n
o
r
u
m
u
l
f
a
x
e
H
/
a
e
r
u
)
l
y
o
z
n
e
b

i

e
n
o
d
-
4
2
-
e
n
d

i

,

i
l

0
1

9

8

7

3
-
6
9
-
4
3
5
7
0
1

2
-
0
4
6
-
3
0
4

K
D

,

i

-
3
-
l
y
h
t
e
m
d
-
4
4
-
)
l
y
n
e
h
p
o
r
o
h
c
-
4
(
-
1

l

4

3

2

1

6
-
2
7
-
7
0
9
4
6
1

8
-
0
5
9
-
3
0
4

E
D

d
n
a

d
i
c
a

c
i
m
a
t
u
l
g

:
f
o

s
t
c
u
d
o
r
p

n
o
i
t
c
a
e
R

i

e
n
m
a
i
d
e
n
e
l
y
p
o
r
p
)
l
y
k
l
a
-
4
1
-
2
1
C
(
-

N

e
l
o
z
a
n
o
c
u
b
e
T

/
l
o
-
3
-
n
a
t
n
e
p
)
l
y
h
t
e
m
l
y
-
1
-
l
o
z
a
i
r
t
-
4
2
1

,

,

(

9

7

6

4
-
9
1
-
2
3
1
8
6

8
-
0
9
6
-
4
0
4

L
P

-
)
l
y
x
e
h
l
y
h
t
e
-
2
(
s
i
b

i

m
u
n
o
m
m
a
)
l
y
h
t
e
y
x

-
o
r
d
y
h
-
2
(
s
i
b
l
y
k
l
a
)
8
1
-
8
C

(

:
f
o

e
r
u
t
x
i
M

-
o
r
d
y
h
l
y
x
e
h
l
y
h
t
e
-
2

i

m
u
n
o
m
m
a
)
l
y
h
t
e
y
x

-
o
r
d
y
h
-
2
(
s
i
b
l
y
k
l
a
)
8
1
-
8
C

(
;
e
t
a
h
p
s
o
h
p

e
t
a
h
p
s
o
h
p
n
e
g

11.12.2007

EN

Official Journal of the European Union

L 325/57

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

8
1

8
1

8
1

8
1

8
1

9
1

2
1

1
1

4

3

2

1

0
-
1
3
-
5
7
2
8
2
1

8
-
0
5
8
-
0
1
4

8
-
7
6
-
6
2
7
5
0
1

9
-
0
6
4
-
4
1
4

6
-
8
0
-
5
6
4
1
9

7
-
0
3
1
-
5
1
4

T
I

S
E

E
S

d
i
c
a

c
i
o
n
a
x
e
h
y
x
o
r
e
p
)
o
d
m

i

i
l
a
h
t
h
p
(
-
6

-
y
x
o
n
e
h
p
-
3
-
o
n
a
y
c
-
a
h
p
l
a

:
f
o

e
r
u
t
x
i
M

i

e
d
m
a
n
a
c
e
d
o
e
n

l
y
h
t
e
M

l

-
o
r
o
h
c
-
2
(
-
3
-
)
S
(
[
-
)
R
3
R
1
(
-
)
Z

,

(

l
y
z
n
e
b

8

3

2

1
-
7
0
-
4
4
8
0
8

2
-
0
8
9
-
7
0
4

T
A

-
2
-
)
l
y
n
e
h
p
y
x
o
h
t
e
-
4
(
-
2
-
l
y
z
n
e
b
y
x
o
n
e
h
p
-
3

x
o
r
p
n
e
f
o
t
E
/
r
e
h
t
e
l
y
p
o
r
p
l
y
h
t
e
m

-
.
a
h
p
l
a
.
-
)
l
y
r
y
t
s
l
y
h
t
e
m
o
r
o
u
l
f
i
r
t
-
4
(
-
.
a
h
p
l
a

.

-
y
h
e
n
e
d

i
l
y
m
a
n
n
i
c
)
l
y
h
t
e
m
o
r
o
u
l
f
i
r
t
-
4

(

n
o
n
l
y
h
t
e
m
a
r
d
y
H
/
e
n
o
z
a
r
d

4
-
9
2
-
5
8
4
7
6

9
-
0
9
0
-
5
0
4

E
I

e
n
o
-
2
-
n
d
m

i

i

i
r
y
p
-
o
r
d
y
h
r
e
p
-
l
y
h
t
e
m
d
-
5
5

i

,

i

-
o
l
c
y
c
l
y
h
t
e
m
d
-
3
3
-
)
l
y
n
i
v
o
r
o
h
c
i
d

l

,

n
i
r
h
t
u
l
f
s
n
a
r
T
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

,

-
2
2
-
]
)
l
y
n
e
-
1
-
p
o
r
p
-
o
r
o
u
l
f
i
r
t
-
3
3
3

,

,

3
1

0
1

9

7

6

4
-
7
0
-
9
9
2
4

7
-
0
9
5
-
0
2
4

Z
C

e
n
o
-
3
-
l
o
z
a
i
h
t
o
s
i
]
d
[
o
z
n
e
b
-
l
y
t
u
b
-
2

5

4

3

2

1

2
-
6
7
-
7
4
0
2
9

2
-
0
7
9
-
0
2
4

E
D

x
e
l
p
m
o
c

e
d
i
x
o
a
c
e
d
o
r
o
h
c
a
r
t
e
T

l

8

8
-
9
6
-
3
6
4
1
0
1

3
-
0
8
6
-
7
1
4

R
F

-
)
y
x
o
l
y
l
o
t
o
r
o
u
l
f
i
r
t
-
p
-
a
,
a
,
a
-
o
r
o
l
c
-
2
(
-
4
(
-
1

,

-
o
r
o
u
l
f
i
d
-
6
2
(
-
3
-
)
l
y
n
e
h
p
o
r
o
u
l
f
-
2

n
o
r
u
x
o
n
e
f
u
l
F
/
a
e
r
u
)
l
y
l
o
z
n
e
b

n
i
r
h
t
o
l
a
h
y
c

a
d
b
m
a
L
/
e
t
a
l
y
x
o
b
r
a
c

-
e
n
a
p
o
r
p
o
l
c
y
c
l
y
h
t
e
m
d
-
2
2
-
]
)
l
y
n
e

i

,

4
1

8
-
8
0
-
5
3
0
0
9

0
-
0
6
9
-
1
2
4

L
N

-
n
e
b
l
y
h
t
e
m
o
r
o
u
l
f
i
r
t
-
4
(
-
4
(
-
3
-
o
r
d
y
h
a
r
t
e
t

;

n
i
r
a
m
u
o
c
)
l
y
h
t
h
p
a
n
-
1
-
)
l
y
n
e
h
p
)
y
x
o
l
y
z

,

,

,

-
4
3
2
1
(
-
3
-
y
x
o
r
d
y
h
-
4
-
s
i
c

:
f
o

e
r
u
t
x
i
M

,

,

,

-
o
r
d
y
h
a
r
t
e
t
-
4
3
2
1
(
-
3
-
y
x
o
r
d
y
h
-
4
-
s
n
a
r
t

)
y
x
o
l
y
z
n
e
b
l
y
h
t
e
m
o
r
o
u
l
f
i
r
t
-
4
(
-
4
(
-
3

/
n
i
r
a
m
u
o
c
)
l
y
h
t
h
p
a
n
-
1
-
)
l
y
n
e
h
p

n
e
f
a
m
u
o
c
o
l
F

-
a
h
p
l
a
;
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p
o
l
c
y
c
l
y
h
t
e
m
d

i

,

-
)
S
3
S
1
(
-
)
Z

(

l
y
z
n
e
b
y
x
o
n
e
h
p
-
3
-
o
n
a
y
c

,

-
1
-
p
o
r
p
-
o
r
o
u
l
f
i
r
t
-
3
3
3
-
o
r
o
h
c
-
2
(
-
3
-
)
R
(
[

l

,

3
-
9
8
-
2
1
7
8
1
1

5
-
0
6
0
-
5
0
4

L
N

,

-
2
2
(
-
2
-
s
n
a
r
t

l
y
z
n
e
b
o
r
o
u
l
f
a
r
t
e
t
-
6
5
3
2

,

,

,

L 325/58

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

9
1

7
-
8
3
-
5
1
5
9
1
1

8
-
0
1
2
-
3
2
4

K
D

i

i

-
e
n
d
i
r
e
p
p
)
l
y
h
t
e
y
x
o
r
d
y
h
-
2
(
-
2

l
y
t
u
b
-
c
e
s

8
1

8
1

8
1

8
1

8
1

3
1

2
1

9

6

8
-
8
7
-
9
2
2
1
5

3
-
0
2
0
-
6
2
4

3
-
7
3
-
8
6
0
0
2
1

5
-
0
1
6
-
4
2
4

R
F

L
P

,

,

-
1
-
a
z
a
i
r
t
-
7
5
3
-
)
l
y
l
l
a
o
r
o
h
c
-
3
(
-
1
-
s
i
c

l

i

e
n
d
i
r
a
c
I
/
e
t
a
l
y
x
o
b
r
a
c
-
1

l
i

n
o
r
p
i
F

9

8

4
-
3
2
-
9
1
7
3
5
1

4
-
0
5
6
-
8
2
4

S
E

m
a
x
o
h
t
e
m
a
i
h
T

-
o
l
c
a
d
m

i

i

I
/
e
n
m
a
n
e
d

i
l
y
-
2
-
n
d

i

i
l

o
z
a
d
m

i

i

d
i
r
p

3
-
1
4
-
1
6
2
8
3
1

8
-
0
4
0
-
8
2
4

E
D

-
o
r
t
i
n
-
N

i

-
)
l
y
h
t
e
m
l
y
-
3
-
n
d
i
r
y
p
o
r
o
h
c
-
6
(
-
1

l

e
d
i
r
o
h
c

l

e
n
a
t
n
a
m
a
d
a
a
i
n
o
z
a

9

6

4

2

1

1
-
0
3
-
0
8
3
3

0
-
0
9
2
-
9
2
4

T
A

5
-
2
7
-
3
6
9
2
7

6
-
0
9
7
-
8
2
4

K
U

-
n
d

i

i
l

o
z
a
d
m

i

i
)
l
y
-
1
-
n
y
p
o
r
p
-
2
(
-
o
x
o
D
-
4
2
[

i

,

-
y
r
h
c
-
s
i
c
-
)
R
1

(
l
y
h
t
e
m

]
l
y
-
3

-
s
n
a
r
t
-
)
R
1

(
l
y
h
t
e
m

]
l
y
-
3
-
n
d

i

i
l

o
z
a
d
m

i

i
)
l
y

n
i
r
h
t
o
r
p
m

i

I
/
e
t
a
m
e
h
t
n
a
s
y
r
h
c

i

-
1
-
n
y
p
o
r
p
-
2
(
-
o
x
o
D
-
4
2
[
;
e
t
a
m
e
h
t
n
a
s

,

l

o
n
e
h
p
)
y
x
o
n
e
h
p
r
o
h
c
-
4
(
-
2
-
o
r
o
h
c
-
5

l

l

1
-
8
6
-
7
3
7
5
9

1
-
0
0
8
-
9
2
4

L
N

-
)
y
x
o
n
e
h
p
-
y
x
o
n
e
h
p
-
4
(
-
2
-
l
y
h
t
e
m
-
1
(
-
2

n
e
f
y
x
o
r
p
i
r
y
P
/
e
n
d
i
r
y
p
-
)
y
x
o
h
t
e

i

3
1

3
1

0
1

9

7

6

4

5
-
0
3
-
9
6
2
3
6
1

6
-
0
3
0
-
1
3
4

T
P

,

,

,

i

-
2
4
1
-
o
r
d
y
h
d
-
6
5
-
l
y
-
2
-
n
e
i
h
t
)
b
(
o
z
n
e
b
-
3

6

5
-
3
7
-
4
4
4
0
2
2

8
-
0
4
4
-
2
3
4

U
H

-
o
n
a
p
o
r
p
o
s
i
i

d

f
o

s
t
c
u
d
o
r
p

n
o
i
t
c
a
e
R

e
d
i
x
o
-
4
,
e
n
i
z
a
i
h
t
a
x
o

)

:

4
1
(
e
d
y
h
e
d
l
a
m
r
o
f

h
t
i

w

i

e
n
m
a
l

3
1

2
1

1
1

4

3

2

2
-
7
3
-
3
2
4
6
8

7
-
0
4
3
-
3
3
4

Z
C

i

e
n
m
a
l
y
t
c
o
)
l
y
p
o
r
p
o
n
m
a
-
3
(
s
i
B

i

2
1

1
1

5

4

3

2

1

-

1
-
0
9
7
-
2
3
4

U
H

,
e
t
a
p
d
a

i

l
y
h
t
e
m
d

i

f
o

t
c
u
d
o
r
p

n
o
i
t
c
a
e
R

e
t
a
n
i
c
c
u
s

l
y
h
t
e
m
d

i

,
e
t
a
r
a
t
u
l
g

l
y
h
t
e
m
d

i

e
n
a
t
s
e
r
e
P
/
e
d
i
x
o
r
e
p

n
e
g
o
r
d
y
h

h
t
i

w

11.12.2007

EN

Official Journal of the European Union

L 325/59

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

8
1

8
1

8
1

3
1

2
1

1
1

0
1

9

8

7

6

9
-
0
1
-
3
0
6
6
6

2
1

1
1

4

3

2

5
-
7
5
-
4
3
7
3
3

2
1

1
1

0
1

9

8

7

6

9

7

5

4

5

3

2

2

2

2

8
-
9
8
-
0
0
6
2
1
3

-

7
-
2
7
-
7
4
4
3
4
1

-

-

-
o
r
c
i
M

m

s
i
n
a
g
r
o

-
o
r
c
i
M

m

s
i
n
a
g
r
o

-
o
r
c
i
M

m

s
i
n
a
g
r
o

5
-
4
5
-
1
0
0
8

e
r
u
t
x
i
M

R
F

T
A

T
A

E
S

T
I

T
I

E
D

,
e
d
i
x
o
-
1

e
n
e
z
a
i
d
y
x
o
r
d
y
h
l
y
x
e
h
o
l
c
y
C

t
l
a
s

m
u
i
s
s
a
t
o
p

r
e
p
p
o
c
-
]
)
-
2
(
o
t
a
m
u
n
e
z
a
i
d
)
O
.
a
p
p
a
k

i

.

,

-
y
x
o
r
d
y
h
(
i
d
-
2
1
-
l
y
x
e
h
o
l
c
y
c
-
1
[
s
i
B

d
i
c
a

c
i
o
n
a
t
c
o
y
x
o
r
e
P

A

e
t
i
l

o
e
z

r
e
v
l
i
S

s
u
c
i
r
e
a
h
p
s

s
u
l
l
i
c
a
B

s
i
s
n
e
l
e
a
r
s
I

.

p
s
b
u
s

s
i
s
n
e
i
g
n
i
r
u
h
t

s
u
l
l
i
c
a
B

4
1
H

e
p
y
t
o
r
e
S

s
i
l
i
t
b
u
s

s
u
l
l
i
c
a
B

i

m
u
n
o
m
m
a
l
y
h
t
e
m
d
-
l
y
z
n
e
b
-
l
y
k
A

l

i

)
1
(

e
d
i
r
o
h
c

l

i

m
u
n
o
k
l
a
z
n
e
B
/
e
d
i
r
o
h
c

l

3
1

2
1

1
1

0
1

9

7

6

4

3

2

9
-
4
8
-
5
6
9
5
5

e
r
u
t
x
i
M

R
F

)

7
-
0
0
5
-
7
4
2

S
C
E
N
I
E
(

e
n
o
-
3
-
l
o
z
a
i
h
t
o
s
i

-

H
2
-
l
y
h
t
e
m
-
2
-
o
r
o
h
c
-
5

l

f
o

e
r
u
t
x
i
M

e
n
o
-
3
-
l
o
z
a
i
h
t
o
s
i
-

H
2
-
l
y
h
t
e
m
-
2

d
n
a

)

6
-
9
3
2
-
0
2
2

S
C
E
N
I
E
(

8

3

5
-
2
9
-
0
8
8
0
1
2

1
-
0
6
4
-
3
3
4

E
D

-
)
l
y
h
t
e
m
l
y
-
5
-
l
o
z
a
i
h
t
-
3
1
-
o
r
o
h
C
-
2
(
-
1
-
)
E
(

l

,

i

i

/
e
n
d
n
a
u
g
o
r
t
i
n
-
2
-
l
y
h
t
e
m
-
3

i

i

n
d
n
a
i
h
t
o
h
C

l

3
1

2
1

1
1

0
1

7

6

4

3

2

1

9
-
5
6
-
4
3
7
9
3
1

e
r
u
t
x
i
M

E
I

3
1

1
1

0
1

7

6

6

5

4

4

3

3

2

2

1

1

2
-
0
5
-
4
7
0
8
0
3

e
r
u
t
x
i
M

-

e
r
u
t
x
i
M

S
E

K
U

d
i
c
a

c
i
t
e
c
a
o
r
o
h
c

l

h
t
i

w
s
t
c
u
d
o
r
p

,
-
i
d
e
n
e
l
y
h
t
e
m

i
r
t
l
y
k
l
a
-
6
1
-
0
1
C
-
n

,
s
e
n
m
A

i

n
o
i
t
c
a
e
r

-
y
x
o
n
e
h
p
-
2

d
n
a

)

7
-
2
2
2
-
2
1
2

S
C
E
N
I
E
(

l

o
-
2
-
n
a
p
o
r
p
y
x
o
n
e
h
p
-
1

f
o

e
r
u
t
x
i
M

)

4
-
7
2
0
-
4
2
2

S
C
E
N
I
E
(

l

o
n
a
p
o
r
p

s
e
d
d
o

i

i

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

L 325/60

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

3
1

2
1

1
1

0
1

9

8

7

6

4

3

2

2

1

5

4

3

2

3
1

2
1

1
1

0
1

9

8

7

6

4

3

2

1

8

-

-

-

-

-

e
r
u
t
x
i
M

K
S

e
h
t

y
b

d
e
r
u
t
c
a
f
u
n
a
m

:
e
n
i
r
o
h
C

l

e
v
i
t
c
A

u
t
i
s

n

i

d
e
c
u
d
o
r
p

l

e
t
i
r
o
h
c
o
p
y
h

i

m
u
d
o
s

d
n
a

d
i
c
a

l

s
u
o
r
o
h
c
o
p
y
h

f
o

n
o
i
t
c
a
e
r

e
r
u
t
x
i
M

E
D

)
1
2
-
5
1
C

(

s
d
i
c
a

y
t
t
a
f

f
o

s
t
l
a
s

m
u
i
s
s
a
t
o
P

f
o

e
r
u
t
x
i
M

T
I

s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

S
C
E
N
I
E

d
e
t
s
i
l

s
e
c
n
a
t
s
b
u
s

w
o

l
l
a
t

,

d
e
t
a
r
u
t
a
s
n
u

d
n
a

d
e
t
a
r
u
t
a
s

-
8
C

m
o
r
f

l
y
k
l
a
(

i

l
y
h
t
e
m
d
l
y
k
l
a
l
y
z
n
e
b
(

,
2
2
C

)
l
y
k
l
a

a
y
o
s

d
n
a

,
l
y
k
l
a

o
c
o
c

,
l
y
k
l
a

f
o

e
r
u
t
x
i
M

T
I

s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

C
K
B
/
)
s
e
d
i
x
o
r
d
y
h

r
o

i

,
s
e
d
m
o
r
b

,
s
e
d
i
r
o
h
c

l

S
C
E
N
I
E

d
e
t
s
i
l

s
e
c
n
a
t
s
b
u
s

w
o

l
l
a
t

d
n
a

,

d
e
t
a
r
u
t
a
s
n
u

d
n
a

d
e
t
a
r
u
t
a
s

,
8
1
C
-
6
C

m
o
r
f

l
y
k
l
a
(

i

l
y
h
t
e
m
d
l
y
k
l
a
i
d
(

-
l
u
s
l
y
h
t
e
m

r
o

i

,
s
e
d
m
o
r
b

,
s
e
d
i
r
o
h
c

l

)
l
y
k
l
a

a
y
o
s

d
n
a

,
l
y
k
l
a

o
c
o
c

,
l
y
k
l
a

C
A
D
D

/
)
s
e
t
a
h
p

f
o

e
r
u
t
x
i
M

T
I

s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

2
1

6
-
1
5
-
1
6
0
8

9

7

6

2

1

9
-
7
4
-
7
7
4
8
9
3

0
1

9

7

4

3

2

1

-

S
C
E
N
I
E

d
e
t
s
i
l

s
e
c
n
a
t
s
b
u
s

l
a
r
u
t
a
N

r
e
m
y
l
o
P

t
e
y

t
o
N

d
e
t
a
c
o

l
l
a

t
e
y

t
o
N

d
e
t
a
c
o

l
l
a

U
H

E
S

-
l
u
s
l
y
h
t
e
m

r
o

i

,
s
e
d
m
o
r
b

,
s
e
d
i
r
o
h
c

l

)
l
y
k
l
a

a
y
o
s

d
n
a

,
l
y
k
l
a

o
c
o
c

,
l
y
k
l
a

C
A
M
T
/
)
s
e
t
a
h
p

e
t
a
n
o
f
l
u
s
o
n
g
i
l

i

m
u
d
o
S

e
t
a
h
p
s
o
h
p
n
o
r
o
b
-
m
u
n
m
u
l
a
-
c
n
i
z
-
r
e
v
l
i
S

i

i

E
S

i

m
u
n
o
c
r
i
z

n
e
g
o
r
d
y
h

i

m
u
d
o
s

r
e
v
l
i
S

e
t
a
h
p
s
o
h
p

-
c
n
i
z

d
n
a

-
r
e
v
l
i
s

,
e
d
i
x
o

s
s
a
l
G
/
s
s
a
l
g

i

g
n
n
i
a
t
n
o
c

w
o

l
l
a
t

d
n
a

,
8
1
C
-
8
C

m
o
r
f

l
y
k
l
a
(

l
y
h
t
e
m

i
r
t
l
y
k
l
a
(

,

d
e
t
a
r
u
t
a
s
n
u

d
n
a

d
e
t
a
r
u
t
a
s

3
1

4

3

2

0
-
8
2
-
0
9
7
3
7

t
n
a
l
P

E
D

,

l

-
o
r
o
h
c
i
d
-
4
2
-
y
x
o
l
y
l
l
a
-
.
a
t
e
b
.
(
-
1
-
)
±

(

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

e
d
a
r
g

l
a
c
i
n
h
c
e
T
/
e
l
o
z
a
d
m

i

i
)
l
y
h
t
e
l
y
n
e
h
p

l
i
l
a
z
a
m

i

11.12.2007

EN

Official Journal of the European Union

L 325/61

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

8
1

8
1

8
1

8
1

8
1

8
1

4
1

8

8

2
-
1
4
-
1
5
7
1
7

3
-
0
1
6
-
5
6
2

L
N

;
a
1
B

n
i
t
c
e
m
r
e
v
A

f
o

e
r
u
t
x
i
M

(

n
i
t
c
e
m
a
b
A

d
n
a

;

3
-
0
1
6
-
5
6
2

S
C
E
N
I
E

,

%
0
8

>

S
C
E
N
I
E

%
0
2

<

;

b
1
B

n
i
t
c
e
m
r
e
v
A

)

9
-
1
1
6
-
5
6
2

3
-
4
0
-
7
5
6
2
8

t
n
a
l
P

R
F

-
2
-
)
Z
1
(
[
-
3

,

d
i
c
a

c
i
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p
o
l
c
y
C

-
a
h
p
l
a
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p
o
l
c
y
c
l
y
h
t
e
m
d

i

n
i
r
h
t
e
m
r
e
p
y
C

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

l

-
o
r
o
h
c
i
d
-
2
2
(
-
3

,

l
y
h
t
e
m

)
l
y
n
e
h
p
y
x
o
n
e
h
p

,

l

-
2
2
-
)
l
y
n
i
v
o
r
o
h
c
i
d
-
2
2
-
)
l
y
n
e
h
t
e

.

5
-
6
0
-
1
6
3
4
9

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

1
-
4
3
-
3
5
6
4
0
1

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

E
I

N

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

,

-
2
2
-
]
l
y
n
e
p
o
r
p
-
1
-
o
r
o
u
l
f
i
r
t
-
3
3
3
-
o
r
o
h
c

l

,

,

-
3
-
]
l
y
n
e
h
p
b
-

i

,

′
1
1
[
l
y
h
t
e
m
-
2

(

,
-
l
y
h
t
e
m
d

i

/
n
i
r
h
t
n
e
f
i
B
/
-
l
e
r
-
)
R
3
R
1

,

(

,
r
e
t
s
e

l
y
h
t
e
m
l
y

e
t
a
n
e
h
p
B

i

,

,

-
1
-
e
l
o
z
a
i
r
t
-
4
2
1
-
H
1
-
)
l
y
h
t
e
l
y
p
o
r
p
o
l
c
y
c

-
1
(
-
.
a
h
p
l
a
.
-
)
l
y
n
e
h
p
o
r
o
h
C
-
4
(
-
.
a
h
p
l
a

l

.

e
l
o
z
a
n
o
c
o
r
p
y
C

/
l
o
n
a
h
t
e

-
)
l
y
-
4
-
)
l
y
n
e
h
p
b
-

i

,

′
1
1
(
-
o
m
o
r
B
-

′
4
(
-
3
(
-
3

-
o
r
d
y
h
-
4
-
)
l
y
h
t
h
p
a
n
-
1
-
o
r
d
y
h
a
r
t
e
t
-
4
3
2
1

,

,

,

i

/
e
n
o
-
2
-
n
h
t
o
z
n
e
b
-
1
-
y
x
o
r
d
y
h
-
4
-
)
l
y
h
t
p
a
n

e
n
o
l
a
i
h
t
e
f
i

D

,

-
1
-
o
r
d
y
h
a
r
t
e
t
-
4
3
2
1
-
l
y
-
4
-
l
y
n
e
h
p

,

,

-
i
b
o
m
o
r
b
-

-
3
/
e
n
o
-
2
-
n
a
r
y
p
o
h
t
o
z
n
e
b
y
x

i

,

′
4
(
-
3
-
)
R
S
3
S
R
1
S
R
3
S
R

,

;

(
(

9

6

8
-
0
3
-
5
7
3
7
6

t
n
a
l
P

E
B

-
3
(
-
o
n
a
y
c
-
)
.
a
h
p
l
a
.
(
-
]
.
a
h
p
l
a
.
3

,
)
*
S
(
.
a
h
p
l
a
.
1
[

4
-
4
0
-
0
3
2
6
6

t
n
a
l
P

T
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

-
)
l
y
n
e
h
p
o
r
o
h
c
-
4
(
-
2
-
)
S
(

l

l
y
z
n
e
b
y
x
o
n
e
h
p

-
3
-
o
n
a
y
C
-
.
a
h
p
l
a
.
-
)
S
(
/
e
t
a
r
e
l
a
v
n
e
f
s
E

e
t
a
r
y
t
u
b
l
y
h
t
e
m
-
3

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

2
-
3
5
-
0
9
7
1
6

t
n
a
l
P

R
F

r
h
u
g
l
e
s
e
i
K
/
e
d
i
x
o
d

i

m
u
i
c
i
l
i
S

6
-
6
1
-
3
3
7
5
6

t
n
a
l
P

E
I

-
1
1
-
)
)
E
E
(
-
s
(

,

l
y
p
o
r
p
o
s
I
/
e
n
e
r
p
o
h
t
e
M
-
S

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

,

-
4
2
-
a
c
e
d
o
d
l
y
h
t
e
m

,

,

i
r
t
-
1
1
7
3
-
y
x
o
h
t
e
m

e
t
a
o
n
e
i
d

L 325/62

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

2

4
-
9
1
-
4
4
0
5
1
1

t
n
a
l
P

K
U

e
t
a
t
e
c
a
i
r
t

e
n
i
t
a
z
a
u
G

8
1

3
1

2
1

0
1

9

8

7

6

0
-
3
7
-
3
5
4
2
2
1

t
n
a
l
P

T
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

-
y
x
o
h
t
e
(
-
1
-
)
l
y
n
e
h
p
o
r
o
h
c
-
4
(
-
2
-
o
m
o
r
B
-
4

l

-
e
l
o
r
r
y
p
-
H
1
-
)
l
y
h
t
e
m
o
r
o
u
l
f
i
r
t
(
-
5
-
)
l
y
h
t
e
m

l

r
y
p
a
n
e
f
r
o
h
C
/
e
l
i
r
t
i
n
o
b
r
a
c
-
3

3
1

7

6

6
-
8
1
-
8
2
3
0
3
1

t
n
a
l
P

E
S

r
e
v
l
i
s
-
e
t
a
c
i
l
i
s

i

m
u
d
o
s

i

i

m
u
n
m
u
A

l

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

e
t
i
l

o
e
z

r
e
v
l
i
S
/
x
e
l
p
m
o
c

8
1

8
1

3
1

6

-

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

L
P

-
l
y
h
t
e
m
y
x
o
h
t
e
m
y
x
o
r
d
y
H
-
5

f
o

e
r
u
t
x
i
M

.

.

e
n
a
t
c
o
)
0
3
3
(
o
l
c
y
c
i
b
a
x
o
d
-
7
3
-
a
z
a
-
1

i

,

-
5

d
n
a

)

%
0
6
1

,

,

2
-
2
4
-
0
2
7
9
5

S
A
C

(

,

i

-
y
c
i
b
a
x
o
d
-
7
3
-
a
z
a
-
1
-
y
x
o
r
d
y
H

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

-
o
l
c
y
c
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m
-
2
(
-
3
-
l
y
h
t
e
m
d

i

n
i
r
h
t
o
n
e
h
P
-
d
/
e
t
a
l
y
x
o
b
r
a
c
e
n
a
p
o
r
p

9

7

6

2

1

0
-
0
2
-
8
2
3
0
3
1

t
n
a
l
P

E
S

c
n
i
z

r
e
v
l
i
s
-
e
t
a
c
i
l
i
s

i

m
u
d
o
s

i

i

m
u
n
m
u
A

l

8
-
4
6
-
0
3
4
0
6
1

t
n
a
l
P

E
B

-

′

N

-
)
l
y
h
t
e
m

i

)
l
y
n
d
i
r
y
p
-
3
-
o
r
o
h
C
-
6

l

(
(
-

N

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
P

e
t
i
l

i

o
e
Z
-
c
n
Z
-
r
e
v
l
i
S
/
x
e
l
p
m
o
c

1
-
6
8
-
3
2
0
8
8
1

t
n
a
l
P

E
I

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

i

i

i

-
a
t
e
c
A
/
e
d
m
a
d
m
n
a
h
t
e
l
y
h
t
e
m
N
-
o
n
a
y
c

-

,

-
2
2
-
s
n
a
r
t
,
s
i
c
-
)
R
1

(

l
y
z
n
e
b
y
x
o
n
e
h
p
-
3

d
i
r
p
m

i

,

6
-
7
5
4
-
9
2
2

S
C
E
N
I
E
(

e
n
a
t
c
o
)
0
3
3
(
o
l
c

.

.

-
y
h
t
e
m
[
y
l
o
p
y
x
o
r
d
y
H
-
5

d
n
a

,
)

%
8
8
2

,

,

i

-
i
b
a
x
o
d
-
7
3
-
a
z
a
-
1
-
l
y
h
t
e
m
]
y
x
o
e
n
e
l

;

8
-
3
1
-
9
0
7
6
5

S
A
C

(

.

e
n
a
t
c
o
)
0
3
3
(
o
l
c
y
c

.

)

%
0
5

(

r
e
t
a
w

n

i

)

%
2
5

,

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

11.12.2007

EN

Official Journal of the European Union

L 325/63

2
2

2
2

8
1

8
1

8
1

8
1

2
1

1
1

1
1

0
1

9

7

6

5

4

3

2

2

3

2
1

1
1

9

6

5

4

3

3

-

-

-

-

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

E
D

-
t
n
e
p
o
l
c
y
c
o
x
o
-
4
-
l
y
h
t
e
m
-
2
-
l
y
l
l

A
-
3
-
)
S
R

(

E
D

-
t
n
e
p
o
l
c
y
c
o
x
o
-
4
-
l
y
h
t
e
m
-
2
-
l
y
l
l

A
-
3
-
)
S
R

(

R
1

:
s
r
e
m
o
s
i

2

f
o

e
r
u
t
x
i
m

(

e
t
a
l
y
x
o
b
r
a
c

-
e
n
a
p
o
r
p
o
l
c
y
c
-
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m

/
n
i
r
h
t
e
l
l
a
o
B
/
)
1
1

i

:

y
l
n
o

S
R
1

:
s
n
a
r
t

n
i
r
h
t
e
l
l

A
-
s
n
a
r
t
-
d

,

i

-
2
(
-
3
-
l
y
h
t
e
m
d
-
2
2
-
)
R
3
R
1
(
-
l
y
n
e
-
2

,

R
1

s
r
e
m
o
s
i

4

f
o

e
r
u
t
x
i
m

(

e
t
a
l
y
x
o
b
r
a
c

-
e
n
a
p
o
r
p
o
l
c
y
c
-
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m
-
2

(

R
1

:

R
1

,
s
i
c

R
1

:

S
1

,
s
n
a
r
t

R
1

:

R
1

,
s
n
a
r
t

,

i

-
3
-
l
y
h
t
e
m
d
-
2
2
-
)
S
3
R
1
R
3
R
1
(
-
l
y
n
e
-
2

,

;

,

n
i
r
h
t
e
l
l

A
-
d
/
)
1
1
4
4

:

:

:

S
1

,
s
i
c

E
D

-
t
n
e
p
o
l
c
y
c
o
x
o
-
4
-
l
y
h
t
e
m
-
2
-
l
y
l
l

A
-
3
-
)
S
R

(

-
e
n
a
p
o
r
p
o
l
c
y
c
-
)
l
y
n
e
-
1
-
p
o
r
p
l
y
h
t
e
m

s
r
e
m
o
s
i

2

f
o

e
r
u
t
x
i
m

(

e
t
a
l
y
x
o
b
r
a
c

i

n
i
r
h
t
o
b
s
E
/
)
3
1

:

y
l
n
o

S
/
R
1

:
s
n
a
r
t

R
1

i

-
2
(
-
3
-
l
y
h
t
e
m
d
-
2
2
-
)
R
3
R
1

,

,

(

l
y
n
e
-
2

t
n
a
l
P

n
o
i
t
c
e
t
o
r
p

t
c
u
d
o
r
p

L
N

l
i

o
s

f
o

t
c
u
d
o
r
p

n
o
i
t
a
t
n
e
m
r
e
f

:

d
a
s
o
n
p
S

i

n
y
s
o
n
p
S

i

i

g
n
n
i
a
t
n
o
c

s

m

s
i
n
a
g
r
o
-
o
r
c
i
m

D

n
y
s
o
n
p
S

i

d
n
a

A

1

8
-
1
4
-
5
5
6
5
2

r
e
m
y
l
o
P

E
S

i

e
n
d
o

i

e
n
o
d

i
l

o
r
r
y
p
l
y
n
i
v
y
l
o
P

0
-
7
9
-
8
8
9
5
2

r
e
m
y
l
o
P

U
H

i

e
n
m
a
n
a
h
t
e
m
l
y
h
t
e
M
N

-

f
o

r
e
m
y
l
o
P

7
-
3
2
-
1
8
7
6
2

r
e
m
y
l
o
P

U
H

n
i
e
l
o
r
c
a

d
n
a

e
d
y
h
e
d
l
a
m
r
o
f

f
o

r
e
m
y
l
o
P

/
)
8
-
9
3
4
-
3
0
2

S
C
E
N
I
E
(

e
n
a
r
i
x
o
)
l
y
h
t
e
m

-
o
r
o
h
c
(

l

h
t
i

w

4
-
7
9
6
-
4
0
2

S
C
E
N
I
E
(

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
q

c
i
r
e
m
y
l
o
P

e
d
i
r
o
h
c

l

2

1

/
8
-
7
2
-
3
8
0
7
2

0
-
8
5
-
9
8
2
2
3

r
e
m
y
l
o
P

R
F

f
o

r
e
m
y
l
o
p

f
o

e
d
i
r
o
h
c

l

o
r
d
y
h
o
n
o
M

′

-
o
n
a
y
c
-

N
[
s
i
b
l
y
i
d
e
n
a
x
e
h
-
6
1
-

,

′
′
′

N
N

,

-
l
y
n
a
u
g
-
)
n
e
l
y
h
t
e
m

i
r
t
(
s
i
b
-
5
1

,

:
r
e
m
o
n
o
m

(

-
4
0
2

S
C
E
N
I
E
(

i

e
n
m
a
i
d
e
n
e
l
y
h
t
e
m
a
x
e
h

i

e
d
n
a
u
g
i
b

e
n
e
l
y
h
t
e
m
a
x
e
h
y
l
o
P
/
)
6
-
9
7
6

d
n
a

)

4
-
2
3
0
-
0
4
2

S
C
E
N
I
E
(

i

]
e
n
d
n
a
u
g

i

l

)
e
d
i
r
o
h
c
o
r
d
y
h
o
n
o
m

i

i

m
u
n
d
n
a
u
g

i

L 325/64

EN

Official Journal of the European Union

11.12.2007

3
2

2
2

1
2

0
2

9
1

8
1

7
1

6
1

5
1

4
1

3
1

2
1

1
1

0
1

9

8

7

6

5

4

3

2

1

r
e
b
m
u
n

S
A
C

r
e
b
m
u
n

C
E

r
u
e
t
r
o
p
p
a
R

r
e
b
m
e
M

e
t
a
t
S

e
c
n
a
t
s
b
u
S

3
1

2
1

1
1

9

2

8
-
4
2
-
5
7
0
1
3

r
e
m
y
l
o
P

K
U

-
a
i
d
e
n
e
l
y
h
t
e
l
y
h
t
e
m
a
r
t
e
T
–
′
N

,

′

,

N
N
N

,

0
2

3
1

2
1

1
1

0
1

9

7

6

5

4

3

2

1

3
-
6
9
-
8
2
0
7
5

r
e
m
y
l
o
P

3
1

2
1

1
1

0
1

1
1

0
1

9

9

8

6

4

4

3

3

2

2

1

8
-
0
5
-
3
0
4
1
9

r
e
m
y
l
o
P

1
-
3
3
-
7
6
6
4
9

r
e
m
y
l
o
P

R
F

R
F

T
I

i

i

m
u
n
d
n
a
u
g

i

i

e
n
m
a
i
d
n
e
l
y
h
t
e
m
a
x
e
h
(
y
l
o
P

)
e
d
i
r
o
h
c

l

-
2
[
-
.
a
h
p
l
a
.

,
)
l
y
i
d
e
n
a
h
t
e
-
2
1
-
y
x
o
(
y
l
o
P

,

i

)
e
d
n
a
u
g
i
b
e
n
e
l
y
h
t
e
m
a
x
e
h
(
y
l
o
P

3
1

0
1

7

6

3
-
7
0
-
6
4
5
1
9
1

r
e
m
y
l
o
P

U
H

-
e
n
a
p
o
r
p

d
n
a

l
a
n
e
p
o
r
p
-
2

f
o

r
e
m
y
l
o
p
o
C

)
t
l
a
s
(

e
t
a
o
n
a
p
o
r
p

,
-
y
x
o
r
d
y
h
-
.
a
g
e
m
o

.

i

-
]
l
y
h
t
e
)
o
n
o
m
m
a
l
y
h
t
e
m
l
y
c
e
d
d
(

i

l

i

o
d
-
2
1

,

0
2

3
1

2
1

1
1

0
1

9

7

6

5

4

3

2

1

5
-
1
9
-
2
7
5
4
7
3

r
e
m
y
l
o
P

R
F

-
i
n
a
u
g
l
y
h
t
e
y
x
o
h
t
e
)
y
x
o
h
t
e
-
2
(
-
2
(
o
g
i
l

O

e
t
a
r
o
b

i

m
u
n
o
m
m
a
l
y
h
t
e
x
o
y
l
o
p
l
y
c
e
d
D
/
e
t
a
r
o
b

i

3
1

2
1

1
1

0
1

9

8

6

2

6
-
4
3
-
0
1
7
4
1
2

r
e
m
y
l
o
P

L
E

i

m
u
n
o
m
m
a
y
x
o
h
t
e
y
l
o
p
d
-
N

i

-
l
y
c
e
d
D
N

-

i

)
e
d
i
r
o
h
c

l

m
u
n
d

i

i

r
e
m
y
l
o
p
o
c

r
e
h
t
e
)
l
y
h
t
e
o
r
o
h
c
-
2
(
s
i
b
e
n
m

l

i

.

C
A
D
D

l

/
)
s
e
t
a
h
p
u
s
l
y
h
t
e
m

.

C
K
B
/
)
s
e
d
i
x
o
r
d
y
h

r
o

r
o

i

,
s
e
d
m
o
r
b

,
s
e
d
i
r
o
h
c

l

i

,
s
e
d
m
o
r
b

,
s
e
d
i
r
o
h
c

l

)
l
y
k
l
a

)
l
y
k
l
a

a
y
o
s

a
y
o
s

d
n
a

d
n
a

,
l
y
k
l
a

,
l
y
k
l
a

o
c
o
c

o
c
o
c

,
l
y
k
l
a

,
l
y
k
l
a

w
o

l
l
a
t

w
o

l
l
a
t

d
n
a

,

d
e
t
a
r
u
t
a
s
n
u

d
n
a

d
e
t
a
r
u
t
a
s

,

d
e
t
a
r
u
t
a
s
n
u

d
n
a

d
e
t
a
r
u
t
a
s

,
2
2
C
-
8
C

m
o
r
f

l
y
k
l
a
(

i

l
y
h
t
e
m
d
l
y
k
l
a
l
y
z
n
e
b
(

s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

m
o
r
f

l
y
k
l
a
(

i

l
y
h
t
e
m
d
l
y
k
l
a
i
d
(

s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

.

C
A
M
T
/
)
s
e
t
a
h
p
u
s
l
y
h
t
e
m

l

r
o

i

,
s
e
d
m
o
r
b

,
s
e
d
i
r
o
h
c

l

)
l
y
k
l
a

a
y
o
s

d
n
a

,
l
y
k
l
a

o
c
o
c

,
l
y
k
l
a

w
o

l
l
a
t

d
n
a

,

d
e
t
a
r
u
t
a
s
n
u

d
n
a

d
e
t
a
r
u
t
a
s

m
o
r
f

l
y
k
l
a
(

l
y
h
t
e
m

i
r
t
l
y
k
l
a
(

s
d
n
u
o
p
m
o
c

i

m
u
n
o
m
m
a

y
r
a
n
r
e
t
a
u
Q

,
8
1
C
-
6
C

,
8
1
C
-
8
C

y
b

y
b

y
b

d
e
r
e
v
o
C

d
e
r
e
v
o
C

d
e
r
e
v
o
C

)
1
(

)
2
(

)
3
(

11.12.2007

EN

Official Journal of the European Union

L 325/65

ANNEX III

Requirements for the complete dossier and the summary dossier

(a) The complete dossier must include the original test and study reports for each point of Annex IIA and IIB, or Annex
IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB thereto, together
with the summary dossier referred to in Article 11(1)(b) of that Directive.

(b) The summary dossier must include the following:

— in the case of a collective dossier, the name of all participants concerned and a person designated by them as
being responsible for the collective dossier and the processing of the dossier in accordance with this Regulation,

— for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the

relevant parts of Annex IIIA and IIIB to the Directive, the summaries and results of studies and trials,

— list of references used,

— risk assessment,

— overall summary and assessment,

— a check by the participant or, where appropriate, by the person designated as responsible for a collective dossier of

the completeness of the dossier.

(c) The formats made available by the Commission must be used for submission of the dossiers. In addition, the special
software package (IUCLID) made available by the Commission must be used for those parts of the dossiers to which
IUCLID applies. Formats and further guidance on data requirements and dossier preparation are available on the ECB
homepage http://ecb.jrc.it/biocides

(d) For existing active substances that have been or are being evaluated under the review programme for plant protection
products in accordance with Article 8(2) of Council Directive 91/414/EEC of 15 July 1991 concerning the placing of
plant protection products on the market (1), the required format for an application for inclusion in Annex I thereto
may be used for the preparation of the dossier for inclusion of the existing active substance in Annex I, IA or IB to
Directive 98/8/EC, taking into account relevant differences in the dossier requirements. A summary of the dossier
must be entered in IUCLID. Additional information related to the biocidal use must be submitted in accordance with
the requirements of this Regulation.

(1) OJ L 230, 19.8.1991, p. 1.